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People with serious mental illness (SMI) die 15-20 years earlier than the general population, 
principally from cardiovascular and respiratory disease. Under-recognition and under-treatment of the 
physical health needs of people with SMI is one of the biggest health inequalities in England. Despite 
growing policy attention, evidence suggests the mortality gap between people with and without SMI 
is widening. This thesis aimed to enhance understanding about factors affecting the quality of primary 
care for people with SMI. 
Methods  
Mixed methods. Qualitative: thematic analysis of semi-structured interviews provided new insights 
from patients and practitioners on the quality of primary care. Quantitative: a difference-in-differences 
approach used to estimate the effect of removal of financial incentives on the proportion of patients 
who had physical health checks (blood pressure/BMI/cholesterol/glucose) recorded in primary care. 
Using a process of triangulation, findings from contrasting paradigms were synthesised. 
Results 
Qualitative study: quality of care for people with SMI is inadequate. Patient and practitioner 
aspirations for continuity and patient-centred care, increasingly undermined by new models of care 
delivery; Quality and Outcomes Framework (QOF) regarded as having been detrimental by 
prioritising a biomedical box ticking agenda in favour of holistic care; and a breakdown in 
communication between primary care and mental health services further eroded quality of care. 
Quantitative study: each difference-in-differences estimate for indicators where financial incentives 
were removed, compared with blood pressure which remained incentivised, indicated a significant 
decrease (p<0.01) in the proportion of patients with health checks recorded: BMI (-14.6%), 
cholesterol (-9.8%) and glucose (-8.8%). 
Conclusion 
Despite growing interest in addressing the mortality gap, policy has focused on a biomedical approach 
in attempts to extend life expectancy, at the expense of addressing what matters to patients: being able 
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Chapter One introduces the thesis and provides evidence of the poor physical health and reduced life 
expectancy faced by people with serious mental illness (SMI).  
Chapter Two sets out the context for the qualitative and quantitative research studies, the two core 
components of this thesis, by discussing existing literature on the effects of financial incentive 
schemes in primary care. The chapter concludes by defining the aims and objectives of the thesis.   
Chapter Three discusses the research methodology and the contrasting philosophical underpinnings 
of the different paradigms selected for the mixed methods approach adopted for this thesis.  
Chapter Four describes the methods used to carry out the qualitative study and considers the 
strengths and limitations.  
Chapter Five presents the results from the qualitative study, which explored patient and practitioner 
perspectives on factors believed to enhance or erode the quality of primary care.  
Chapter Six describes the methods used to carry out the quantitative study and considers the 
strengths and limitations.  
Chapter Seven presents the results from the quantitative study, which examined electronic health 
records data to estimate the effect that removal of financial incentives had on the proportion of 
patients who received a physical health check.  
Chapter Eight summarises what the research found and discusses what the findings mean in the 
context of existing literature. It presents the strengths and limitations specific to this thesis and 
synthesises findings from the contrasting paradigms. The chapter then considers the implications of 





Chapter One: Introduction  
 
1.1 Chapter content 
This chapter provides the context for the thesis. It begins by summarising the characteristics and 
epidemiology of schizophrenia and bipolar disorder, the two psychiatric conditions central to the 
research. It then provides background information on the poor physical health and reduced life 
expectancy associated with serious mental illness. The chapter goes on to summarise policy attempts 
to reduce the mortality gap, highlighting the need for further research to provide new insights into 
how to better meet the physical health needs of people with serious mental illness.  
1.2 Serious mental illness 
The term ‘serious mental illness’ (SMI) – also known as ‘severe mental illness’ or ‘severe mental 
disorder’ – is used in the scientific literature to refer to a group of serious, and typically enduring, 
mental health conditions. SMI refers principally to schizophrenia and bipolar disorder but includes 
other non-organic psychoses such as schizoaffective disorder and psychotic depression (Keeley et al., 
2015, NHS England, 2018a). Whilst it is recognised that SMI encompasses several other conditions, 
this thesis focuses on schizophrenia and bipolar disorder. Hence, from now on the term SMI refers to 
people with schizophrenia or bipolar disorder, unless otherwise specified. 
1.2.1 Diagnostic criteria 
The two diagnostic classification systems most commonly used in psychiatry are the World Health 
Organisation’s International Classification of Disease, 10th revision (ICD-10) and the American 
Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) 
(American Psychiatric Association, World Health Organziation). Both diagnostic classification 
systems share similar definitions for schizophrenia and for bipolar disorder.  
Schizophrenia is a condition characterised by: positive symptoms (also known as psychotic 
symptoms) which include disturbed thoughts, hallucinations, delusions; and negative symptoms such 
as social withdrawal and neglect of daily routine (Saha et al., 2005).  Bipolar disorder, formerly 
known as manic depression, is a severe mood disorder characterised by extreme highs (known as 
mania) as well as periods of extreme lows, marked by depressive symptoms (Rowland and Marwaha, 
2018). Typically, people with bipolar disorder experience periods of stable mood between episodes. 
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Both these conditions profoundly impair a person’s level of functioning and negatively impact on 
quality of life. Although people can ‘recover’ to some extent, and regain aspects of functioning they 
had lost, they cannot be ‘cured’ and many endure substantial disruption across the life course 
(Ruggeri, 2000).  
1.2.2 Epidemiology  
The aetiology of serious mental illnesses is uncertain and multifactorial (Addington et al., 2018). For 
both schizophrenia and bipolar disorder onset is attributable to a complex array of risk factors rather 
than being determined by a single cause (Rowland and Marwaha, 2018). Furthermore, evidence 
suggests that interaction between multiple risk factors substantially increases the likelihood of a 
person developing a serious mental illness, although knowledge of which combinations of factors 
present the highest risk is limited (Zammit et al., 2010). At present, there are a number of known 
biological, socioeconomic and environmental risk factors, including: genetics, age, gender, ethnicity, 
deprivation level, traumatic life experiences, living in an urban area, and social isolation (Kirkbride et 
al., 2012). Moreover, evidence suggests that living in areas characterised by social fragmentation 
increases the risk of serious mental illness independent of deprivation or urban/rural status (Allardyce 
et al., 2005).  
Schizophrenia 
Lifetime prevalence of schizophrenia is approximately 1 per cent of the population (McGrath et al., 
2008) coupled with a relatively stable incidence over time (Kirkbride et al., 2012).  Men tend to have 
earlier onset of schizophrenia, typically between the ages of 15-25 years (Häfner et al., 1993) and men 
also have a higher incidence (Ochoa et al., 2012). Furthermore, schizophrenia appears to be more 
common in urbanised areas and among migrant populations (McGrath et al., 2004).  
Bipolar disorder 
Lifetime prevalence of bipolar disorder is around 1 to 1.5 percent of the population (Bebbington and 
Ramana, 1995). Incidence has increased slightly following the inclusion of bipolar II to the DSM-IV 
(Ferrari et al., 2016). Bipolar II is a less severe form of the condition on the bipolar disorder spectrum, 
for individuals who have never experienced a full blown manic episode (American Psychiatric 
Association, 1994). Typically women have an increased risk of bipolar II though gender ratios for 
bipolar disorder are relatively equal (Diflorio and Jones, 2010). As with schizophrenia, men appear to 
have an earlier onset of bipolar disorder (Kennedy et al., 2005) although evidence suggests that there 
are two peaks when men and women are more likely to present with bipolar disorder: during early 
adulthood (15-24 years) or later in life (45-54 years) (Kroon et al., 2013). 
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1.3 Health inequalities 
Evidence of a 15-20 years mortality gap across the developed world suggests that men with SMI tend 
to die 20 years earlier, and women 15 years earlier, than those without SMI (Thornicroft, 2011). This 
is one of the biggest health inequalities of the modern era with the mortality gap for SMI far 
exceeding those attributed to smoking or type 2 diabetes (Chang et al., 2011). Moreover, the early 
deaths are predominantly attributable to common physical health conditions such as cardiovascular 
and respiratory disease (Correll et al., 2017), which tend to be managed better in people without SMI 
(Osborn et al., 2011). Furthermore, evidence suggests the health inequalities are more pronounced at 
younger ages, so that the relative risk of an individual with SMI developing diabetes or COPD is far 
greater when they are younger than when they are older where the difference in risk level between 
those with and those without SMI narrows (Public Health England, 2018). 
The reasons why people with SMI have a shorter life expectancy than the average person are complex 
and multifactorial, which may explain why the mortality gap has proved difficult to address. Health 
inequalities are deeply rooted in the fabric of society and underpinned by numerous socioeconomic 
and environmental factors. Consequently, people with SMI tend to face multiple challenges to stay 
healthy and carry an increased risk of developing common physical conditions such as heart disease 
and diabetes (Pearsall et al., 2014, Osborn et al., 2011). They often have higher levels of health need 
than the average person but poorer access to health services (Robson and Gray, 2007). They are less 
likely to seek help; to have their health needs met; or to be targeted for health promotion activities 
such as smoking cessation (Connell et al., 2012).  
The risk of premature death among people with SMI is increased by unhealthy diets, physical 
inactivity and addictive behaviours such as smoking, alcohol and substance misuse (Reilly et al., 
2015, Lester et al., 2010). The physical health of people with SMI is further burdened by adverse 
metabolic effects and weight gain caused by psychotropic medication, principally from anti-
psychotics (De Hert et al., 2011). In addition, people with SMI are likely to be subjected to the largely 
unknown effects of polypharmacy and interactions from medications prescribed to treat physical 
health comorbidities and/or multiple types of psychotropic drugs (RCPSYCH, 2015a, RCPSYCH, 
2015b).  
People with SMI face additional challenges looking after their physical health due to aspects relating 
to their mental health which may include self-neglect, lack of motivation and difficulty 
communicating their health needs (Kirkbride et al., 2012, Lawrence and Kisely, 2010). Added to this 
are structural socio-economic inequalities, often marked by poor housing and living conditions, social 
isolation and exclusion, poverty and unemployment (Luciano and Meara, 2014).  
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1.4 Mortality gap: ‘lethal discrimination’  
The mortality gap persists despite having been targeted by a number of policy initiatives over recent 
years such as the Quality and Outcomes Framework (NHS Employers), Parity of Esteem (Davies, 
2014), the Five Year Forward View (NHS England et al., 2014), the Five Year Forward View for 
Mental Health (The Mental Health Taskforce, 2016) and the NHS Long Term Plan (NHS, 2019). 
Indeed, evidence suggests the mortality gap is widening rather than narrowing (Lomholt et al., 2019, 
Hayes et al., 2017, Saha et al., 2007). This implies that existing policy attempts to address the 
inequality have thus far been ineffective at closing the mortality gap.   
Evidence that people with SMI die at younger ages than people without SMI from the same types of 
physical health conditions, such as lung and heart disease, is a huge social injustice and one of the 
biggest health inequalities in England (NHS England, 2014a, Yeomans et al., 2014, NHS England, 
2014b, RCPSYCH, 2013). It is unacceptable that in high income countries such as the UK, the life 
expectancy of people with SMI is equivalent to the average adult in the 1950s (Public Health England, 
2019). This inequality has been categorised as an issue of human rights (Lawrence and Kisely, 2010) 
and labelled as ‘lethal discrimination’ (Thornicroft, 2013: online). 
1.5 Gaps in knowledge 
Even though the problem of premature mortality is well recognised and has become topical, there 
seems to be uncertainty about how to tackle it effectively. Evidence the mortality gap is widening 
underscores the need for critical appraisal of existing evidence and further research about how to 
better address the problem. Efforts to improve the physical health of people with SMI include the 
Lester Tool (Shiers et al., 2014) designed to optimise the conduct of physical health checks for people 
with SMI and reports by royal colleges and faculties (RCPSYCH, 2016). In addition, an expanding 
scientific literature includes systematic reviews and meta-analyses of physical activity interventions 
(Rosenbaum et al., 2014) and the effect of exercise on sleep (Lederman et al., 2019), as well as a 
number of randomised controlled trials on modifiable risk factors such as smoking and cardiovascular 
disease (Gilbody et al., 2019, Osborn et al., 2018). The Lancet Psychiatry Commission’s recent 
‘blueprint’ for protecting physical health in people with mental illness (Firth et al., 2019a) further 
demonstrates a building of momentum in attempts to address the health inequalities. Much of this 
activity, however, has focused on interventions to support health promotion for SMI through 
behaviour change such as giving up smoking, which focuses on the individual and may have limited 
reach. Moreover, evidence on the effectiveness of interventions targeted at improving physical health 
outcomes of people with SMI remains limited (Vancampfort et al., 2019).  
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So far, little is known about system level solutions that may enhance quality of care and improve the 
physical health of people with SMI at the population level, thereby reducing the risk of premature 
mortality. To expand understanding about other factors underpinning the mortality gap, in addition to 
risky behaviours such as smoking and a sedentary lifestyle, it is timely to explore the perspectives of 
people with lived experience of managing SMI, by speaking to patients and practitioners about what 
factor enhance or erode the quality of primary care: to provide insight into what is happening in 
practice. This should provide pointers and new evidence from a different angle on how to address the 
mortality gap and improve both the quality and longevity of life for people with SMI.    
1.6 Rationale for this thesis 
The management of serious mental illness is conducted principally within primary care and specialist 
secondary care mental health settings. Typically, it is primary care where people with SMI have most 
of their physical health needs met (Planner et al., 2014) – regarded as the cornerstone of healthcare for 
people with SMI (Lester et al., 2005) – and secondary care where their mental health needs are 
addressed. However, both care settings have responsibilities for monitoring the physical health of 
people with SMI as those that are more difficult to manage are monitored in secondary care until their 
condition has stabilised when their care is transferred to primary care (NICE, 2018)..  Primary care 
thus has the substantive responsibility for meeting the physical health needs of people with SMI: 
indeed, up to 30 per cent of SMI patients in the UK are seen only in the primary care setting (Reilly et 
al., 2012). Consequently, primary care has a pivotal role in addressing the mortality gap, which 
accounts for why both of the research studies conducted for this thesis are based in the primary care 
setting. Following on from this introduction, Chapter Two sets out the context for the qualitative and 
quantitative research studies, the two core components of this thesis, by discussing existing literature 
on the effects of financial incentive schemes in primary care. It also defines the aims and objectives of 
the thesis.  
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Chapter Two: Financial Incentives in Primary Care   
2.1 Chapter content  
This chapter provides background to the qualitative and quantitative research studies conducted for 
this thesis by exploring evidence on the effects of pay-for-performance in primary care. It begins by 
outlining the historical context and development of financial incentives in general practice before 
focusing on the Quality and Outcomes Framework (QOF), which was introduced nationwide across 
the UK in 2004. It goes on to critically examine evidence on the effectiveness of QOF with reference 
to a selection of primary research studies and systematic reviews. A scarcity of evidence on the 
impact of QOF financial incentives on the quality of care for people with serious mental illness 
underpins the rationale for the thesis. The chapter concludes by defining the aims and objectives of 
the thesis.   
2.2 Overview of financial incentives 
The origins of financial incentive schemes stem from a social sciences behavioural economics 
paradigm, drawing on aspects of psychology and economics to influence human behaviour (Vlaev et 
al., 2019). Widely used across a range of industries in the private and public sector, financial 
incentives have, in recent decades, become increasingly popular amongst health policymakers as a 
tool to promote quality improvement (Roland and Olesen, 2016). Also termed pay-for-performance 
the intent of financial incentives is to motivate behaviour change (Michie and West, 2013). In the 
context of healthcare, the intended outcome is either to improve the quality of care by motivating 
practitioners to change their actions and/or meet targets (Conrad and Perry, 2009), or by rewarding 
patients to adopt healthier behaviours (Marteau et al., 2009). Given the continuous rising costs of 
healthcare across the world, interest in the potential for pay-for-performance to improve quality of 
care has grown markedly, particularly in high-income countries in Europe, North America and 
Australasia (Christianson et al., 2009). 
To date, however, despite extensive discussion and evaluation of the effectiveness of pay-for-
performance schemes on quality of care, evidence remains uncertain and inconclusive (Mandavia et 
al., 2017). A Cochrane meta-review found that whilst there is limited evidence that financial 
incentives may be effective at changing process and practice, there is no evidence that they affect 
patient outcomes (Flodgren et al., 2011). Indeed, a more recent review underpinned those findings, 
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stating that studies typically focus on process measures rather than health outcomes (Ogundeji et al., 
2016), which produces evidence on measures of clinical activity rather than outcomes.  
2.3 Pay-for-performance in primary care in the United Kingdom  
Before the Quality and Outcomes Framework (QOF) was introduced in 2004, primary care in the UK 
had relatively limited experience of pay-for-performance (Roland, 2004) with practice funding 
comprising largely of capitation payments (Rhys. G et al., 2010). Indeed, capitation was the principal 
payment system in England and provided core practice funding based on the number of patients in a 
population rather than on the amount or type of care delivered (BMA, 2017). However, there were a 
few examples of early pay-for-performance schemes prior to the QOF (Horder et al., 1986). During 
the 1990s evidence emerged from two different quality improvement initiatives, which indicated that 
financial incentives can be effective at improving clinical activity. The first involved practices being 
offered payment if they vaccinated a high proportion of children with the MMR vaccine (Middleton 
and Baker, 2003). The second offered payments to practices who achieved high rates of cervical 
screening (Baker and Middleton, 2003). Both studies provided evidence that financial incentives had a 
positive effect, increasing coverage as intended. Moreover, for cervical screening financial incentives 
had a positive effect on reducing inequality as they resulted in an increased proportion of women from 
more deprived areas attending practices for a smear test. 
2.4 Quality of care 
Quality of care is a complex term which is challenging to define, particularly in the context of primary 
care, as it relates to an array of different – sometimes competing – elements. As such, the World 
Health Organisation asserts that a culture of quality needs to be embedded in primary care to foster 
sustainable quality improvement of healthcare (WHO, 2018). There are a number of core aspects, 
however, which appear central to defining quality of care including: access, holistic care, patient-
centred care, continuity of care, coordination of care, treatment effectiveness and clinical safety 
(Goodwin et al., 2011). Evidence suggests that quality of care in primary care was improving prior to 
the introduction of the QOF (Campbell et al., 2005) as a result of the development of clinical IT 
systems in the late 1990s (de Lusignan and Chan, 2008), and a number of reforms introduced by the 
New Labour government to raise standards, and to increase efficiency and equity in the care delivered 





2.5 Quality and Outcomes Framework  
2.5.1 Overview 
The UK Quality and Outcomes Framework (QOF) is an annual incentive scheme that financially 
rewards general practices for achieving targets for evidence-based indicators developed by the 
National Institute for Health and Care Excellence (NICE) (Sutcliffe et al., 2012). Introduced in 2004, 
it was at the time the largest and most comprehensive pay-for-performance scheme in the world 
(Roland, 2004). Driven by decades of underinvestment compared with other health services, the 
principal aim of the QOF was to improve the quality of care across the nation and reduce variation 
within primary care, which had become an increasing concern (Doran et al., 2006). Given that QOF 
was a national scheme, however, it did not provide the opportunity to address healthcare needs at the 
local level (Roland and Olesen, 2016). From the outset QOF encompassed all nations in the United 
Kingdom: until 2016, when Scotland abolished the QOF (Roland and Guthrie, 2016).  
QOF payments supplement core practice funding (capitation payments), which is based on the 
number of patients registered at a practice after adjustment for certain patient and geographical area 
characteristics (NHS Digital, 2017). The QOF financially rewards practices based on their 
achievement in relation to individual indicators by a payment-per-point system. Since the QOF was 
introduced, payment-per-point has risen from £76 in the first year 2004/05, to £188 in 2019/20 (NHS 
England, 2019a) though this has not resulted in practices being paid more as the number of QOF 
indicators has been reduced. Furthermore, the QOF now accounts for a smaller share of overall 
practice income. (Moberly and Stahl-Timmins, 2019). However, there still remains wide geographic 
variation in how much income practices derive from the QOF. For example, in  2017/18 QOF 
payments accounted for more than 11% of income for some practices in England whilst for others it 
was less than 1% (NHS England, 2018b). 
The QOF consists of a complex set of indicators divided into four domains: clinical care; practice 
organisational; patient experience and additional services (HSCIC, 2005). Although serious mental 
illness has been part of the clinical domain since the inception of the QOF (along with common 
chronic conditions such as cardiovascular disease, diabetes, asthma and COPD) (NHS Confederation, 
2004) research studies investigating the effectiveness of QOF indicators have tended not to include 
SMI. Generally, the QOF does appear to have narrowed the gap in performance between the least and 
most deprived practices, though the evidence on whether it has reduced health inequalities and 
improved outcomes for patients from more deprived practices remains limited (Dixon A et al., 2011). 
It has been argued, however, that offering financial rewards to meet certain targets based on clinical 
activity or the recording of measurements forces practitioners to make compromises on the quality of 
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care they deliver given the time constraints imposed under the current system of primary care 
(Peckham and Wallace, 2010). 
2.5.2 Evidence on the effectiveness of the QOF 
Evidence on the effectiveness of the QOF derives largely from quantitative studies, which have 
examined its impact on clinical activity for a range of long-term conditions incentivised by the QOF. 
Fewer studies have used qualitative methods to explore the effectiveness of the QOF.  
Quantitative evidence 
Quantitative studies examining the effectiveness of the QOF have tended to use observational data to 
conduct research using retrospective longitudinal designs: from primary care databases (Calvert et al., 
2009, Serumaga et al., 2011) or from IT systems supporting the QOF (Kontopantelis et al., 2012).  
Effectiveness is typically defined by performance level as measured by achievement of QOF 
indicators, but this indicates clinical activity rather than patient outcomes. Although numerous studies 
have examined the impact of the QOF on aspects of clinical activity, evidence of its effectiveness at 
improving the quality of primary care remains weak (Doran et al., 2017). Indeed, systematic reviews 
appraising evaluations of the QOF have consistently concluded that the evidence is uncertain and 
inconclusive (Gillam et al., 2012, Langdown and Peckham, 2014, Houle et al., 2012, Emmert et al., 
2012, Forbes et al., 2017, Mandavia et al., 2017). Furthermore, in 2018 NHS England reviewed 
outcomes of the QOF (NHS England, 2018b) concluding that the scheme needs to be refreshed to 
deliver better patient-centred care and support the growth and sustainability of practices. 
Effectiveness of the QOF on quality of care for SMI  
Evidence is particularly sparse in relation to the impact of QOF financial incentives on people with 
serious mental illness. Only one study (Kontopantelis et al., 2015b) has focused specifically on the 
impact of clinical indicators targeted at SMI patients. Examining the effect of QOF incentives on 
consultation rates, it found the frequency of contact between SMI patients and practitioners increased. 
However, it was unable to determine whether the increase in monitoring had any effect on patient 
outcomes.  
Removal of incentives  
A few studies have examined the effect of withdrawal of incentives on the quality of care documented 
to determine if there is any continued effect in clinical activity after financial incentives have been 
removed. However, the evidence is both limited and inconsistent. In 2014, a study by Kontopantelis et 
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al (2014) found that removal of incentives across a range of clinical indicators did not have a 
significant effect on performance with levels of recorded activity remaining relatively stable in 
subsequent years. In contrast, findings from later studies produced different results. In 2018, NHS 
England commissioned a group of experts to examine changes in recorded achievement of indicators 
across a range of clinical diseases where QOF incentives had been removed. Results showed there 
was an immediate decrease in the proportion of patients who had an indicator recorded in the first 
year after incentives were removed (Wilding et al., 2018). Another study (Minchin et al., 2018) 
demonstrated similar findings showing significant decreases in documented quality of care measures 
in the year directly after incentives were removed.  
Qualitative evidence  
Fewer studies have used qualitative methods to explore perceptions of the impact of QOF on quality 
of care (Gillam et al., 2012), and those that have tended to focus solely on provider experiences. One 
study (Campbell et al., 2008) which explored practitioner views found that whilst there were 
noticeable improvements in disease-specific aspects of care and the recording of data, there were also 
unintended consequences, including less scope to deliver patient-centred care. This was similar to 
another study (Maisey et al., 2008) which found that disease-specific aspects of care had improved 
and the role of practice nurses had increased, but that GPs felt the QOF had compromised their 
capacity to listen to patients concerns, which undermined a core aspect of quality of care. Closely 
aligned to this was a study by Lester et al (2013) which found that although the QOF was generally 
welcomed, GPs questioned its impact on their clinical autonomy and decision making skills. 
However, very little is known about patient views of the QOF and its impact on quality of care 
(Gillam, 2015). One study by Lester et al (2011), which conducted focus groups with patients as well 
as practitioners, found that the QOF negatively impacted on person-centred care and prioritised 
incentivised procedures over non-incentivised procedures. Furthermore, findings from a study by 
Hannon et al (2012) indicated that most patients were not aware of the QOF and few could identify 
any changes to quality of care or the way in which their care was delivered. 
2.6 Rationale for this thesis 
At present, evidence that the QOF has produced improvements in quality of care in any of its clinical 
areas is unclear (Mandavia et al., 2017, Forbes et al., 2017). Although there is some evidence that 
financial incentives influence practitioner behaviour (Vlaev et al., 2019) and increase clinical activity 
in incentivised domains (Peckham and Wallace, 2010), there is concern that unintended consequences 
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of the QOF adversely affect patient-centred care (Lester et al., 2011). Evidence on the effectiveness of 
the QOF at enhancing the quality of care stems principally from studies which have used 
observational data to quantitatively examine changes in activity relating to quality indicators, though 
these are measures of process not outcome. Fewer studies have examined the effect of the QOF on 
outcomes such as mortality (Kontopantelis et al., 2015c, Ryan et al., 2016) and/or hospital admissions 
(Ride et al., 2019, Ride et al., 2018), which can be used as proxies for quality of care. Virtually no 
studies have investigated the effect of the QOF on patient reported outcomes (McShane and Mitchell, 
2015). 
Several qualitative studies have explored practitioner views of how QOF affects quality of care 
(Campbell et al., 2008, Maisey et al., 2008, Gillam et al., 2012, Lester et al., 2013) as well as a few 
that have explored patient views (Hannon et al., 2012). Given that the evidence on the effectiveness of 
the QOF for all its clinical areas is uncertain and largely unconvincing (Gillam, 2015, Forbes et al., 
2017), there remain gaps in knowledge about the impact of the QOF on the quality of primary care. 
Furthermore, as discussed earlier, evidence is particularly sparse relating to how the QOF affects 
quality of care for people with serious mental illness.  
This thesis therefore aims to expand the quantitative and qualitative evidence base about the role of 
financial incentives for the management of SMI, to deepen understanding about the impact of such 
incentives on the quality of care for this population.  
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2.7 Aims and objectives of the thesis 
2.7.1 Aims 
This thesis aims to assess the association between the QOF financial incentive scheme and the quality 
of care for people with SMI, and to provide new insights into what quality of care means for people 
with SMI. The overarching aim is to produce evidence that will provide pointers about how the 
quality of primary care can be enhanced to improve SMI patients’ physical health, so they can live 
longer, healthier lives. The five main objectives underpinning this central aim will be examined using 
a mixed methods approach.  
2.7.2 Objectives 
Qualitative research study 
1) To explore how people with SMI perceive and experience quality of care in general practice.  
2) To explore practitioner perspectives on the quality of care provided to people with SMI in 
general practice.  
Quantitative research study 
3) To assess if removal of financial incentives for three QOF indicators impacted on the 
proportion of SMI patients who received physical health checks. 
4) To compare rates of health check where incentives were removed with an indicator where 
incentives remained. 
5) To investigate if certain types of patients were more likely to receive a physical health check. 
This is the first study to address these specific objectives using a mixed methods approach, with the 





Chapter Three: Methodology 
3.1 Chapter content 
The previous chapter examined the literature relating to quality improvement in healthcare and 
underlined the aims of the thesis, its objectives and research questions. This chapter provides rationale 
for the research methodology adopted to guide the mixed methods approach, selected as the best way 
of meeting the aims of this thesis. It outlines the longstanding philosophical debates relating to 
different ontological and epistemological beliefs about how the world is viewed and what counts as 
knowledge. It then discusses how these philosophical standpoints informed decisions about what type 
of methods were used in this thesis.  It goes on to compare differences in how quality is assessed for 
quantitative and qualitative approaches. The chapter then explains why a mixed methods approach 
was chosen to address a complex research question, concluding that using different methodological 
approaches and methods adds value to study findings by providing a broader and deeper 
understanding of the topic. 
3.2 Philosophical underpinnings 
Different research paradigms such as the natural world paradigm or social world paradigm reflect 
different ways of thinking about the world and are shaped by two core concepts, ontology (the nature 
of reality) and epistemology (the theory of knowledge). For centuries many complex and opposing 
understandings about how we view the world have been contested and debated. Indeed, disagreement 
over the theoretical and philosophical underpinnings of research methodologies continues today.  
However, research paradigms and their ontological and epistemological stances offer researchers 
guidance about the best methodological framework to adopt to structurally support their methods. 
Researchers, therefore, choose to adopt a particular ontological and epistemological position 
depending on their own personal beliefs and the aims of their research study.  
3.2.1 Ontology 
The natural world paradigm emerged during the period of Enlightenment and was characterised by the 
concept of realism, which believes there is a single truth and that external reality is not dependent on 
human factors (Guba, 1990). However, given the aims of this thesis a different understanding of what 
reality is and how the world is viewed was required. Consequently, a post-realist ontological approach 
was adopted, which views reality from a social world paradigm (Lincoln and Guba, 1985) with the 
belief there is no single reality given the complexity of the world, and that multiple realities can only 
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be understood through human experiences (Ritchie and Lewis, 2003). A post-realist paradigm seemed 
a preferable guide to address the research questions of this thesis, to enable different accounts of 
reality to be explored through human experiences of healthcare. 
3.2.2 Epistemology  
Epistemology relates to the theory of knowledge, how it is created and what is accepted as credible 
knowledge. Different epistemological stances reflect different world views.  A positivist approach, 
stemming from a natural sciences paradigm, believes knowledge is created objectively and acquired 
deductively. Positivism believes the research process and production of knowledge is neutral, 
unaffected by the researcher (Neuman, 2000). In contrast, a social sciences paradigm believes 
research cannot be objective or neutral as researchers unavoidably, even if unintentionally, impact on 
the research process due to human nature (Mason, 2002).  
Given that one of the primary aims of this thesis was to explore the experiences of SMI patients and 
primary care practitioners, a social constructionist post-positivist approach was adopted in the belief 
that knowledge is subjective and acquired inductively, constructed by people who attach meaning to 
their experiences (Guba and Lincoln, 1994).  This was a pragmatic decision as it was deemed the most 
appropriate way to guide the aims of the thesis which include research questions relating to quality of 
care from contrasting research paradigms: a qualitative approach exploring human experiences to 
address what and why questions; and a quantitative approach using numerical data to address 
questions about how many and how much (Green and Thorogood, 2004).  
3.3 Assessing quality in research    
Given the opposing ontological and epistemological positions held by the natural science and social 
science paradigms, it is not surprising that there has been continuous debate in the scientific literature 
about whether or not concepts such as reliability and validity, originally coined for quantitative 
research, can be applied to qualitative research. These concepts stem from a natural sciences paradigm 
and focus on standardising measurements and controlling external variables to determine causality, 
hence they do not fit readily with the different philosophical underpinnings of social sciences. 
Consequently, questions have been raised about alternative ways to assess quality in qualitative 




3.3.1 Reliability or trustworthiness 
The concept of reliability emerged from a positivist philosophy. It relates to replicability and whether 
findings would reoccur if the same methods were adopted for another study. In qualitative research 
the notion of replicability is contested, however, given the belief that there is no single reality 
(Lincoln and Guba, 1985). Furthermore, given that qualitative research is a dynamic process where 
researchers are required to respond to participants, precise replication of the same methods is rarely 
possible. Consequently, the concept of ‘trustworthiness’ (Glaser and Strauss, 1967) has been deemed 
a better way to assess the quality and soundness of qualitative research. This has led to an emphasis 
on truth and transparency as core aspects of assessing quality (Lincoln and Guba, 1985). In an attempt 
to demonstrate trustworthiness for the qualitative research undertaken for this thesis, a detailed and 
transparent description of the methods is provided in the proceeding chapter, to enable readers to 
assess the quality of the research for themselves. Furthermore, a statement of reflexivity in Chapter 
Eight provides evidence of critical reflection on the research process. 
3.3.2 Validity or credibility  
The concept of validity also stems from a positivist approach about how knowledge is created. It 
relates to assessing the precision of data and accuracy of findings to determine if a study is sound and 
robust. The quantitative part of this study focused on internal validity (quality of data) and external 
validity (how well the findings translate to the real world).  However, due to its numerical focus 
validity is an inappropriate concept for the qualitative part of the study where alternative concepts 
such as ‘plausibility’ and ‘credibility’ (Glaser and Strauss, 1967) seemed more relevant. This thesis 
aimed to demonstrate credibility for the qualitative study by illustrating how interpretation of findings 
meaningfully reflects the data (Mays and Pope, 2000). Given that qualitative results are so dependent 
on context and the individuality of participants, however, it was not expected that results would be 
readily generalisable to other settings (Patton, 1999).  
3.3.3 Reflexivity 
Reflexive practice is an essential part of qualitative methodology, used to establish trustworthiness 
and rigour by providing the reader with insight into how decisions were made during the research 
process (Seale, 1999). More than just recalling an event and remembering what happened, reflexive 
practice enables researchers to learn by experience, known as experiential learning (Kolb, 1984). 
Throughout the research process for this thesis, reflexivity was practiced and conscious effort was 
made to examine why things happened in a certain way, and how, on the basis of that experience, it 
may be better to do things differently in the future (Boyd and Fales, 1983).  
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Reflexivity encourages researchers to constantly critique the research process. It enabled me to 
question my own beliefs and assumptions and how they might impact on research participants, 
potentially skewing the process of data collection (Silverman, 2000). It also made me consider aspects 
of qualitative research that can challenge its credibility such as becoming over-involved and not 
retaining a level of objectivity (Jasper, 2005). This was vital due to the contradictory demands placed 
on qualitative researchers, who are expected to be deeply involved in data collection and analysis, 
whilst maintaining distance and objectivity (Malterud, 2001). I therefore endeavoured to strike a 
balance and remain neutral while continuing to show empathy towards participants (Noble and Smith, 
2015). 
In addition, I considered what effect my physical presence may have on the participants with serious 
mental illness, who were interviewed face-to-face. I chose to dress informally rather than wearing 
professional attire to minimise the distance between researcher and participants (Mays and Pope, 
2000). I also remained consciously aware of my body language, tone of voice and eye contact. 
Furthermore, I was aware that as a female who attended interviews unaccompanied, it may have 
prompted participants to reveal sensitive and personal information, which had not been requested 
(Padfield and Proctor, 1996). As discussed later, in Chapter Five, sensitive information was disclosed 
voluntarily by a number of participants who talked about distressing side-effects of medication, such 
as sexual dysfunction or wetting the bed. 
Using a notebook to record learning points allowed me to document critical and constructive thinking 
about what happened during interviews (Silverman, 2000). This helped me to further develop self-
awareness and think creatively about alternative ways to address a problem (Pope and Mays, 2006). 
For example, despite intending to actively listen to participants (Abrahams, 2017), I learnt early on 
from the initial interviews that I needed to resist the temptation to interrupt long silences. Developing 
self-awareness made me realise that when people stop talking and pause for some length they may not 
have finished, but rather, they may be in deep thought and contemplating their response. Learning to 
not fill the silence and providing participants with time and space to consider their thoughts is a 
valuable skill to develop, which was demonstrated in subsequent interviews by the richness of data 
that typically followed a prolonged silence.  
3.3.4 Other validation methods  
This thesis will adopt a number of other techniques used to validate qualitative research findings. 
Constant comparison (Silverman, 2000) will be used to continuously check and compare data during 
the coding and analysis process, which will take place concurrently. This will enable analysis of 
deviant cases or outliers, which differ from the rest of the sample, thus acting as a point of 
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comparison. Triangulation (Denzin, 1978) is another technique used to check the validity of data 
which can take a number of different forms  (Patton, 2002). This thesis adopted triangulation of 
methodologies and methods to provide broader and deeper understanding of the topic. Therefore, the 
process of triangulation was used to gain a more complete picture of the problem being investigated 
rather than to improve accuracy and precision (O'Cathain et al., 2010). Respondent validation, which 
involves returning findings to research participants to check for accuracy and meaning, is another 
technique used to enhance validity of qualitative research, though it is not always feasible (Lincoln 
and Guba, 1985). Although the value of giving participants the opportunity to validate findings is 
acknowledged, it was not deemed necessary for this study given that interviews were digitally 
recorded to ensure a high level of accuracy of participant data. 
3.4 Mixed methods approach 
Despite continuous debate over whether or not quantitative and qualitative research paradigms and 
their methods should be mixed (Teddlie and Tashakkori, 2009), there is a pragmatic philosophical 
approach which advocates choosing the most appropriate methodology and method to examine the 
research question (Creswell and Plano Clarke, 2011). This thesis thus adopted a mixed methods 
approach to examine research questions relating to quality of care from contrasting research 
paradigms: to address both qualitative what and why questions, as well as quantitative how many and 
how much questions.  
Selecting methods from different philosophical paradigms, known as ‘methods triangulation’(Patton, 
1999), allows data to be looked at from different standpoints: numerically, to examine to what extent 
something is happening, alongside words to reveal meaning and explanation about why something is 
happening (O'Cathain et al., 2010). This thesis examined data from different philosophical paradigms 
using different methods to enable broader and deeper understanding of the problem than would be 
possible with a single method (Bryman, 2001).  Furthermore, the process of triangulation has the 
potential to uncover new, unexpected findings which may not have been visible through the lens of a 
single method of research (Barbour, 1999).  
A convergent, parallel mixed methods design was selected for this thesis, using two methods from 
contrasting theoretical paradigms, to enable questions relating to the mortality gap to be explored 
from different angles. Typically researchers using this type of design would collect and analyse data 
in parallel. However, delays obtaining access to the quantitative data (as discussed in Chapter Six and 
Chapter Eight) resulted in a more sequential approach to data collection and analysis, though the 
integration and synthesis of findings remained convergent.  
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Overall, the research focus for this thesis was exploratory rather than explanatory in response to gaps 
in our current knowledge about the unmet physical health needs of people with serious mental illness. 
Consequently, the qualitative component of this thesis was prioritised, a type of mixed methods 
approach described by Morse as ‘QUAL + quant’ (Morse, 2003) to demonstrate that the qualitative 
research is dominant. This type of research approach is also defined as a ‘parallel mixed methods 
design’ (Teddlie and Tashakkori, 2009) where the two phases are conducted independently of each 
other – either at the same time or shortly after the other, chronologically. The research for this thesis 
was conducted using a ‘parallel’ design rather than a ‘sequential’ design as data collection and 
analysis for the quantitative component (part two) were not dependent on findings from the qualitative 
component (part one). –Creswell’s ‘convergent parallel mixed methods design’ (Creswell, 2015), as 
shown below, illustrates the research approach adopted for this thesis, demonstrating how the two 
parts were conducted independently before interpretation of the data was guided by themes emerging 
from the qualitative study, with the quantitative findings adding context and breadth of understanding.  
Figure 3. 1    Convergent parallel mixed methods design          
 
The qualitative study for this thesis involved talking to patients and primary care practitioners to 
explore their perspectives on the quality of care for people with SMI. The process of speaking to 
people and listening to their experiences aimed to generate new insights about factors that enhance 
and erode the quality of primary care, providing valuable information about how we can better meet 
the physical health needs of SMI patients and address the ‘scandal’ (Thornicroft, 2011, p.441) of 
premature mortality.  
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To complement this approach, the quantitative study examined quality of care from a different 
standpoint by interrogating a large dataset of routinely collected electronic health records, to look at 
the impact of a quality improvement initiative on care quality. Following analysis of both datasets, the 
findings were compared and integrated. The process of synthesising data provided interlinked strands 
of research evidence, particularly valuable to policy makers and practitioner audiences. 
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Chapter Four: Qualitative Study Methods 
4.1 Chapter content 
The previous chapter provided rationale for the pragmatic philosophical approach adopted to select 
the most appropriate methodologies to address the research questions for this thesis. This chapter 
describes the methods used to carry out the qualitative study, which was the first of the two core 
components of this thesis. It begins by highlighting gaps in the evidence relating to human 
perspectives about the quality of care for people with SMI, before defining the aims and objectives of 
the qualitative study. It then explains why the method of individual semi-structured interviews was 
chosen to explore patient and practitioner perspectives. The chapter goes on to describe ethical 
considerations given to the study and the involvement of Experts by Experience. It then describes the 
methods used for data collection and analysis. Finally, it considers the strengths and limitations of 
conducting individual interviews. Findings are discussed in the proceeding chapter.  
4.2 Rationale  
Chapter two demonstrated that existing evidence on the quality of primary care and unmet physical 
health needs of people with SMI is relatively sparse, particularly with regard to qualitative studies 
(Doran et al., 2014, Liu N et al., 2017). Whilst a small number of qualitative studies have explored 
practitioner views of the Quality and Outcomes Framework (QOF) (Campbell et al., 2008, Mercer et 
al., 2007, Maisey et al., 2008, Lester et al., 2011, Lester et al., 2013), fewer have explored SMI patient 
views of general practice (Lester et al., 2005, Hannon et al., 2012), and, to my knowledge, none since 
Lester et al (2005) have provided a voice for both providers and patients. This demonstrates the need 
for new evidence and provides rational for the exploratory study conducted for this component of the 
thesis. 
4.3 Aims and objectives  
The aim of the qualitative study for this thesis was to explore views on the quality of primary care for 
people with serious mental illness from a dual perspective by speaking with patients and providers.  
Objectives: 
1) To explore the views and experiences of people with SMI on their use of physical healthcare 
in general practice. 
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2) To explore practitioner views on the current provision of physical and preventative healthcare 
in general practice. 
3) To identify factors which enhance and erode the quality of care for people with SMI. 
4) To investigate the perceived effect of the Quality and Outcome Framework (QOF) on the 
quality of care for people with SMI. 
5) To consider potential pathways to improve the quality of, physical healthcare for people with 
SMI. 
4.4 Study design 
A qualitative study design using individual semi-structured interviews was selected to explore patient 
and practitioner perspectives on the quality of care for people with SMI. Individual interviews were 
chosen as the qualitative method for this thesis because they provide researchers with a useful way of 
exploring complex and sensitive issues from participant perspectives (Mason, 2002).  Furthermore, 
semi-structured interviews were deemed most appropriate to meet the aims of the thesis to ensure core 
topics were discussed with each respondent whilst providing the scope to explore issues that emerged 
during discussion, which had not been anticipated before the interview (Patton, 2014).  Given the 
potentially sensitive nature of the topic relating to the physical health needs of participants, individual 
interviews were chosen in favour of focus groups (Creswell, 2007) to enable respondents to talk 
openly about their experiences without fear of being judged by other participants (Barbour and 
Kitzinger, 1999). 
4.5 Ethical and Research Governance approvals 
Ethical approval from an NHS Research Ethics Committee (REC) is required for all research studies 
where NHS patients are participants. In addition, any NHS site involved with data collection requires 
Research Governance approval. Furthermore, because this study was being conducted by a PhD 
student at the University of York, it required approval from the Health Sciences Research Governance 
Committee before documents could be submitted to the NHS REC.  
Approval from the University of York Health Sciences Research Governance Committee was granted 
in March 2017. Following this, documents were submitted to the NHS REC which entailed the 
researcher attending a REC meeting face-to-face in May 2017. Approval was granted in June 2017 by 
the Social Care Research Ethics Committee, London (17/IEC08/0025) (Appendix 4.1).  
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Research Governance approval from the Health Research Authority followed in July 2017 for all the 
CCGs and six mental health trusts in the Yorkshire and Humber Region. Letters of Access were 
obtained in August 2017 for one mental health trust and all general practices located in four of the 
Yorkshire and Humber CCGs.  The approval process took approximately 6 months from start to 
finish. 
4.5.1 Main ethical considerations  
The main ethical issues raised during the approval process for this study are outlined below. 
Safeguarding participants 
Before starting the study, the issue of risk had been carefully considered given that SMI patients are a 
vulnerable population. The Participant Information Sheet (Appendix 4.2) informed participants that if 
they demonstrated a risk of harm to themselves or others the researcher would ask them questions to 
explore the nature of the risk, and it may be reported to their General Practitioner (GP). The Research 
Ethics Committee further reinforced the importance of safeguarding SMI patients as research 
participants and a protocol was written by the researcher, which systematically detailed how to 
respond should a participant disclose a risk to themselves or others (see Appendix 4.3).  
Researcher safety 
The REC raised concern about the safety of the researcher in relation to two items. First, it questioned 
the researcher’s plan to conduct interviews unaccompanied, which it perceived as a risk given the 
study population concerned; and the researcher’s plan to allow participants the choice of being 
interviewed at their homes.  The researcher was advised to adhere strictly to the documented 
University of York lone worker policy (see appendix 4.4).  Secondly, the REC rejected the final 
method of recruitment (which had proposed to use social media to recruit people with SMI) on the 
grounds that there would be no mechanism for screening out participants who posed a risk. Instead the 
REC advised that participants be recruited via primary care or mental health trusts where the identity 
of those invited was known to health professionals. 
Reward for participation in research study  
The Research Ethics Committee approved that patients should be thanked for taking part in the study 
and rewarded with a gift voucher to the value of £10. In contrast, the REC discouraged the 





Confidentiality is critical throughout the entire research process and the REC sought assurance from 
the researcher about how this issue had been considered. For this study, each participant was assigned 
a unique four digit, anonymised participant identifier once they had consented to take part (HPXX for 
practitioners, PTXX for patients). This ID code was written on their consent form (Appendix 4.5) and 
used as the participant identifier throughout the rest of the research process. Consent forms were the 
sole documents that included personally identifiable data. They were kept separately from all other 
study data in a locked filing cabinet, which only the researcher had access to, in a room with restricted 
access at the University of York. The ID code was then added to the anonymised transcript and any 
other data relating to the participant, which ensured it was the only means of distinguishing 
participants within the dataset. Electronic data were stored on the University of York secure IT 
system. In line with REC approvals, participant digital data will be removed after 5 years. Study data 
protection is GDPR compliant (https://www.york.ac.uk/records-management/dp/). 
4.6 Sample 
4.6.1 Inclusion criteria 
Primary care practitioners were eligible to be included in this study if they were GPs or practice 
nurses working in general practice in the Yorkshire and Humber region. Patients were eligible to be 
included in this qualitative study if they were: aged 18 years or over; had a documented diagnosis of 
schizophrenia or bipolar disorder from a GP practice or mental health trust; lived in the community 
(including residential facilities); and had capacity to provide informed consent to participate in the 
study.  
4.6.2 Sampling strategy 
This thesis used a form of purposive sampling, to sample participants with a range of experiences and 
different characteristics, in an attempt to maximise data variation (Patton, 2014, Strauss and Corbin, 
2008). Several variables were identified as important, and potentially feasible to sample by, to show 
variations in participant experiences.  Practitioners were sampled by clinical role and gender. Patients 





Table 4. 1   Primary care practitioner characteristics 
Participants in individual interviews (n=11) 
Clinical role No. Male Female 
GP 7 5 2 
Practice nurse 4 0 4 
 
Table 4. 2     SMI patient characteristics 
                    Participants in individual interviews (n=19) 
Diagnosis No. Gender 
Male          Female                            
Age 
mean (yrs)        range (yrs) 
Bipolar disorder 11 5 6 54  21-71 
Schizophrenia 8 6 2 55 37-69 
 
4.7 Recruitment of participants  
Interviews were conducted between September 2017 and May 2018 in the Yorkshire and Humber 
region. Practitioners and the majority of patients were invited to interview from a range of general 
practices who had expressed interest in the study after receiving information from the local Clinical 
Research Network (CRN). Typically it was a GP who first expressed interest in the study and who 
acted as the practice point of contact with the researcher for recruitment of patients to the study. On 
two occasions, however, it was the lead research nurse who contacted the researcher and coordinated 
the practice involvement in the research study.  
Patients with schizophrenia or bipolar disorder, who had been selected from the Quality and 
Outcomes Framework (QOF) SMI register, were sent an invitation pack from their practice. This 
included a letter of invitation (Appendix 4.6) and Participant Information Sheet (Appendix 4.2) along 
with a reply slip and stamped envelope, which was addressed to the researcher at the University of 
York who had provided the practices with the invitation packs. Those interested in taking part were 
able to contact the researcher directly by telephone (mobile or landline), email or post.  
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4.7.1 Practitioner recruitment 
The sampling strategy used to recruit practitioners to interview was a hybrid (Barbour, 2001) of 
purposive and snowballing. Although the plan had been to select a purposive sampling strategy based 
on practitioners’ clinical role and gender, in reality the recruitment of practitioners was more 
opportunistic, based on a pragmatic rather than a theoretical approach. Initially, the researcher invited 
– and subsequently interviewed – each of the ‘key contact’ practitioners who had expressed interest to 
the CRN about their practice taking part in the study. Several of these GPs or practice nurses went on 
to recommend one of their colleagues who they believed would be interested in the study. Following 
up these leads resulted in the recruitment of all the remainder of participants required for the sample 
and introduced a snowballing effect (Patton, 2014) as potential respondents were identified by 
existing participants. Where feasible, however, to ensure the sample included a range of participants, 
practitioners were still selected on the basis of clinical role or gender although this was not always 
possible. For example, there was no opportunity to invite any male practice nurses to take part in the 
study within the sample of participating practices. 
4.7.2 Patient recruitment 
The sampling strategy used to recruit patients to interview was purposive with the emphasis on 
generating maximum variation in the data. The aim was to ensure the sample varied by diagnosis 
(schizophrenia or bipolar disorder) and core demographics (age and gender) to enable the data to 
include a range of experiences, which may be more generalisable to the wider SMI population. 
Eligible patients were identified by searching the practice QOF SMI register and removing any 
patients without a current diagnosis of schizophrenia or bipolar disorder; aged under eighteen; without 
capacity to provide informed consent.  
Constructing a sampling frame for patients 
Rather than inviting all eligible participants, or selecting a sample at random, practices purposively 
selected a sample of ten patients at a time (classed as one mail out) who varied according to diagnosis, 
age and gender. This model was adopted to avoid generating a large number of positive respondents 
from a single practice, which would have skewed the sample. It was expected, based on the 
researcher’s previous experience of recruiting patients via postal invitation to a large mental health 
study in primary care (Gilbody et al., 2017) that response rates would be around 10 to 20 per cent, 
given the mean for that study was 16 per cent. Consequently, it was predicted that there would likely 
be one or two positive responses per 10 invitations, which was believed to safeguard against one 
practice recruiting a disproportionate share of the sample. In reality though, only two practices 
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generated more than one response from their first mail out. The other five practices mailed out a 
second time to 10 different patients in order to generate additional respondents; and one practice 
mailed out on three separate occasions without a single response.  
Flexibility to adapt sampling frame 
Obtaining a varied sample of SMI patients was complicated by the practicalities of recruiting patients 
through primary care, which meant that potential participants could not be contacted by the researcher 
unless they responded to invitation from the practice mail out.  There was no guarantee, however, 
which patients would respond or whether or not they would vary by characteristics. In an attempt to 
achieve a varied sample by diagnosis, age and gender, the sampling process was shaped by a process 
of next selection, guided by emerging categories (Glaser and Strauss, 1967). As such, selection of 
who to invite at future practices was guided by who responded from previous mail outs. For instance, 
the first few practices invited eligible patients with a broad range of characteristics.  Early respondents 
were predominantly older, however, which resulted in the next few practices being asked to adjust the 
sampling criteria to invite a younger age range in order to recruit younger participants.  
Alternative method of recruitment  
As the study progressed it became evident that fewer people with schizophrenia had responded to 
invitations sent from their practice compared with those with bipolar disorder. Even though early on 
in the recruitment process there had been three positive responses from people with schizophrenia, 
from three different practices, subsequent mail outs generated no more interest from people with 
schizophrenia. To rebalance the sample size an alternative, more opportunistic, method of recruitment 
was adopted based on advice from CO, an Expert by Experience advisor. This involved approaching 
people directly at two different clozapine clinics run by a local mental health trust.  The researcher 
was able to sit in on one-to-one sessions between patients and the Healthy Living (HLA), which lasted 
approximately 10-15 minutes, and was given the opportunity to briefly describe the study to 
individuals and hand out information packs to those who were interested to take home to read. Whilst 
not all patients attending the clozapine clinic opted to see the HLA, 19 of the 28 who met the HLA 
during the two morning sessions, expressed interest in the study and took home an information pack. 





All potential participants were sent a written information sheet about the study and what taking part 
would involve – for patients this was done by post and for practitioners by email. All participants who 
returned an expression of interest in the study were then contacted by the researcher who called them 
to explain the study and discuss any queries they may have before arranging a time to conduct an 
interview. Before data collection began, informed written consent was obtained from participants after 
they had been given time to ask any further questions about the study. This was done via email for 
practitioners and face-to-face for patients with schizophrenia or bipolar disorder. Once patients had 
signed two copies of the consent form they completed a background information sheet to provide 
details of their demographics before the interview began (Appendix 4.7). 
4.9 Participant characteristics 
All practices in the sample were located within four Yorkshire and Humber CCGs. There were 
marked differences in list size (7,200 to 32,700 patients), rural/urban classification, area of 
deprivation using the index of multiple deprivation (IMD) by decile (1 = most deprived) and QOF 
achievement score for clinical mental health (93.0% to 100%) (see sample demographics Appendix 
4.8). Participant characteristics are shown in Table 4.3 for practitioners and Table 4.4 for patients.  
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Table 4. 3     Practitioner characteristics 
 
ID code CCG Clinical role  Gender IMD decile* (practice level) 
HP01 Harrogate and Rural District GP Male 4 
HP02 Vale of York 
 
GP Female 2 
HP03 Vale of York 
 
Practice Nurse Female 2 
HP04 Leeds West 
 
GP Male 6 
HP05 Vale of York 
 
GP Male 2 
HP06 Vale of York 
 
GP Male 5 
HP07 Vale of York 
 
Practice Nurse Female 5 
HP08 Vale of York 
 
Practice Nurse Female 5 
HP09 Vale of York 
 
GP Female 3 
HP10 Hull Practice Nurse Female 1 
HP11 Vale of York GP Male 2 




Table 4. 4     Patient characteristics 
ID code  Diagnosis Gender  Age  IMD* decile  
(patient level) 




PT01 Bipolar disorder Female 62 9  via GP practice Telephone  
PT02 Schizophrenia Male 67 9 High cholesterol, hypertension, hypothyroidism via GP practice Telephone  
PT03 Bipolar disorder Male 63 10 High cholesterol via GP practice Email 
PT04 Bipolar disorder Male 71 5  via GP practice Email 
PT05 Bipolar disorder Female 50 3  via GP practice Email 
PT06 Schizophrenia Male 69 9 Hypertension via GP practice Telephone  
PT07 Bipolar disorder Female 48 9 ADHD, fibromyalgia via GP practice Telephone  
PT08 Bipolar disorder Female 49 5 Arthritis,asthma, hypothyroidism, incontinence via GP practice Post  
PT09 Bipolar disorder Male 59 9  via GP practice Post  
PT10 Schizophrenia Female 62 5 Asthma, autism, hypothyroidism via GP practice Post  
PT11 Bipolar disorder Male 58 6  via GP practice Post  
PT12 Bipolar disorder Male 50 10 Cancer via GP practice Email 
PT13 Bipolar disorder Female 21 **unmatched**  via GP practice Email 
PT14 Bipolar disorder Female 64 1 Asthma, cancer, high cholesterol,  via GP practice Post  
PT15 Schizophrenia  Male 37 5 Anxiety, depression  Clozapine clinic A Telephone  
PT16 Schizophrenia Male 50 3 Arthritis, depression, type 2 diabetes Clozapine clinic A Post  
PT17 Schizophrenia Female 57 3 Pre-type 2 diabetes Clozapine clinic B Post  
PT18 Schizophrenia Male 49 7 Asthma Clozapine clinic B Post  
PT19 Schizophrenia Male 49 8 Type 2 diabetes Clozapine clinic A Post  
        
* English indices of deprivation 2015 Lower Layer Super Output Area (LSOA) http://imd-by-postcode.opendatacommunities.org/  
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4.9.1 Patient characteristics 
All patients were White British, eight female (three with schizophrenia, five with bipolar disorder), 
eleven male (five with schizophrenia, six with bipolar disorder), age ranged from 21 to 71 years 
(mean age 54 years). There was wider variation in deprivation level for patients than for practices, 
spanning across the full range of IMD deciles from 1 (most deprived) to 10 (least deprived). Four of 
the nineteen patients, all with bipolar disorder, attained higher education. Four worked full time, three 
with bipolar disorder (two female, one male), and one with schizophrenia (female). Twelve of the 
nineteen patients had worked previously but had stopped working due to their condition and/or the 
side-effects of medication (five with schizophrenia and seven with bipolar disorder). Living 
arrangements varied from owner occupied and privately rented, to council houses and social 
housing/supported accommodation. Eleven patients lived alone (four with schizophrenia, seven with 
bipolar disorder). Five were married (three with bipolar, two with schizophrenia), seven were 
divorced/separated (all with bipolar disorder) and seven were single.  
Eight of the nineteen patients (42 per cent) were current smokers, four with bipolar disorder and four 
with schizophrenia. Around half of the sample (nine patients) had a community psychiatric nurse 
(CPN) at the time of being interviewed. All patients with schizophrenia had been diagnosed in their 
late teens or early twenties. A number of those with bipolar disorder had been diagnosed later in their 
life course: in their forties and early fifties. Thirteen patients, more than two thirds of the sample, had 
at least one comorbidity (eight with schizophrenia and five with bipolar disorder) – see Table 4.4.  
4.10 Data collection 
Semi-structured interviews were conducted with patients and practitioners supported by a topic guide, 
tailored to each group (Appendix 4.9). As this research study was designed to be deductive and data 
driven it did not use a theoretical framework. Whilst there are limitations to not using a theory, there 
are also advantages as emergent findings from the data tend to be more visible (Collins and Stockton, 
2018). Topic guides were informed by relevant literature, particularly previous research on barriers to 
healthcare and the effect of the QOF.  The researcher then developed the interview schedules by 
constructing a groups of topics central to the research question and consulted with  with thesis 
advisors and Experts by Experience who offered guidance on both content and language. Topic guides 
were further refined following the pilot interviews, resulting in a framework of the core topics to be 




Interviews followed more of a conversation style than a question and answer formulae. Participants 
were asked to consider their own experiences and given time to reflect on what aspects of care they 
valued and what they perceived as challenging. The researcher endeavoured to actively listen to 
participants and to respond to them by seeking additional information in the context of what they had 
spoken about rather than following a list of pre-set questions (DeJonckheere and Vaughn, 2019). As 
the interview progressed questions moved away from personal experiences and focused more on how 
participants envisaged the future of primary care, not just relating to the challenges faced in providing 
and accessing good quality of care for SMI patients, but also relating to enablers and what could be 
done to improve care.  
4.10.1 Pilot interviews 
Pilot interviews were conducted with one GP and two people with SMI before data collection began. 
As mentioned earlier, this enabled the topic guides to be further honed in relation to each group (Kim, 
2010).  The pilot interviews were particularly informative on use of language, highlighting some 
subtle differences about terms used by people with SMI. They also demonstrated the value of 
including a narrative opening question which helped build rapport by encouraging people to tell their 
story and feel comfortable speaking to the researcher. In addition, they forewarned the researcher the 
potential for participants to wander off topic. A balance had to be struck, therefore, between allowing 
participants to respond to questions freely without restriction, and refocusing their attention if 
required. The pilot interviews were not included in the analysis. 
4.10.2 Main interviews 
Practitioner interviews were conducted over the telephone at a convenient time for the participant. 
Interviews lasted for a mean duration of 30 minutes, ranging from 23 to 39 minutes. Discussion 
focused on practitioner experiences of providing care to people with SMI, their views of the 
challenges associated with meeting the physical health needs of this group, and their perception of the 
physical health checks for SMI patients reimbursed by the QOF. Patient interviews were conducted 
face-to-face at a convenient time for the participant. All interviews took place at participant homes as 
this was every participant’s preferred choice of venue. Interviews lasted for a mean duration of 53 
minutes, ranging from 29 to 107 minutes. Discussion focused on exploring patient views and 
experiences of quality of care with questions about what worked well and what they found 
challenging. Whilst the term ‘QOF’ was not used directly during interviews with patients they were 
asked questions about being invited for a health check and their experiences of what happened when 
they attended. From the responses it seemed likely that patients and practitioners were talking about 
the same issues in relation to QOF health checks. However, given that patients were not asked 
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precisely the same questions as the practitioners, differences in the discussion of QOF between the 
two groups cannot be ruled out. 
Before interviews began, the researcher reminded participants about the research aim and asked them 
if they had any questions relating to the study information sheet. The researcher reiterated to 
participants the expected length of the interview and reminded them that they could stop the interview 
at any point and that any direct quotations used from the interviews would not be identifiable to them. 
Following consent from participants, all interviews were digitally recorded which enabled the 
researcher to actively listen to participants without being distracted by having to take notes during the 
interview. This ensured the interviews were able to adopt a conversational style rather than needing to 
pause for note taking after each response. Furthermore, being able to audio-record all the interviews 
enhanced the truth value of the data by minimising risk of bias through inaccurate or incomplete note 
taking (May, 2001).  
Data collection ended when there appeared to be sufficient depth of material relating to the research 
question and little new information was emerging (Nelson, 2016). The decision was not based on the 
size of the sample (Bowen, 2008) but on the apparent richness of data and relevance of information, 
which suggested a level of saturation had been reached (Morse et al., 2002). As described earlier, 
recruitment of the final five patients with schizophrenia via secondary care had entailed a delay of 
approximately two months to the planned timetable. It succeeded, however, in bringing a more 
balanced representation of diagnoses to the sample as the number of participants with schizophrenia 
increased from three to eight, more in line with the eleven with bipolar disorder. At this point, the 
sample appeared rich enough in breadth and depth to explore the research topic effectively (Saunders 
et al., 2018). 
4.11 Data analysis 
Thematic analysis was chosen to identify patterns in the data and to highlight similarities and 
differences between participants and groups of participants. Despite being widely used, thematic 
analysis has until recently been poorly demarcated from other qualitative methods (Braun and Clarke, 
2006). It is, however, increasingly regarded as a method in its own right rather than just as a tool used 
by other more established analytic methods, which also seek to describe patterns such as grounded 
theory (Glaser and Strauss, 1965, Strauss, 1997) or interpretive phenomenological analysis (IPA) 
(Smith and Osborn, 2015). A key strength of thematic analysis as a method is that it can be used to 
identify, analyse and report patterns both within and across data (Pope and Mays, 2006). Furthermore, 
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it can generate unanticipated insights through the theoretical freedom it offers compared to grounded 
theory or IPA which are theoretically bounded (Braun and Clarke, 2006). 
A scarcity of literature on the research topic determined that coding should be data driven (inductive) 
rather than theoretically driven (Patton, 2014). It was not deemed appropriate to construct a list of 
codes pre-data analysis, which were unsupported by research evidence (Barbour, 2001). Consequently 
the data analysis was largely inductive. Drawing on grounded theory, a constant comparative method 
(Strauss and Corbin, 2008) was used to enable continuous comparison of the views and experiences of 
participants who had been purposively selected to highlight subtle, but potentially important, 
differences. Using a constant comparison method in combination with thematic analysis strengthened 
the validity of data interpretation, and identification of both anticipated and emergent themes (Pope 
and Mays, 2006). Validity was further increased by actively seeking unusual cases who differed from 
the rest of the sample (Patton, 2014) and endorsing anomalies to highlight the exception (Barbour, 
1999). 
4.11.1 Data transcription 
All interviews were transcribed verbatim by an external professional transcription service 
(http://www.uk-transcription.co.uk/about.htm). To ensure participant anonymity, any identifiable 
information from the recordings was not included in the transcripts. To comply with University of 
York data security, all digital recordings and transcripts were deleted by the transcription service 
seven days after the researcher had received them. As stated previously, no identifiable data were 
included on transcripts, which were recognisable by a four digit ID code. Only the researcher had 
access to participant consent forms and personally identifiable data.  
On receipt of a transcript the researcher re-listened to each digital audio recording to check the 
accuracy of the corresponding transcription. Listening back to the interview audio recordings served 
two functions. First, it began the process of data familiarisation (Ziebland and McPherson, 2006), 
which was further enhanced by the researcher’s subsequent reading and rereading of the interview 
transcripts to become more deeply immersed in the data. Second, it allowed the researcher to identify 
and correct transcription errors and check there were no identifiable data included in the text. 
Transcription errors consisted largely of singular words having been misheard and incorrectly typed 
by the transcriber, which altered the meaning of what participants had reported (Marshall and 
Rossman, 2006), coupled with instances where transcribers had replaced colloquial dialect with 
Standard English.  
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4.11.2 Data management 
NVivo version 11 (NVivo) was the computer software programme which was used to support the 
organisation and management of data. Once transcripts had been checked for accuracy they were 
uploaded onto NVivo, which enabled interview transcripts to be stored in an easily retrievable way 
(Nowell et al., 2017). NVivo offered a useful platform to begin the analysis process by providing the 
tools required to organise and code data. Nvivo could not, however, assist in the analytical thinking 
required for data analysis and interpretation. 
4.11.3 Thematic analysis  
Braun and Clarke (2006) identify six phases as core components of thematic analysis, which are 
broadly defined in Table 4.5. They emphasise, however, that thematic analysis is not a linear process 
where one phase needs to be completed before the next one begins, but rather a recursive process 
where elements are revisited. Consequently, analysis was an iterative process, which began with the 
researcher becoming familiar with the audio recordings and transcripts and making hand written notes 
on the early interview transcripts to construct a coding framework. To enhance validity a second 
researcher and PhD supervisor (PC) coded the first few transcripts independently, also by hand. Any 
differences identified were compared and discussed and the emergent coding framework was refined 
in response. The researcher then uploaded transcripts to NVivo 11 to begin working with the data 
electronically. Interview data were coded according to the coding framework, but with the flexibility 
to include new unanticipated codes that emerged from the data. When new codes emerged, they were 




Table 4. 5    Six stages of thematic analysis     
 
1) Becoming familiar with the data 
Required the researcher to immerse themselves in the data; listening to audio-recordings at least once; 
reading and re-reading transcripts, making notes of any observations.  
 
2) Generating codes 
Required the researcher to generate codes by labelling interesting aspects of the data across the whole 
dataset and then collating all data extracts relevant to each code.  
 
3) Searching for themes 
Required the researcher to look for meaningful patterns in the data relevant to the research question. 
Identifying themes was an active process which required analytical thinking. Following this, all the coded 
data relevant to each theme were collated.  
 
4) Reviewing themes 
Required the researcher to think about whether the themes ‘worked’ in relation to both the coded extracts 
and the full data-set and to make any necessary revisions.   
 
5) Defining and naming themes 
Required ongoing analysis by the researcher to contemplate the key essence of each theme and construct a 
fitting name and description to demonstrate the story it tells. 
 
6) Writing up 
Required the researcher to weave together the analytic narrative with illustrative data extracts to tell the 




Drawn from  (Braun and Clarke, 2006) 
Once coding was completed, common codes were merged to create categories, enabling the analysis 
of data to reflect recurring and representative themes. Themes represented meaningful patterns in the 
data, which became visible during the analytic process. An OSOP (‘one sheet of paper’) method 
(Ziebland and McPherson, 2006) was used to summarise different and sometimes contradictory issues 
within sections of data by writing them on a single sheet of paper in a free thinking, non-systematic 
manner. This enabled ideas to be mapped in order to visualise what story the data were telling and 
prompted a move away from codes and categories to a more conceptual understanding of the data.  
Following on from the thematic analysis of data, a case study research method was used to provide a 
more in-depth investigation (Creswell, 2007) . This type of method was adopted to enable deeper 
examination of patient and practitioner perceptions of the effect of the QOF on quality of care, which 
enabled the nuances and complexities arising from the data to be discussed in more detail.  
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4.12 Strengths and limitations  
One of the key strengths of semi-structured interviews is that they provide flexibility by including a 
topic guide of core questions, as well as providing respondents with the freedom to speak freely about 
their experiences (Mason, 2002). Moreover, the researcher is able to probe respondents for additional 
information to explore certain questions in greater depth or to obtain clarification (Creswell, 2007). 
Researchers also given the freedom to refine the data collection approach by seeking information on 
topics that have emerged during earlier interviews (Patton, 2014). One-to-one interviews provide rich 
sources of information about a topic, which can be compelling. Providing respondents trust the 
researcher and feel comfortable talking to them, they often offer powerful insights into sensitive or 
personal matters (Hinton et al., 2012), which display the complexities and subtleties associated with 
human experiences.  
However, there are a number of limitations associated with of semi-structured interviews. Primarily,  
given sample sizes are relatively small, data are not easily generalisable to the study population or the 
wider community(Creswell, 2007). Furthermore, semi-structured interviews require a considerable 
amount of time – to conduct data collection as well as analysis and interpretation – which can limit 
feasibility (Patton, 1999).The quality of the interview data is also largely dependent on the skills of 
the researcher and their ability to conduct reflexive and transparent research to enhance validity (Pope 
and Mays, 2006), which accounts for their personal biases and potential influence during the research 
process. Reflexivity refers to the influence of the researcher on each stage of the research process in 
relation to their background, values and preconceptions (Malterud, 2001). To be reflexive, researchers 
need to carefully consider what effect they may have had on the data collected and the findings drawn 
from the analysis (Britain et al., 1995) – see Chapter Eight for a statement of reflexivity on this 
research process. 
4.13 Chapter summary 
This chapter has provided rationale for why individual semi-structured interviews were the method 
chosen to collect primary source data for this thesis. It has described the ethical considerations and 
data protection requirements needed to involve vulnerable adults in research. It then discussed the 
sampling strategy and process of recruiting patients and practitioners to interview. It went on to 
describe the process of data collection providing summaries of the study sample and participant 
characteristics. The chapter then discussed the methods of thematic analysis with constant comparison 
used to conduct data analysis. Finally, it presented strengths and limitations associated with using 
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Chapter Five: Qualitative Study Findings  
5.1 Chapter content 
This chapter presents findings from the qualitative study, the first of two core components for this 
thesis. The methods used to conduct the research were described in the previous chapter, along with 
participant characteristics. This chapter begins by providing justification for why the dual perspectives 
of patients and practitioners were presented together rather than as two separate pieces of analysis. It 
then summarises each of the four core themes that emerged through thematic data analysis in relation 
to factors perceived to enhance or erode quality of care for SMI patients. Themes are supported with 
quotations, which enrich the findings by providing illustrative insight from patients and providers. 
The chapter then explores patient and practitioner views of the implementation of physical health 
checks, mandated by the quality and outcomes framework (QOF). Consolidating many of the key 
findings, the QOF illustrates how a policy intervention affected participant experiences of delivering 
or receiving care in practice. This chapter concludes by outlining the concept of visibility, which acted 
as a thread throughout the findings, interweaving many of the core themes and subthemes.  
 
Figure 5. 1   Clarifying a term of reference: referring to people as ‘patients’ 
Consistent with the rest of the thesis, interview participants diagnosed with schizophrenia or bipolar 
disorder are referred to as ‘patients’ in preference to other terms such as ‘service user’, ‘customer’ or 
‘client’. Aligning with recent research evidence that revealed people receiving healthcare prefer 
‘patient’ to other terms (Costa et al., 2019), it was considered acceptable to adopt an unambiguous and 
uniform term of reference for SMI participants throughout the thesis, which reflected the healthcare 
context of the study. Furthermore, the term was used neutrally without any connotation that it 
undermines the whole person perspective or labels individuals as passive recipients of care rather than 
active participants.  
  
5.2 Context behind presenting dual perspectives in parallel 
It is important to contextualise the process of data collection and analysis to explain why, despite 
there being some distinct differences between patient and practitioner perspectives on the quality of 
care provided to people with SMI, findings were presented in parallel. As described in Chapter Four, a 
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total of 30 interviews were conducted: 11 with practitioners (seven GPs, four practice nurses) and 19 
with patients (eleven diagnosed with bipolar disorder, eight diagnosed with schizophrenia).  
With the exception of the final five patients who were recruited from clozapine clinics (see Chapter 
Four), the first fourteen patients interviewed were registered at participating general practices, the 
same practices from which practitioners were interviewed. Data were also analysed concurrently to 
enable comparisons to be drawn and to deepen understanding by triangulating patient and practitioner 
perspectives. However, it is important to emphasise that practitioners did not know which patients 
from their practice had participated in interviews. Hence, practitioner views did not directly refer to 
patients in the sample, but rather to their wider experiences of caring for SMI patients in general.  
Consequently, during the analysis process, some themes were driven more by patient data, whereas 
others were primarily a reflection of practitioner data.  Presenting the dual perspective of patients and 
practitioners simultaneously, therefore, resulted in some themes being more representative of the 
patient narrative whilst others were more indicative of practitioner views. However, despite 
imbalances in how data in each theme were weighted, it was deemed more appropriate to present 
findings from both patient and practitioner perspectives together to demonstrate how some themes 
were particularly salient to one group. Although it was more challenging to present the two discourses 
in conjunction, it provided a richer narrative by offering insights from both the provider and the 
recipient. By doing so, it was possible to pull out elements of discord as well as congruence between 
patient and practitioner perspectives within each theme which strengthened the evidence.  
Four core themes encompassing a number of subthemes were identified from the thematic analysis of 
patient and practitioner interview transcripts, as shown in Figure 5.2. . Each core theme: Theme 1) 
Patient-centred care; Theme 2) Provider challenges; Theme 3) Patient expectations; Theme 4) 
Primary/secondary care interface, and respective subthemes, are then presented and discussed with 









5.3 Theme 1: Patient-centred care  
Patient-centred care was regarded by both patients and practitioners as being critically important to 
people with SMI. Both groups spoke about how seeing the same practitioner and developing a trusting 
relationship were key elements for enhancing the quality of care for this group.   
5.3.1 Continuity 
Nearly all patients spoke of how much they valued being able to see a doctor they knew when they 
attended the practice. Practitioners also stressed the importance of patients developing a relationship 
with a doctor, particularly for those managing a complex condition such as serious mental illness. 
Seeing the same practitioner – known as relational continuity of care (Freeman and Hughes, 2010) – 
was regarded as vital to enhancing quality of care by both patients and practitioners.  
Many patients reported that finding a doctor they liked and trusted was challenging, but once they had 
found one, they would endeavour to see them again, even if it entailed a substantial wait. Such 
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patients were often willing to compromise one aspect of care for another, sacrificing speed of access 
for relational continuity of care.  
‘It’s very difficult to get an appointment. I prefer to see [my doctor] if I can, but he’s very 
popular, and so they’re booked up a couple of months in advance ... it’s just that we have a 
relationship and I don’t have to explain my situation to him.’ (PT03, bipolar disorder) 
There were two notable exceptions, however, relating to patients who claimed to prioritise urgency 
over continuity. Patients PT04 and PT05 revealed they preferred to take the next available 
appointment and risk seeing a doctor they were unfamiliar with rather than waiting to see their GP of 
choice.  
‘To ask for a specific doctor, it’s like four weeks … if I want to see somebody I want to see 
somebody, not in four-weeks-time, so I just really take whoever is going to be on.’ (PT04, 
bipolar disorder) 
The only apparent difference between these two patients and the rest of the sample was that both 
worked (one full-time, one voluntary) and neither had a long term condition.  Whilst this could 
explain their different perspective regarding access and continuity, it may simply reflect individual 
preferences.  
Supporting the patient narrative, practitioners also viewed continuity as critical to enhancing quality 
of care. Moreover, they viewed it as dually beneficial to both patient and provider. GPs reported that 
this group of patients tended to opt for continuity over being seen quickly. 
‘[SMI patients] are always keen to have their own GP, so they would rather wait.' (HP01, 
GP) 
Many also spoke of how continuity prevents duplication by removing the need for patients to 
continuously repeat information to different doctors, described as ‘going over old ground’ (HP04). 
Furthermore, continuity was regarded as a protective factor against patient disengagement, which 
links closely to the subtheme of patient engagement, discussed later in Theme 2.  
Regarding the beneficial effects of continuity to them as providers, several GPs explained that seeing 
a particular patient regularly allowed them to develop understanding of their idiosyncrasies, enabling 
them to detect subtle changes that may have been missed by other practitioners. 
‘Continuity helps because they know me, and they seem to trust me and I get to know the 
nuances of how they are.  And, if they’re suddenly looking very blank and can’t talk it’s just 
the way they are and they just need a bit of a chat and closer monitoring.’ (HP04, GP) 
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Moreover, several GPs reported that building a relationship with SMI patients not only fosters better 
understanding of their health needs, but reduces the likelihood of an uncomfortable interaction 
between a patient and one of their colleagues who may be unfamiliar with their characteristics. 
‘Continuity of care with these folk is a definite benefit to them, and to us, in that they can be 
quite startling. They can be – if you’re not used to it – frightening, when you first come across 
them.’ (HP05, GP) 
With the exception of the two patients who preferred to opt for rapid access, continuity of care was 
regarded by all the other participants, both patients and practitioners, as critical to enhancing quality 
of care. 
5.3.2 Trust and respect  
Patients claimed that having a GP who actively listened was crucial for fostering a trusting 
relationship, based on mutual respect. Many patients revealed they could only be open about their 
concerns with GPs who actively listened to them and believed them because it gave them confidence 
to share their inner thoughts without fear of being judged.  
‘He’s [my GP] been brilliant, he’s always been prepared to listen.’ (PT05, bipolar disorder) 
Patients regarded seeing a practitioner who listened to them and who treated them as a ‘normal human 
being’ (PT14), as crucial to enhancing their quality of care.  
Furthermore, nearly all patients seemed to favour the relationship aspect – how well they 
communicated with a GP and trusted them – over a GP’s clinical expertise. Many revealed they did 
not expect a GP to have expert knowledge about their mental health condition, but what mattered to 
them was that they trusted the GP to take their concerns seriously and respect them; and to refer them 
to specialist services if necessary. 
‘I’ve got a good doctor now … I picked him, because he was the only one who helped me … 
he believes me.’ (PT07, bipolar disorder) 
In contrast, several patients recalled the difficulties they had encountered trying to find a GP they 
trusted. One patient described his frustrations.  
‘[I] used to see a different doctor every time and they would just say, “oh, try this, oh that 
hasn’t worked, I’ll tell you what … try this.” It was pot luck.’ (PT12, bipolar disorder) 
For patients, finding a GP they trusted and respected seemed a critical component for enhancing 
quality of care.  
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5.3.3 Holistic care 
Holistic care and being treated as a whole person was also highlighted throughout the patient narrative 
as imperative to enhancing quality of care. Virtually all patients spoke about how much they valued 
practitioners who used a holistic approach rather than those who treated their mental and physical 
complaints separately. Many patients revealed, however, that holistic care was more of an aspiration 
than a reality and that, typically, there was too little time to focus on the interconnectedness of the 
mind and body. 
‘For me, a care package would be designed around eating, sleep patterns and physical 
activity, and that would help …a whole person, for the wellbeing of all the body …rather than 
just cater for them highs and lows. You can mend your head but if you can’t mend everything 
else there’s no point in mending that, is there? But I don’t think that’s going to happen 
sometime soon because they haven’t got the time, have they?’ (PT14, bipolar disorder) 
 
Furthermore, several patients described how their mental health condition impacted on their physical 
health with distinct physical symptoms, but that GPs tended to overlook their concerns about the 
effects of their mental health on their physical health, preferring to concentrate on their state of mind.  
‘Everything’s faster [during manic episodes], so you look like you’ve actually taken 
amphetamines … the sweating, irregular heartbeats, totally soaked …the anxiety is just 
horrendous, it goes through the roof.  Then, depressed … I can’t be bothered, I put loads of 
weight on, I overeat to extreme. I just eat and eat and eat.  I cannot be bothered … I’ll sleep 
and wear the same clothes for a week and won’t bath or anything.’ (PT07, bipolar disorder)  
Most patients claimed holistic care was lacking and that practitioners did not appreciate how 
interdependent and closely intertwined their physical and mental health were. They reported that the 
shortness of consultation length – discussed further in Theme 2 – meant that there was virtually no 
time to discuss their complex needs relating to how their mental health was impacting on their 
physical health.  
‘Because that’s the problem, you go in and you’ve got a ten-minute appointment, so you can 
only nail one thing at a time … being able to get a double appointment would be useful so you 
can deal with at least two things, the bipolar disorder and whatever else it is … causing a 
problem at the moment. ’ (PT11, bipolar disorder) 
Patients repeatedly claimed that time deprivation severely limited what could be discussed during 
consultations, preventing GPs from adopting a holistic approach and engaging in discussion about the 




5.4 Theme 2:  Provider challenges  
Practitioner discourse about the challenges of providing care to SMI patients focused on patient 
engagement along with a number of system level factors, which they believed undermined their 
ability to provide adequate quality of care. Most practitioners spoke of the conflict which arose 
between the type of care they aspired to provide and the reality of what was achievable under the 
current model of primary care. 
5.4.1 Patient engagement 
Patient engagement emerged as a recurrent theme within practitioner responses. Many GPs referred to 
the challenges associated with providing care for SMI patients who, they claimed, were more likely to 
miss appointments and who proved more difficult to engage than the average patient.  
‘Quite a lot of them [SMI patients] just don’t turn up, despite repeated letters and things, and 
telephone calls. They just sort of decline to, more so than normal patients … they’re just a 
challenging cohort of patients really, they often aren’t engaging particularly well and it is 
more difficult to manage them.’ (HP04, GP) 
Added to this, several GPs spoke of the difficulties they had encountered engaging patients, even 
when they did attend an appointment, because their physical presence did not necessarily translate 
into patients engaging with them and communicating their health needs.   
‘[SMI patients]They fall into two categories really. The ones who are very dependent will 
appear lots and lots, and sometimes it’s difficult to see the wood for the trees because they 
bombard you with so many bits of information … then there are the ones who are chaotic, 
who often live in a worse state, but never roll up. You can’t pin them down, they never 
respond other than in a crisis.’ (HP05, GP) 
Patient engagement (or dis-engagement) was a concern voiced repeatedly by practitioners regarding 
their experiences of providing care for SMI patients.  
5.4.2 Time constraints 
Nearly all GPs spoke about how time constraints imposed at the system level, such as ten minute 
appointments, eroded quality of care by reducing their capacity to provide patient-centred care. A 
number admitted, however, that they felt a sense of relief when a patient did not attend (DNA) an 
appointment as it presented them with an opportunity to catch up on unfinished paperwork, despite 
their concern about the unmet need and invisibility of patients who missed appointments.  
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‘Because of the treadmill problem from our point of view, which is we still work on ten- 
minute appointments. But you can’t do it in that, if someone doesn’t turn up, actually, there’s 
a feeling of “phew” it gives me a breather, and I can actually catch up to where I was 
before.’ (HP05, GP) 
Furthermore, many GPs revealed that given the unrelenting time pressures they operated under, they 
tended not to chase patients who missed appointments.  
 ‘If a patient makes an appointment and then they don’t come, unless we’ve got concerns 
about safeguarding, we tend not to follow up people who have DNAed.’ (HP11, GP) 
‘Patients who had got lost to follow-up were … it’s just the lack of time … unfortunately 
[we’re] paying lip service to managing them.’ (HP04, GP) 
From the practitioner perspective, time constraints accounted for their passive response to patients 
who did not engage. Nevertheless, GPs were troubled by the absence of patients who disengaged, 
concerned that by not being seen they became less visible and missed out on having their needs met. 
Practitioners consistently expressed regret that not enough primary care resources were invested in 
engaging this group of SMI patients. Furthermore, many GPs claimed that at the personal level they 
were under too much pressure ‘firefighting’ and dealing with their day-to-day commitments to have 
the time to reach out to the most vulnerable patients who they were struggling to engage.   
However, not all GPs adhered to practice time boundaries on appointment length. Two GPs stood out 
as exceptions to the other respondents, revealing they offered some SMI patients longer appointments 
to extend the scope of what could be discussed.  
‘Patients with severe mental health problems need more time, may need double appointments 
… one or two who I’ve got … they have a double appointment so that I’ve got time to talk to 
them and discuss problems. ’ (HP04, GP) 
‘A consultation takes how long it’s going to take … sometimes we might book a double 
appointment for somebody but generally, in our practice anyway, we just accept the fact that 
sometimes the consultation is going to take half an hour or longer.  And that’s just life really, 
you give the patient the time they need.’ (HP02, GP) 
Although all GPs unanimously agreed that ten minute consultations were too brief to address the 
complexity of SMI patients’ needs, in practice only two practitioners revealed they offered SMI 
patients additional time, which reinforces the issue raised in Theme 1where patients claimed that time 




5.4.3 Access vs. continuity 
A recurring theme throughout practitioner interviews was the tension between access and continuity.  
GPs claimed that current policy initiatives to create larger practices and improve access – increasing 
the volume and availability of care – compromised their capacity to provide continuity. As reported 
within Theme 1 the patient/practitioner relationship and continuity were regarded as integral to 
delivering appropriate care for SMI patients. Many GPs expressed deep regret that structural changes 
within the primary care model had made continuity increasingly difficult to provide.  
‘It is one of my sadnesses of general practice, it’s been made bigger and bigger and more, oh 
they love this word “corporate”, and “practice at scale”, and that simply means we’re 
distant and inaccessible to the patient … as you get bigger, you get more remote and you get 
less personal, and the continuity goes.'  (HP05, GP) 
‘The larger the practice the less the continuity, because, if they want to see someone urgently 
on the day, they will just get pushed in with someone random.' (HP01, GP) 
Nearly all GPs claimed that the policy drive to expand practice size and to improve access had 
systematically eroded important aspects of care quality by undermining their ability to provide 
patient-centred care, forcing patients to be more ‘distant’ and ‘remote’. 
5.4.4 SMI: peripheral not core 
Many practitioners claimed serious mental illness occupied a second tier position in primary care, 
being placed on the margins rather than being part of its core practice. Practice level factors, such as 
lack of specialist SMI training and the minimalist role given to practice nurses, were identified as key 
reasons why serious mental illness has remained marginalised despite the increased policy attention 
over recent years (as described in Chapter One).  
Practitioners attributed lack of specialist training on mental health – and SMI in particular – as one of 
the key barriers to enhancing quality of care.  
‘There was a mental health update I went to as part of my PDP, but there are no updates on 
that [SMI].  We have lots of things for dementia wise, but not with serious mental illness.’ 
(HP06, GP) 
Added to this, nearly all practice nurses revealed they lacked confidence treating patients with SMI 
conditions because they had not received any specialist training and had limited experience of caring 
for patients from that group. 
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‘It [training] would be worthwhile … I don’t know about my colleagues, but you do have a 
certain apprehension when you’re seeing a patient if you aren’t very clued up on what their 
problem is.’ (HP03, PN)  
A minority of practitioners revealed, however, that they compensated for the lack of professional 
training by offering less confident colleagues peer support, drawing on their years of experience 
caring for patients with serious mental illness.  
‘If someone has got a serious breakdown of their mental health, if the GP or trainee doctor 
themselves feel that they’re out of depth, they might refer it to me or ask my opinion.  So, 
some GPs tend to be like mini-consultants within the practice. I suppose that happens with me 
and severe mental health.  But we haven’t done any training in the practice.’ (HP11, GP) 
In addition, a number of GPs asserted that training around serious mental illness should be delivered 
to more than just practitioners, given the influential role played by non-clinical staff such as 
receptionists who were often the first point of contact with patients.  
‘I think it would be really good for us all as a practice to get specific training to help 
understand these conditions better … [Receptionists] deal with all the phone calls that are 
presented, they’re making the decision when these patients come in as to how urgent 
appointments are, or whether they need seeing straight away, or whether it can wait until 
tomorrow, or another week. So, if they don’t pick up on these triggers then these patients are 
vulnerable really … so they’ve got quite a lot of responsibility.’ (HP08, PN)  
Furthermore, practitioners spoke about the marginal role given to practice nurses in providing care for 
SMI patients. This was seen as a missed opportunity to enhance the quality of care as many 
practitioners suggested that practice nurses may have more time and be better placed to engage with 
SMI patients’ complex needs. 
‘[Nurses] more time to approach a patient in a more appropriate manner’ (HP07, PN).  
‘If we had nurses who were trained in speaking to and giving advice and treating people with 
mental health issues, it would be really good.  Because, as I said, if they’re coming in and 
having injections, they’re perfect for the nurses to kind of have a chat with when they come in, 
over and above that they’ve come for an injection and giving them that.’ (HP09, GP) 
Moreover, several GPs questioned why practice nurses were not empowered to have delivered 
physical health advice to SMI patients in the same way they did with patients they see for other 
chronic QOF conditions, which had specialist clinics run by specially trained nurses. 
 ‘I don’t think we deal with it particularly well as a chronic disease, we haven’t got a specific 
chronic disease clinic that we do for asthma, COPD, ischaemic heart disease, diabetes, but it 
is a chronic disease. Maybe things will change in the future … it’s just hard to manage at the 
moment because we’re snowed under with diabetics and COPD.’(HP04, GP) 
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This GP highlighted an underlying tension relating to the gap between aspirations and delivery of 
care. Although GPs repeatedly stated that SMI deserved the same quality of care as other chronic 
conditions, in practice it missed out because other chronic conditions were prioritised in front of SMI 
when resources were overstretched. GPs stated it was difficult to address the needs of SMI patients 
because they were so busy, ‘snowed under’ even, with other patient groups. The inverse care law 
(Tudor Hart, 1971) was therefore reinforced as those SMI patients with the highest level of need 
would have been least likely to engage. As discussed earlier in this theme, despite acknowledgement 
from practitioners that the most vulnerable patients were the most difficult to engage, they also 
admitted that they did not have capacity to chase those patients who disengaged. Consequently, it was 
those SMI patients most at need who were most likely to have missed out. 
5.5 Theme 3: Patient expectations 
Patient expectations about quality of care emerged as a core theme because much of the patient 
discourse centred on aspects of care where expectations had not been met or where patients had not 
been able to convey their needs effectively. In contrast to Theme 1, where the subthemes displayed 
congruence between patient and practitioner perspectives, Theme 3 demonstrates elements of 
apparent discord. The respective subthemes illustrate a number of tensions that emerged from the data 
showing differences in how patients and practitioners prioritised health needs, which often resulted in 
patient expectations being unaddressed. Furthermore, the topic of side-effects from psychotropic 
medication is an illustrative example of where an issue was raised by virtually all in the patient group 
but was largely ignored by practitioners. 
5.5.1 Whole person approach 
All patients expected to be treated as a whole person and stressed the importance they placed on this.  
Practitioner interviews revealed, however, that this expectation was increasingly difficult to meet 
given the time constraints they operated under, as described in Theme 2. There appeared to be real 
tension between the type of care GPs wanted to provide and the reality of what they were able to 
deliver with so many competing priorities. Despite having been trained to offer holistic care and it 
being one of the core principles of primary care (Baird et al., 2018), GPs stated repeatedly that it had 
become more difficult to provide in practice. Consequently, even though the aspiration for treating 
someone as a whole person was uncontested, evidence from the patient interviews suggested that in 
practice it was largely absent.  
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‘[GPs]They’re just interested in controlling the disease, they’re not interested in the whole 
person.’ (PT03, bipolar) 
This claim was supported by many patients who reported that GPs tended to focus on one issue rather 
than treating them as a whole person. One patient described his daily routine, which had contracted 
substantially compared with life before his mental health diagnosis and subsequent treatment. He 
reflected on how his condition had negatively impacted on his quality of life as he had been forced to 
stop working. He also revealed that he never been given the opportunity to discuss the issue with his 
GP because of time pressures, which left him feeling despondent and hopeless. 
 ‘Typically, at the moment, I’m woken at eight o’clock to take tablets, then I go back to sleep 
again because it’s olanzapine so it tends to knock me out.  And I then, I don’t really move 
until about half eleven, twelve o’clock.  I then get up, have breakfast, and sometimes fall 
asleep again.  I’ll maybe go out and get a paper, read the newspaper. That’s about it really. 
Things are not tremendous at the moment.’ (PT11, bipolar disorder) 
The challenges patients reported engaging with their GP as a whole person suggests that GPs do not 
have adequate visibility of SMI patients’ needs, partly due to competing priorities with other aspects 
of care and also due to time constraints (both discussed earlier in Theme 2).   
5.5.2 Healthy living advice 
All patients and practitioners spoke about how health promotion and prevention are key factors to 
enhancing quality of care, although patients referred to it as healthy living advice rather than 
preventative medicine. Tensions emerged, however, in relation to how patients and practitioners 
perceived its delivery and uptake. Nearly all patients revealed that, despite high expectations, they had 
not received adequate or relevant information about how to look after their physical health. Most 
practitioners, on the other hand, stated that health promotion had limited value for this group as it was 
generally poorly received by SMI patients.  
‘Motivation has to come from them and loss of motivation is a well-recognised issue with 
schizophrenia.’ (HT05, GP) 
However, according to patients, even when written materials were provided, they tended to be 
inaccessible and meaningless. Several claimed that leaflets were not user-friendly and did not tell 
them what they wanted to know. 
‘You get the leaflet … and when you read, really read it, you think, “why have they give me 
that? How’s that going to help me?”’ (PT14, bipolar disorder) 
Regarding verbal physical health promotion and advice, patients reported similar frustrations. Most 
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could only recall being asked brief questions about smoking, alcohol, diet and exercise without any 
discussion about the risks and benefits of behaviours or why it is important to adopt a healthy 
lifestyle.  
‘They say, “do you go for walks?” and stuff like that.  But the ones they focus on are the five 
a day, and the drink, and the smoking.’ (PT04, bipolar disorder) 
In addition, several patients called for more personalised care, claiming that healthy living advice was 
generic and not tailored to them as an individual.  
‘I suppose I could always join a keep fit class or something like that, but it’s not really my 
scene.’ (PT02, schizophrenia) 
Furthermore, a number of patients revealed GPs had failed to take into account their personal 
situation, which meant that advice was often rendered purposeless. For example, one patient contested 
the concept of healthy eating when he could barely afford to buy any food.  
‘But that [healthy diet] goes out the window because you just have to eat anything you can 
food banking. Second hand food, third hand food.’ (PT16, schizophrenia) 
The absence of meaningful physical health advice about how to adopt healthier lifestyles and how to 
access support was viewed by most patients as a missed opportunity as they deemed practitioners well 
placed to educate them or signpost them to relevant information. One patient described it as being 
made to feel ‘neglected’ (PT07) by not being treated as a whole person where mind and body are 
interdependent. This links back to subthemes earlier in this theme and Theme 1. 
‘Nobody has said, “we’ll sort out a diet for you,” or “what activities can you do?” It’s more 
about, “are you taking your medication?” … I’d just like them to look at me as a normal 
human being.’ (PT14, bipolar disorder) 
In contrast, practitioners viewed health promotion from a different perspective. They believed it had 
limited impact on SMI patients due to two factors. First, practitioners questioned patients’ capacity to 
‘receive’ information and ‘act’ on healthy living advice. Many claimed that SMI patients tend to be 
less receptive and motivated than people without SMI to receive and implement advice about healthy 
living. 
‘In terms of health promotion and trying to get them to quit smoking or cut down alcohol or 
get regular exercise, you know, it doesn’t really sort of work particularly well. I don’t think 
they are particularly receptive to doing those sorts of things on the whole ... it’s just the 
motivation and inclination that they often don’t have, most of them, I don’t think.  I’m not 
tarring them all with the same brush but I think the majority just won’t.’ (HP04, GP) 
Second, a number of GPs pointed to structural changes in primary care and cuts in practice funding 
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which have further impeded the delivery of health promotion to this group. 
‘We don’t have a smoking cessation service in general practice anymore. That’s been 
defunded.  There is a council driven one, and I don’t know how effective – or active – it is. 
But we’re specifically not funded to provide any smoking cessation advice other than to tell 
people generally about it.’ (HP05, GP) 
There was an exception, however, which contrasted with the majority of respondents. One patient 
(PT17) described a positive experience, which illustrated what could be achieved. Recruited via a 
clozapine clinic, PT17 had been invited by her family practice (not part of this study) to attend a pre-
diabetic clinic as part of a preventative measure, an example of good practice. In addition, she was 
offered a place on a weight maintenance programme. No other patients or practitioners reported 
anything similar, highlighting that few practices were engaged in delivering proactive health 
promotion or preventative care. 
5.5.3 Managing side-effects 
The patient narrative on psychotropic medication centred on managing side-effects. Although patients 
did not question having to take medication to control their psychiatric symptoms, nearly all claimed 
that side-effects had severely reduced their quality of life by impacting on their emotional and 
physical health. Patients revealed deep frustration at the limited opportunity they had to consult with 
their practitioner about how they could manage the side-effects of their psychotropic medication. 
Contrastingly, practitioner data demonstrated different priorities, which may explain why patient 
expectations were often marginalised. The issue of side-effects from psychotropic medication was 
hardly touched upon by practitioners who made virtually no reference to patients’ concerns, 
demonstrating that the theme of managing side-effects was particularly salient to patients. . 
Practitioners’ primary concern when discussing psychotropic medication was whether SMI patients 
were adhering to what had been prescribed alongside how well the medication was managing the 
patient’s mental health condition, rather than reported side-effects.  
‘[SMI patients] more at risk of not taking the medication regularly, because if they’re not 
feeling well, they’re motivation is down.’ (HP03, PN) 
Consequently, a clear tension emerged indicting patients and practitioners had conflicting values. 
However, the data showed that given the time constraints of consultations, practitioners prioritised 
any discussion about medication, which tended to leave patients’ concerns about side-effects largely 
unheard and unaddressed. 
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Nearly all patients reported finding it difficult to raise the issue of side-effects or to ask for 
meaningful information about how to manage them because GPs were often unreceptive or they ran 
out of time. One patient claimed his GP would ‘skirt round’ (PT16) the subject in an effort to avoid 
talking about side-effects of psychotropic medication.  Even when patients were able to raise the issue 
they reported that practitioners commonly downplayed their concerns by telling them it is just one of 
the side-effects of that drug, to be expected and tolerated in order to control their psychiatric 
symptoms. 
‘I was on depakote and olanzapine … I went up to 14 stone [from 9 stones]. I went to the 
doctors … she weighed me and she said, “oh well, you know, it is one of the side-effects of the 
medication.”  She doesn’t see me as overweight, but I am, and I don’t feel right.” (PT14, 
bipolar disorder)  
This disconnect between how a patient rates the severity of a side-effect compared with practitioners 
was echoed by virtually all patients.  
Weight gain 
Many patients reported weight gain as their principal cause of distress, due to its impact on their self-
esteem, motivation and physical health (Curtis et al., 2016). Whilst weight gain seemed to be a side-
effect of all psychotropic medication, those prescribed atypical antipsychotics, particularly 
olanzapine, reported gaining an unprecedented amount of weight. Many also claimed that unrelenting 
hunger, which they attributed to psychotropic medication, made their life miserable as they were 
constantly ravenous and never felt satiated. 
‘Nobody is really interested in the fact that I’m struggling with my appetite because I’m 
permanently hungry. I’m permanently hungry … because of the Olanzapine, because my 
metabolism has slowed … I’m just surviving day to day at the moment’ (PT11, bipolar 
disorder) 
Patients repeatedly claimed that insatiable hunger severely impacted on their quality of life, though 
this suffering was not visible to practitioners.  
 ‘…it’s olanzapine, and I’m just getting up in the middle of the night and eating packets of 
biscuits, anything I can eat. So, I went a couple of weeks ago to see the GP ... but she hasn’t 
said anything about my diet…  I can sit and eat a full packet of chocolate biscuits at 2 o’clock 
in the morning, and the craving, it’s an awful feeling because it wakes you up … it wakes you 
up and unless you eat something you can’t go back to sleep and I have trouble sleeping 
anyway.’ (PT14, bipolar disorder) 
However, other patients claimed they had not altered their diet since their diagnosis, hence, they could 
not understand why they had gained so much weight or why they had not been offered any advice 
from their GP about how to address the problem.  
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‘They talk about the obesity thing in hospitals, it’s costing the NHS millions, and I’m sat there 
thinking, “some of the side-effects of my meds are weight gain.” You know, I’d like to lose 
another four stones if I could, but that’s not going to happen at the minute … when I was 
growing up in school and that, I was big into sport.  I played football every day, I had a six-
pack ... I’m thinking, “how did I put all that weight on?” You know, I’m eating the same sorts 
of things that I was back then.’ (PT15, schizophrenia) 
Weight gain was seen as all pervasive by patients. Practitioners did not share patients’ concern, 
however, despite its physical nature and it being a potent manifestation of a patient’s health problem.  
Although all patients attributed weight gain to the side-effects of psychotropic medication, two 
patients (PT05, PT12) conceded they had struggled with their weight before being diagnosed with 
SMI, but that psychotropic medication had resulted in additional weight gain. These two patients also 
reported feeling let down by their GPs who made no effort to offer them advice about how to address 
it. In response to the lack of support offered by her GP, PT05 revealed she had tackled the problem 
herself by paying privately to have a gastric band fitted, fearing that she would have had to give up 
her job as she was becoming increasingly out of breath and tired at the workplace.   
‘My BMI in July 2016 was 44 ½, so I actually used some PIP money to get a gastric band.  
So, for the last year, or just over a year, I’ve been working with the gastric band, because the 
medication that I take changes your metabolism, how you metabolise food. Although I could 
lose a bit of weight, it was very, very difficult, even something like Slimming World, to 
actually continually lose, because the medication fights against it.’ (PT05, bipolar disorder) 
This highlights the difficulty widely reported by patients that antipsychotics biologically affect their 
metabolism and make achieving a healthy body weight particularly challenging (Firth et al., 2019b).   
Other side-effects 
Other side-effects patients felt uncomfortable discussing with their GP magnified the tension between 
what patients were willing to present openly to practitioners and what they kept hidden and covered 
up, which further demonstrated the difficulty patients faced in having their expectations met.  Many 
patients referred to the disempowerment and physically disabling effect of medication which 
reinforced the evidence that side-effects severely impacted on quality of life and limited daily 
functioning. Patients claimed they found it difficult, however, to raise feelings of lethargy with their 
GP for fear of being judged and accused of being unmotivated and lazy. 
‘Some drugs make you that you can’t even get out of a chair for three hours of a morning … 
like you’ve been hit by a truck.’ (PT07, bipolar disorder) 
 ‘It’s like carrying rocks and walking on sand.  Your body feels heavy.  You drag your feet.  
You feel a bit off balance.’ (PT19, schizophrenia)  
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One patient (PT01) who revealed (voluntarily) that psychotropic medication had adversely affected 
her sex life, admitted she had not been able to bring herself to discuss sexual dysfunction with her GP. 
Consequently, by not raising the issue with her GP, this participant had not made her physical health 
problem visible, so it had not been addressed. 
‘I just don’t have any physical feelings anymore. I think the sodium valproate and the 
olanzapine dampen any emotions, physical feelings that you do have.  I’m just not interested 
… it must be frustrating for [my partner].’ (PT01, bipolar disorder) 
In contrast, another patient admitted to having had a particularly humiliating side-effect which 
involved wetting the bed. He claimed to have only told a few people about it – his mum, GP and CPN 
(and myself) – given how shameful it had made him feel, but because he had spoken to his GP the 
problem had been successfully addressed.   
 ‘Sometimes of an evening I wet myself.  So, they put me on meds … I’m off that now and I 
haven’t had a problem with that for months now, so that’s a good thing, ‘cause it was quite 
embarrassing, I’m thirty-seven and I’ve wet the bed.’ (PT15, schizophrenia) 
These personal stories illustrated how humiliating problems were able to be dealt with if patients were 
willing to share them with their GP, but if they were reluctant to speak about their needs, such as the 
sexual dysfunction, then practitioners could not be expected to see a problem that had not been 
disclosed. One participant illuminated this tension further when she revealed how frustrated she was 
at not being able to open up to her GP about her concerns.  
‘It’s real strange because when I set off to go to the doctors I get a taxi, and in the taxi I’m 
saying to myself, “I’m going to tell her [my GP] this and I’m going to tell her that”, and when 
I get there I don’t, I just say, “oh I’m fine”… you learn to cover up how you really feel.’ 
(PT14, bipolar) 
This demonstrated further how some patients found it difficult to raise issues that were important to 
them, opting to keep them hidden during consultations despite their good intentions. Consequently, 
patients’ impression that practitioners did not share their concerns about side-effects may reflect a 
practitioner’s blind spot of a patient’s beliefs (Alderson et al., 2014) rather than a lack of concern for 
the patient’s overall wellbeing.  
When side-effects were visible, however, there was evidence of additional tension in that practitioners 
did not regard them as being as functionally impairing as the person experiencing them. One patient 
claimed his GP was not concerned about his tremors even though they prevented him from driving 
and doing routine tasks that required a steady hand. 
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‘They don’t see the tremors being an issue, whereas I do.  So, there is a conflict there.’ (PT03, 
bipolar) 
Not all patients felt so burdened by side-effects, however, as illustrated by one patient who claimed 
that her side-effects on clozapine (obesity and excess nocturnal salivation) are a small price to pay for 
managing her mental health condition and enabling her to continue to work.  
‘Excess salivation, that can be a pain … so at night-time, you know, I dribble … if I wake up 
during the night, sometimes my pillow case is quite wet …it’s a small drawback really for 
keeping me so well. And I mean thankfully, over all this time, I’ve managed to keep a full-time 
job.’ (PT17, schizophrenia) 
This example, though not typical of the sample, illuminated how individuals experienced and 
responded to side-effects differently. What may be debilitating for one person may be manageable for 
another.  
5.5.4 Summary 
In summary, patients regarded side-effects of psychotropic medication as the primary concern relating 
to their physical health, principally weight gain and its negative impact on their self-esteem, 
motivation to do physical activity and overall quality of life. Nearly all patients’ initial response to 
being asked about physical health problems was to cite the side-effects of psychotropic medication. 
This seemed to take precedence over long term physical health conditions such as asthma and 
diabetes, as any patients with chronic disease(s) had to be probed further to talk about them, even 
when asked direct questions about their physical health. The enduring message from patients was that 
despite their expectations and strong desire to have been able to discuss how to manage side-effects 
with their GP, in reality the issue tended to be marginalised and their concerns were either not raised 
or not heard. 
 
5.6 Theme 4: Primary/secondary care interface 
5.6.1 Delayed communication  
Timely and effective communication between primary care and mental health services was seen by 
respondents as essential to providing good quality of care for SMI patients.  However, most patients 
and practitioners reported that, in recent years, there had been a marked deterioration in 
communication between general practices and community mental health teams. Practitioners revealed 
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the sharing of information had slowed down and been reduced, which resulted in it becoming 
increasingly distanced: stretched across time and space.  
Nearly all GPs spoke about the apparent disconnect between services, which had impacted on the 
quality of care they could provide. The primary issue reported by GPs was a progressive breakdown 
in communication, which meant they were no longer confident that they received up-to-date 
information about patients still under secondary care. According to some practitioners, they either 
received information late, or in some cases, not at all. Consequently, as communication broke down, 
patient information was either missing or out-of-date at the time when it was most needed.  
‘The communication, in terms of letters from clinics and things is terrible, often waiting 
months to get a letter about medication changes. By the time you get the letter, the medication 
has changed again, so that’s really difficult.’ (HP02, GP) 
‘We have difficulty with the medication side of things because of poor communication with 
psychiatry services.’ (HP05, GP) 
Furthermore, GPs reported that even when information was received, it was generally difficult to 
decipher or to identify the important details.  
‘It’s usually by – if they let us know at all, and they don’t always – it would usually be by 
letter.  Some letters highlight it quite clearly that there has been a change in medication. And 
then they’re easy to pick up.  Sometimes the change in medication is hidden in the text. And 
you have to read each letter carefully, sometimes, in order to be sure you’re not missing 
something.’ (HP11, GP)  
Delays in communication and the sharing of information from mental health services was repeatedly 
flagged as poor practice. Many GPs claimed that not having up-to-date information limited how 
effectively they could respond to a patient’s health needs, in some cases endangering their safety.  
However, the problem encountered by most GPs was brought into sharp relief by the positive 
experience of a GP whose proactive approach showcased how care delivery and sharing of 
information might be improved.  
‘[communication] has improved … we had a meeting with the mental health service providers 
and highlighted two issues.  Then they changed the [patient letter] format and now they say, 
“GP to action” as a separate line at the end.  So, that helps because otherwise it’s buried in 
the whole information.  So, we have an entry for “GP to action”: “change this”, or “do this”, 
or “take bloods”… if anything urgent comes in, they either call or fax things now.  So, those 
things have got better.’ (HP06, GP) 
This GP deviated from the others in this study sample, standing out as a positive example. It 
highlights, however, that for most practices communication with mental health services had become 
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increasingly stretched, which distanced patients and eroded quality of care. Furthermore, the language 
used by GPs reinforced the overarching theme around visibility, discussed at the end of this chapter, 
as even when they received correspondence, key information was not visible but rather 
‘hidden’(HP11, GP) or ‘buried’(HP06, GP) in the text. 
5.6.2 No point of contact 
Practitioners also spoke about how it had become increasingly difficult to identify a professional point 
of contact in secondary care as system level structural changes over recent years have further 
distanced primary care from mental health services. Many GPs recalled a time when communication 
with mental health providers was more embedded, and CPNs had a physical presence at practices, 
which enabled GPs to share information with them face-to-face. According to some, current mental 
health teams are far more transient than in the past with fewer CPNs present at practices, causing 
further fragmentation and delays in communication. 
‘I remember when I was training, you would know the local CPN and they would be able to 
come to practice meetings and discuss patients they were concerned about … now, that all 
seems to have broken down completely, there seems to be a new team every five minutes … 
we don’t really know who’s under what team so it’s difficult to know who to speak to.’ (HP02, 
GP)  
Most practitioners claimed the current lack of integration of community mental health workers within 
practices was a key barrier to providing adequate quality of care to SMI patients.  Moreover, GPs 
revealed that any direct communication via telephone or email with members of the community 
mental health team was becoming increasingly rare.  
‘We don’t have a great relationship with secondary care.  I mean if a patient has got a CPN 
… we don’t have any records particularly of who their CPN is unless they’ve got that 
information in a letter.  And we don’t have any regular contact with anybody’s CPN.’ (HP09, 
GP) 
One GP spoke despairingly at how communication between primary and secondary care services had 
deteriorated.  
‘I have no contact with secondary care. None whatsoever. I do not know who the psychiatrists 
are who are supposedly overseeing our patients … I don’t have a contact psychiatrist 
anymore. I’m unable to get a psychiatric opinion, even if I specifically ask for it.’ (HP05).   
He questioned how practitioners could be expected to provide SMI patients with the quality of care 
they deserved when the gap between primary care and mental health services was widening, and they 
now had virtually no point of contact with professionals from psychiatric care. 
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5.6.3 Who is responsible for care? 
The patient narrative on the interface between primary and secondary care centred on their frustration 
about having to endure increasing delays in decisions on their care. Closely linked to subthemes in 
Theme 3, their principal concern related to medication and who was responsible for making changes 
to it or discussing its side-effects. All patients still under secondary care revealed that GPs avoided 
discussing possible changes to their psychotropic medication as they did not regard it as their 
responsibility. However, due to the increasing difficulty of communicating with psychiatric care, 
patients claimed they were left unsupported and felt in limbo, unsure about when a decision would be 
made or who would be making it.  
‘It’s kind of difficult because it’s the psychiatrist who’s prescribed the drugs … and the GP 
doesn’t want to really interfere with that.  So, if I’m having side-effects from the drugs, the 
GP says, “speak to the psychiatrist”.’(PT11, bipolar disorder) 
‘I can talk to [my GP] about it, but he won’t do anything about adjusting the medication, he’ll 
just refer me to the mental health team again.’ (PT03, bipolar disorder) 
Patients revealed the apparent breakdown in communication between their general practice and 
mental health provider had caused substantial delays to decisions made about their care. Not only did 
they report finding it difficult to initiate discussion about their medication, but, even when they did 
speak up, little action was taken. One patient described feeling ‘lost’ and ‘abandoned’ (PT14) because 
neither her GP nor psychiatrist seemed willing to take responsibility for certain aspects of her care. 
 
5.7 Narrative case study 
Core themes encapsulated by implementation of the QOF  
The next section examines how patient and practitioner data, relating specifically to the Quality and 
Outcomes Framework (QOF) physical health checks, impacted on the quality of care delivered to and 
received by SMI patients. It draws on aspects of care and experiences described in Themes 1 to 4, 




5.7.1    Background  
The QOF, a nationwide quality improvement scheme, was rolled out across the UK in 2004 to 
improve quality of care (Roland, 2004). One of the aims within the mental health category was to 
reduce the mortality gap (Kendrick, 1996), underpinned by evidence that people with SMI have a 15-
20 year reduced life expectancy (Thornicroft, 2011) compared with the general population (discussed 
in Chapter One). From the outset QOF offered practices financial incentives (discussed in Chapter 
Two) to conduct physical health checks on SMI patients in an attempt to reduce the likelihood of 
premature mortality from common chronic conditions such as cardiovascular and respiratory disease. 
 
Physical health checks for SMI patients, which are discussed in more detail in Chapter Six and 
Chapter Seven, have been part of the QOF mental health category since its inception in 2004 (NHS 
Employers). In summary: 
 From 2004/05 until 2010/11 GPs were offered financial incentives to conduct an annual 
review for SMI patients, which included taking a number of physical health measurements.  
 In 2011/12 the annual review was removed and four separate physical health indicators were 
introduced. These rewarded practices for recording measurements of a patient’s blood 
pressure, cholesterol, body mass index (BMI) and blood glucose.  
 In 2014/15, the indicators for cholesterol, BMI and glucose were removed. Blood pressure 
was the only physical health indicator to remain incentivised.  
Consequently, given the interviews were conducted between September 2017 to May 2018, and asked 
participants about their previous experiences of providing or receiving health checks, patient and 
practitioner responses could have been referring to time periods when different incentives were in 
place compared with the recent period, since April 2014, when only blood pressure was incentivised. 
5.7.2      Effect of QOF implementation on SMI patient care 
In practical terms QOF increased the physical visibility of SMI patients as they were invited to attend 
the practice to undergo physical health checks. As practices were financially rewarded to record 
measurements for each patient, there was a direct incentive to encourage patients to attend, at least 
once a year. During the interviews, all patients and practitioners were asked what they thought about 
the QOF physical health checks, although the term ‘QOF’ was not used with patients as it could have 
been an unfamiliar term to them. With the exception of the youngest (PT13), each patient claimed 
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they had undergone at least one annual health check. All practitioners were familiar with the QOF.  
The principal finding from both the patient and practitioner discourse was that, despite its good 
intentions to improve quality of care, the QOF had negatively impacted on patient-centred care, which 
encapsulated many of the key findings and core themes discussed previously. Respondents claimed 
the QOF focused attention on disease risk and recording of measurements at the expense of a whole 
person approach. From both the patient and provider perspectives, the discourse suggested that health 
checks had prioritised the ticking of boxes at the expense of other aspects of care, which created 
unwanted outcomes, described as ‘unintended consequences’ (Lester et al., 2011).  
 
5.7.3 Participant perceptions of the implementation of the QOF  
Participant experiences of the QOF physical health checks, detailed throughout the patient and 
practitioner interviews, were closely intertwined with the core themes and subthemes around patient-
centred and holistic care, the whole person approach, healthy living advice, time constraints and 
patient engagement. Focusing directly on views of the QOF as part of a narrative case study therefore 
exemplified a number of the key findings, further reinforcing many of the core themes and subthemes. 
Patient perspective 
Nearly all patients claimed QOF physical health checks had eroded the quality of primary care. Most 
recalled their disappointment at attending a health check, describing it as a rapid ‘in-out’ (PT07) once 
a year event, which involved a few questions and the ticking of boxes on the computer. 
‘They take the samples, ask all the questions, tick the boxes on the computer …I know they’ve 
got a lot on, I’m not trying to be facetious or anything, it’s just that’s the way it happens. 
(PT04, bipolar disorder) 
‘Just weight, height, questions about lifestyle, how many units of alcohol, do I smoke … 
there’s no discussion about it, they just take the measurements.’ (PT03, bipolar disorder) 
Moreover, many patients revealed the absence of any dialogue during health checks made them feel 
they were not being treated as a whole person, corresponding closely to subthemes in Theme 1 and 
Theme 3. Patients questioned why there was no explanation for why they had been invited to attend a 
health check. Furthermore, most could not understand why practitioners did not discuss what the 
checks meant for their physical health or offer any healthy living advice. These frustrations was 
exemplified by one patient who revealed that her GP would weigh her and record the measurement, 
but, even when it was obvious she had gained a substantial amount of weight, would not offer any 
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advice about how to lose weight.  
 ‘We get one a year [health check].  You jump on the scales … I’d put three stones on … they 
have no interest in helping you lose weight, none of that gets done.  You just jump on the 
scales, blah, blah, blah. And then you’re gone. It’s just in and out as quick as you can … 
blood test, your weight, and that’s it , anything you need to do you’ve got to do it yourself, 
basically, because there’s no time.’ (PT07, bipolar disorder) 
In theory, patients regarded health checks as an ideal opportunity for meaningful discussion about 
why the checks were being done and what it meant for their health risk.  In practice, they felt let down 
as many believed the opportunity for practitioners to give them healthy living advice was repeatedly 
missed, further reinforcing subthemes in Theme 1 and Theme 3. 
Practitioner perspective 
Similar to the patient discourse, most practitioners revealed the QOF physical health checks had 
undermined the quality of care they could feasibly provide. A number of GPs who had been in 
practice for several decades claimed that patient-centred care had been eroded because the QOF had 
prioritised the recording of measurements and bureaucratic administrative tasks, which left virtually 
no time to provide holistic care and speak to a patient as a whole person. Once again, this exemplified 
subthemes from Theme 1 and Theme 3.   
Furthermore, most practitioners questioned the value of QOF health checks for SMI patients given 
that it is the recording of measurements that is incentivised rather than taking any action or follow-up. 
Many GPs mirrored patients’ concerns that the QOF simplified their complex health needs and 
reduced health promotion to a box ticking exercise.  
‘To be quite frank … our requirement to report for the Quality Outcomes Framework is just a 
little nudge to remind us to do some health promotion.  But then again, it’s only recording the 
information, there’s no particular incentive for acting on the information. The reward is 
simply having recorded that someone drinks too much, you don’t get any benefit for actually 
treating them. So, that relies on our professional integrity to go further than that.’ (HP11, 
GP)   
‘Just to check they’ve got a higher risk of health problems … but the follow-up is difficult 
after that. It won’t generally be on my radar to check … if I’ve taken the blood and it comes 
back normal that’s reassuring, but it’s not actually helping them get their weight down, it’s 
just acting on a normal blood result.’ (HP04, GP) 
Moreover, practitioners complained about the difficulty of persuading patients to attend a health 
check, which may account for the relatively high rates of exception reporting among SMI patients 
(Campbell et al., 2011). This corresponds with subthemes in Theme 2 around patient engagement and 
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time constraints.  
Nuanced perceptions of the QOF 
Perceptions of the QOF were not all negative, however, with a minority of participants delivering 
more nuanced responses. First, a few patients revealed that they welcomed receiving invitations for a 
health check as it demonstrated the practice was taking an interest in their health; and second, a 
number of GPs spoke positively about the QOF, though it was only those who had not experienced 
general practice in the pre-QOF era, as more experienced GPs were unequivocal that patient-centred 
care had been eroded by the implementation of the QOF, exemplifying key findings in Theme 1 and 
Theme 3.  
A few more recently qualified GPs did claim, however, that the QOF had raised awareness of the 
physical health risks facing SMI patients and brought into view the unmet needs of this vulnerable 
group. Moreover, they revealed financial incentives had encouraged them to persevere with more 
vigour in engaging patients to attend for a health check in a way they would not do routinely for non-
incentivised aspects of care. 
‘QOF makes you do it [a health check], and it’s probably good in a way that it does make you 
do it because otherwise, it’s easy to think, “Well, we’ve written to people and said, you need a 
health check and they haven’t come, so let’s just ignore that for another year.”  So, I think 
QOF probably helped in terms of these people getting a health check.’ (HP09, GP) 
Furthermore, several practitioners claimed they had continued to conduct checks for cholesterol, BMI 
and blood glucose, even after the incentives had been removed  in 2014 (NHS Employers, 2014). 
These GPs explained that if they had succeeded in engaging a patient to attend surgery and be seen, it 
was as a missed opportunity not to take the full range of checks. 
 ‘QOF has helped because it’s made us realise that this group should have an annual health 
check. And … cutting down what’s required is not a great thing really, because if we’re going 
to call them in, we might as well be doing everything we can for them.’ (HP09, GP) 
‘We’re still doing it, it’s still on our template to do it, so I think as a rule we generally follow 
the template rather than notice what the [QOF] points are.’ (HP02, GP) 
These two GPs, who incidentally were both female and relatively newly qualified, provided a rare 
example of where the QOF had arguably embedded good practice (Roland and Lester, 2007). 
However, it was only a minority of GPs who reported that they had continued to record retired QOF 
indicators without incentives. The majority of GPs admitted to breathing a sigh of relief that they were 
no longer expected to record a series measurements for the QOF, for which there was no evidence of 
benefit to quality of care or patient outcomes (Doran et al., 2014).   
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5.7.4 Exception reporting 
Patients who do not respond to invitation for a QOF health check, or who do not present at another 
time where the check can be done opportunistically, can be removed from the indicator denominator 
to avoid penalties for the practice (Roland and Guthrie, 2016). This used to be known as exception 
reporting whereby GPs could remove a patient from an indicator for a specific reason such as clinical 
inappropriateness or patient choice (NHS England, 2019a), though its practice in relation to 
performance targets has been widely questioned (Doran et al., 2006).  
‘We generally have to exception report quite a few people because we do go through the 
process of inviting them for a review appointment, or doing it if they present for another 
reason … but quite a lot of them just don’t turn up, more than normal patients [with LTCs].' 
(HP04, GP) 
‘We do quite often struggle to get patients to come in ... they can just be difficult to 
communicate with.' (HP09, GP) 
Exception reporting is thus another instance of where the visibility of SMI patients within practices 
was compromised, discussed further in Chapter Eight. 
5.8 Chapter summary  
This chapter has presented findings from the qualitative component of this thesis, which explored 
perceptions about factors believed to enhance or erode quality of care for SMI patients. Categorised 
into four core themes the main findings are summarised below. 
 Theme 1: Patients and practitioners viewed continuity as a critical factor for developing a 
trusting and respectful relationship to enhance quality of care. 
 Theme 2: Practitioners attributed time constraints and system level factors for the decline in 
their capacity to deliver patient-centred care. 
 Theme 3: Evidence of discord and conflicting priorities between patients and practitioners 
resulting in patient needs not being heard or addressed. 
 Theme 4: Shared perspective between patients and practitioners that quality of care has been 
undermined by disconnect and a slowing down of communication with secondary care. 
Consolidating many of the key findings, the narrative case study of the QOF health checks provided 
an example of the ways in which a quality improvement scheme affected how care was provided and 
received, underlining many of the core themes and subthemes. Although opinions were nuanced, the 
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principle finding from both patient and practitioner perspectives was that the QOF had eroded quality 
of care by prioritising box ticking and the recording of measurements at the expense of patient-centred 
holistic care. Moreover, with the option to exception report patients who did not engage, the QOF 
further demonstrated that the visibility of SMI patients is transitory and inadequate. 
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Chapter Six: Quantitative Study Methods 
 
6.1 Chapter content 
The previous chapter presented and interpreted findings of the qualitative component of this thesis, 
which explored quality of care from the perspectives of patients with serious mental illness (SMI) and 
primary care providers. This chapter describes the methods used for the quantitative component, 
which examined quality of care for SMI patients from a different methodological standpoint. It begins 
by providing background and context to the study before defining the research questions and study 
objectives. It then describes the study design, data source and processes of data extraction. The 
chapter goes on to explain the methods used for statistical analysis which included a difference-in-
differences design and a multivariate logistic regression model, before considering strengths and 
limitations associated with observational data. The chapter concludes with a summary of the key 
points.  
6.2 Contextual background to research questions  
Since its inception in 2004, the Quality and Outcomes Framework(QOF) incorporated SMI as an area 
of clinical focus under the heading Mental Health, which referred specifically to diagnoses of serious 
mental illness: schizophrenia, bipolar disorder or other psychoses (NHS Employers, 2011).  
One of the original QOF indicators was an annual review, along with a practice register of SMI 
patients, and lithium monitoring. The annual review required GPs to: record a selection of physical 
health measurements; review a patient’s medication; and if relevant, check coordination with 
secondary care. The introduction of a programme of physical health monitoring reflected increased 
awareness in the scientific literature that SMI patients had higher levels of unmet physical health need 
compared with the general population (Kendrick, 1996). Elements of the QOF annual review were, 
therefore, viewed as a way of improving the quality of physical healthcare for SMI patients, 
particularly in relation to monitoring an increased cardiometabolic risk faced by SMI patients (De 
Hert et al., 2009).  
Figure 6.1 displays a timeline demonstrating at what point QOF physical health indicators were 
introduced and removed. The timeline shows that from the outset in 2004/05, QOF incentivised GP 
practices to conduct and record an annual review of SMI patients’ physical health. Initially, the time 
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period was every 15 months (NHS Employers, 2011) though this was reduced to 12 months in 
2013/14 (NHS Employers, 2013).  
 
 
Figure 6. 1   QOF timeline: SMI patient physical health indicators 
In 2011/12 policy changed and the annual review was divided into separate physical health indicators 
– blood pressure, body mass index (BMI), cholesterol and glucose/HbA1c – which were rewarded 
individually, rather than being combined to form a single incentive as had previously been the case. 
This system change lasted for only three years, however, until the end of 2013/14, after which three of 
the four cardiometabolic indicators – BMI, cholesterol and glucose/HbA1c – were retired (NHS 
Employers, 2014).Consequently, for the final two years of this study (2014/15 and 2015/16) blood 
pressure was the only physical health indicator to remain incentivised.  
However, the decision to remove the 3 indicators was not supported by the NICE advisory committee, 
and in 2015 it recommended that the 3 indicators should be reintroduced along with a new indicator 
using QRISK2 to assess cardivascular risk (NICE, 2015). In addition, the NICE QOF menu proposed 
that the age range be reduced from ≥ 40 years to ≥18 years for the cholesterol and glucose/HbA1c 
indicators, to match the age range for the blood pressure indicator ( the BMI indicator had also been 
for anyone aged ≥18 years.  
Finally, before moving onto the study design and methods, it is worth noting that Figure 6.1 displays 
additional changes to QOF physical health indicators, which occurred after this study time period 
ended. It provides two key pieces of information relevant to this thesis, which are discussed in 
Chapter Eight: first, blood pressure has remained incentivised up to the present time (March 2020); 
and second, BMI was reintroduced in 2019/20. 
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6.2.1 A natural experiment 
The removal of QOF indicators in 2013/14 thus presented  a unique opportunity to carry out a natural 
experiment (Craig et al., 2017), to investigate the effect that withdrawal of incentives had on the 
proportion of patients who received a health check. Given that blood pressure remained financially 
rewarded throughout the study period, it acted as a control for the other three indicators – BMI, 
cholesterol and glucose/HbA1c – where incentives had been removed. 
6.3 Aims and objectives  
6.3.1 Research questions  
The quantitative arm of the study, which is the second core component of research for this thesis, 
aimed to address two main research questions: 
1a.) Did the removal of incentives for three QOF indicators – BMI, cholesterol, and 
glucose/HbA1c – affect the proportion of SMI patients who received a health check 
for those indicators?  
 
1b.) Were there any differences between the proportion of SMI patients who received a 
recording for BMI, cholesterol, and glucose/HbA1c compared with blood pressure, 
which continued to be incentivised, in the time period before and after incentives 
were removed? 
 
2.)  Is there any evidence that certain types of SMI patients were more likely to have 
received physical health checks, in relation to the demographic variables of: age; 
gender; ethnicity; SMI diagnosis type; or deprivation level? 
6.3.2 Objectives 
1) To conduct descriptive analysis of patient level data to:  
a. Examine patient demographics and the representativeness of the dataset 
b. Measure the crude proportions of patients who received a health check by financial 
year for each indicator. 
2) To estimate the effect of policy change (removal of incentives) on the proportion of SMI 
patients who received a physical health check by measuring differences before and after 
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incentives were removed for BMI, cholesterol, and glucose/HbA1c compared with blood 
pressure, which remained incentivised. 
3) To investigate the effect of other, potentially confounding, independent variables on the 
proportion of patients who received a health check, to determine which patients were more 
likely to have received a check. 
4) To conduct descriptive analyses at the practice level to examine variation in practice 
performance (proportion of a practice’s SMI population who received a health check) before 
and after incentives were removed, in relation to the number of SMI patients registered at a 
practice and practice deprivation level. 
6.4 Study design  
The design for this study was a retrospective, longitudinal observational cohort.   
6.5 Study setting 
The study setting was a UK primary care database, the Clinical Practice Research Datalink, which 
provided access to electronic health records from over 700 general practices. The study period was 
five years: from 1 April 2011 until 31 March 2016. 
6.6 Data source 
6.6.1 CPRD 
The principal data source for this study was the Clinical Practice Research Datalink (CPRD), 
previously known as the General Practice Research Database, established over 30 years ago. CPRD 
provided this study with anonymised real world patient data, routinely collected from general 
practices in the UK (Clinical Practice Research Datalink, 2019). Until recently CPRD collected data 
solely from participating practices using Vision (Vision) software, though it now also collects data 
from  practices using EMIS Web (Emis Health), known as CPRD AURUM. These two software 
systems have not yet been synthesised, however, so at present the datasets cannot be combined. 
Consequently, the dataset for this study was extracted from the CPRD GOLD database, consisting of 
data from Vision practices. 
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CPRD is a rich source of observational data, which has provided increasingly high quality data over 
the years (Springate et al., 2014), particularly since the introduction of the QOF in 2004, which 
enhanced the quality of data recoding in primary care (Herrett et al., 2015).  Indeed, in the UK CPRD 
is one of the most widely used sources of primary care health data, valued for providing access to 
real-world data (McDonald et al., 2018). It supplies data across a range of variables including 
demographics, symptoms, diagnoses (from Read codes), prescriptions and referrals, from electronic 
health records of all patients registered at participating practices, except for those patients who have 
actively requested to opt-out from having their data shared. To ensure data quality, CPRD checks that 
data are of an ‘acceptable’ level from a practice before issuing an ‘up to standard’ date, which reflects 
the time point from when data are deemed to be of high enough quality to be included in research 
studies (Padmanabhan, 2017).  
The expansion of CPRD over recent decades has vastly increased its coverage. By 2017, it included 
around 8% of the UK population, comprising of approximately 17 million patients – historical and 
current – registered at over 700 practices (Kontopantelis et al., 2018). The CPRD database is also 
considered to be broadly representative of the UK population in relation to key demographic variables 
such as age, sex and ethnicity (Mathur et al., 2014). Practices are not considered to be nationally 
representative, however, in relation to either practice list size or geographic location  (Campbell et al., 
2013). In general, CPRD practices have larger list sizes than the national average and are 
disproportionately located in urban areas within the South and North West regions of the country 
(Herrett et al., 2015).   
6.6.2 Data accessed for this study 
This thesis obtained access to CPRD data from the dataset used by EMERALD, a related study 
(Bellass et al., 2019) conducted at the University of York, which explored variation in diabetes 
outcomes for people with serious mental illness. This had not been part of the original plan, rather it 
reflected a pragmatic response to overcoming challenges presented at the time GDPR was being 
introduced. From the outset, the intended plan had been to obtain access to a CPRD dataset remotely 
via CALIBER (UCL Insitiute of Health Informatics). After prolonged delay, however, with no 
indication from the CALIBER team about when remote access provision would resume, an alternative 
plan was adopted. The EMERALD study dataset was a timely and suitable substitute, consisting of 
SMI patient data extracted from the CPRD GOLD database. Moreover, linkages to additional sources 
of health and demographic data were already in place, which had been the plan for the original dataset 
to provide a richer dataset than would have been possible from the CPRD database alone.  
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6.6.3 Data linkages with CPRD 
CPRD provides the opportunity for electronic data linkages at the individual patient level with other 
health related datasets such as Hospital Episode Statistics (HES), the Office for National Statistics 
(ONS) mortality data and the Index of multiple deprivation (IMD). Linkages are carried out by a 
trusted third party (Padmanabhan et al., 2019) using an identifiable data variable – typically a 
patient’s NHS number for HES and ONS, or a patient’s postcode for IMD – for patients registered at 
practices who have consented to have their data linked with other sources  (Herrett et al., 2015).   
Hospital Episode Statistics (HES) 
HES is a secondary care database containing detailed information on all admissions, emergency 
presentations and outpatient appointments at NHS hospitals in England (NHS Digital). CPRD had 
provided linkage to HES data for hospital admissions for the EMERALD study. This study combined 
the CPRD and HES recordings of a patient’s ethnicity to strengthen the data and minimise recordings 
of missing data.  
Office for National Statistics mortality data (ONS) 
The ONS mortality data provides information recorded on the death certificate for all deaths 
registered in England and Wales (NHS Digital). CPRD provided linkage with the ONS mortality data 
for all patients included in the EMERALD study. Consequently, this study had access to a dataset 
with information on both cause and date of death for any patients who died during the study period.  
Index of multiple deprivation (IMD) 
The IMD is an English indices of deprivation used to measure relative deprivation in small areas in 
England – known as lower-layer super output areas (LSOAs) – which include populations of 
approximately 1500 people (Allik et al., 2020). Combining seven multiple socioeconomic indicators – 
income, employment, health and disability, education, barriers to housing and services, living 
environment, and crime – the IMD provides a broad measure of deprivation (Department for 
Communities and Local Government). Deprivation level is categorised into either quintiles or deciles, 
though this study used quintiles where the first category (1) represents the least deprived and the last 
category (5) the most deprived. Patient level IMD is assigned by the patient’s postcode of residence; 
practice level IMD is based on the postcode of the general practice. CPRD provided dual linkage to 
the EMERALD study, allowing this study to access data for area deprivation at both the patient and 
the practice level. 
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6.7 Ethical approval  
Access to data from CPRD required approval of the study protocol by the Independent Scientific 
Advisory Committee (ISAC). Scientific approval for the original CPRD protocol for this thesis was 
granted by ISAC in April 2018 to access the CPRD dataset remotely via CALIBER (UCL Insitiute of 
Health Informatics) (see Appendix 6.1).  However, as previously described, plans had to be revised 
and access to a suitable dataset was granted by Professor NS the EMERALD study’s chief 
investigator at the University of York. In addition, an EMERALD study protocol amendment was 
submitted to ISAC to obtain approval for this thesis to use the EMERALD dataset (see Appendix 6.2).  
6.8 Data preparation 
The EMERALD dataset accessed by this study consisted of electronic health records for patients with 
and without SMI (see Appendix 6.3), however, this thesis was only concerned with SMI patients. 
Hence a subset of the dataset was created, which only included patients with an SMI diagnosis who 
were eligible for all linkages. In total, there were 32, 759 individual patients from 328 different 
practices.  
6.8.1 Data cleaning and extraction  
Early stages of the data cleaning process had already been conducted by LH, –one of the investigators 
on the EMERALD study (NIHR HS&DR study (Lister et al., 2021)) and a co-supervisor for this PhD.  
Principally, this involved importing linkages to the patient file (including deprivation level, ONS 
death dates, ethnicity categorisation from HES data) along with cross referencing SMI diagnosis dates 
to check whether the earliest date documented in CPRD was accurate, as patients seen in secondary 
care may not have had their earliest diagnosis date recorded in primary care. Consequently, the subset 
of the EMERALD dataset used to conduct secondary data analysis for this thesis was already 
relatively ‘clean’, requiring fewer data quality checks than a dataset extracted directly from CPRD. 
The reliability of the dataset was, however, further validated by cross checking core demographics 
included in the data (such as age, gender, SMI diagnosis) to check their representativeness and 
performing checks to assess the extent of missing data particularly for the core variables (Virdee et 
al., 2020).  
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6.9 Participant eligibility  
Participant eligibility for the study was determined by whether or not they were aged 18 and above at 
the time of SMI diagnosis; they had been diagnosed for at least 3 months before the start of each 
financial year; and they had been registered for the duration of each financial year, including 3 months 
before it began – see Table 6.1.  
6.10 Configuration of CPRD data files 
The way in which CPRD data are configured enabled analysis to be conducted at different levels – 
patient, staff or practice – all of which have unique identifiers. As shown in Table 6.2 information on 
different aspects of patient care is held in ten files, and this study merged and appended different units 
of data from other CPRD files to attain a more comprehensive set of data into an overarching patient 
file. The aggregation of different types of data into a singular file created a rich source of information 
at the individual patient level allowing multiple variables to be included in analyses.  
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Table 6. 1     Data specifications for patient eligibility 
 
Inclusion criteria Justification 
 
 
Diagnosed with SMI at least 3 months (90 
days) before start of each financial year. 
In line with QOF Business Rules (HSCIC, 2013) which allow 
practices to exception report patients who have been registered for 




Registered at practice for 15 months (includes 
3 months before start and full term of each 
financial year). 




Aged 18 years or over at first SMI diagnosis. 
 
SMI diagnosis more difficult to ascertain in children. Also QOF 
mental health indicators only relate to SMI patients aged 18 and 
above (NICE, 2015). 
 
    
 
Table 6. 2   CPRD data files and how they are linked     
 Dataset Description  
 Patient file Information on patient (demographic/registration details) unique patient identifier  
 Practice file Details on practice (region and last collection date) unique patient and staff identifier  
 Staff file Information on practice staff (gender/role) unique patient and staff identifier  
 Consultation file Information on consultations (type/duration/event date) unique patient and staff identifier  
 Clinical file Information on all medical events (symptoms/signs/diagnoses) unique patient and staff identifier  
 Additional clinical details file Data linked to events in clinical file unique patient identifier and additional identifier  
 Immunisation file All immunisations recorded on GP system unique patient and staff identifier  
 Referral file Any patient referrals to secondary or tertiary care unique patient and staff identifier  
 Test file All tests requested for patients unique patient and staff identifier  
 Therapy file All information on prescriptions issued to patients unique patient and staff identifier  
 Based on CPRD GOLD Data Specification (Padmanabhan, 2017)  
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6.11 Statistical analyses 
Stata v.15 (stata) was used to conduct analyses for both the descriptive and the statistical modelling 
parts of this study. 
 Descriptive analysis, carried out at both the patient and practice level, was used to describe 
the main features of the data: 
1) Patient level – included patient demographics and the crude proportion of patients 
who received a health check by financial year for each indicator. 
2) Practice level – included practice demographics and comparisons between 
practice performance (proportion of patients to have received a health check) 
before and after incentives were removed, in relation to the number of SMI 
patients registered and deprivation level. 
 Statistical analysis used two types of mathematical modelling to investigate the primary and 
secondary aims of the study. 
1) Primary outcome: a difference-in-differences approach was used to estimate the 
effect of removal of incentives on the proportion of patients who received a 
health check, compared with an indicator that remained incentivised. 
2) Secondary outcomes: a multivariate logistic regression model was constructed to 
measure the effect of independent variables on the likelihood of a patient 
receiving a heath check. 
6.11.1 Rationale for methods 
Quasi-experimental methods 
For evaluating public health policies, quasi-experimental methods such as interrupted time series and 
difference-in-differences designs provide a strong alternative to the gold standard method of 
randomisation (Kontopantelis et al., 2015a). Quasi-experimental methods have become an 
increasingly popular way of measuring the impact of large-scale population health interventions that 
cannot be tested experimentally for ethical or practical reasons (Wagner et al., 2002). Given the 
primary aim of this study was to measure the effect of a health policy change that occurred at the 
national level – removal of QOF incentives across the UK – it was not feasible to conduct a 
randomised control trial (RCT). Quasi-experimental methods were the next best alternative. 
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Moreover, such designs offered stronger external validity through the use of real-world data, 
compared with RCTs where data are collected under control conditions  (Shadish et al., 2002). 
Furthermore,  because the policy change under investigation for this study  took place at a single point 
in time and at the population level, it provided the opportunity to conduct a natural experiment 
(Kontopantelis et al., 2015a) to assess outcomes before and after, amongst the same population.  
Selecting a quasi-experimental design 
Choosing which quasi-experimental design to use to evaluate a natural experiment should depend on 
specific features of the study such as allocation of the intervention, data time points and size of the 
sample exposed, rather than which methods are viewed as strongest (Craig et al., 2017).  Based on 
these criteria, at the planning stage of this study, either interrupted time series or a difference-in-
differences design would have been an appropriate guide to measuring the effect of policy removal as 
the intended dataset would have satisfied the criteria for both designs (Shadish et al., 2002). 
From interrupted time series to a difference-in-differences design  
Initially, interrupted time series had been the favoured option to inform data analysis. Plans had to be 
revised, however, as the dataset which replaced the original one that had been approved by ISAC (to 
be accessed remotely via CALIBER, as discussed earlier), did not have sufficient post-intervention 
time points for interrupted time series analysis, which requires a minimum of three data points post-
intervention (Cochrane Effective Practice and Organisation of Care Review Group, 2013). Given that 
QOF reports annually, there were only two data points (2014/15 and 2015/16) post intervention 
available from the EMERALD study dataset. Furthermore, it was not feasible to increase the number 
of data points by introducing monthly or quarterly measures as they would not have been an accurate 
reflection of QOF achievement (Minchin et al., 2018).  Consequently, a difference-in-differences 
design was selected as the preferred method to conduct analysis and the study design and statistical 
analysis plan were revised accordingly. 
6.11.2 Difference-in-differences design 
A difference-in-differences design compares change in outcome between people exposed to an 
intervention with the outcome change of those who were not exposed. Developed as a method within 
econometrics, the origins of the difference-in-differences approach stem back to the 1850s when  John 
Snow’s evidence was published (1855) showing cholera was transmitted through the water supply 
rather than the air.  In recent years, difference-in-differences designs are being used increasingly to 
evaluate health policy impact, principally, because they control for one of the key confounders 
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associated with observational data: background changes in outcomes that occur over time (Ryan et al., 
2015). A difference-in-differences design thus offered a robust means of estimating the impact of a 
QOF health policy intervention, by comparing changes in outcomes over time between a group 
exposed to the intervention (Group 1), which was removal of incentives, and a group unexposed to the 
intervention (Group 2).  
Modelling the outcome 
The study aimed to measure the difference in the proportion of patients who received a health check 
for BMI, cholesterol and glucose/HbA1c, before and after incentives were removed, comparing the 
difference in outcomes with blood pressure, which remained incentivised, so acted as a control.  
Given this study involved a single difference-in-differences analysis (Villa, 2016) the statistical model 
used, shown in Figure 6.2, was a standard regression model for difference-in-differences estimation, 
as described by Craig et al (2017).  
 
Figure 6. 2     Regression model for difference-in-differences estimation    
 
Model 1: Yit = β0 + β1Ei + β2Pt + β3Ei × Pt + εit  
In Model 1 Y is the outcome, observations are made on different units i, at times t, and the regression 
model includes an additional term for the period (P) in which the observation took place (coded 0 for 
pre-intervention or 1 for post-intervention), and an interaction term between the period and exposure, 
which provides the difference-in-differences effect estimate β3: 
Source: (Craig et al., 2017) 
 




Figure 6.3 visually displays the predictive model for the difference-in-differences estimate for this 
study. It shows the removal of incentives was expected to have resulted in a negative outcome, 
displayed by a smaller proportion of patients receiving health checks in Group 1 after financial 
incentives had been removed.  
The difference-in-differences estimate β3 is demonstrated by the difference between two differences: 
difference 2 minus difference 1, displayed in the model by β2 (C-D) minus β1 (A-B). The difference-
in-differences coefficient β3 thus equates to the ‘treatment effect’ or, in the case of this study, the 
‘removal of incentives effect’. It is the difference in outcomes between group 1 (retired incentives) 
and group 2 (still incentivised) post-intervention, minus the difference in outcomes between group 1 
and group 2 pre-intervention.  If, however, there was no change in outcomes between Group 1 and 
Group 2, and the difference-in-differences estimate was equal to zero, it would be assumed that the 
removal of incentives had had no effect (Ryan et al., 2015).   
6.11.3 Secondary outcomes analysis 
A multivariate logistic regression technique was selected to examine the effect of other (potentially 
confounding) factors on the dependent variable of whether or not a patient received a health check 
each financial year. Due to the yes/no binary outcome of the dependent variable, logistic regression 
was the most appropriate statistical model to use (Peng et al., 2010). Thus, a multivariate logistic 
regression model was constructed, shown in Figure 6.4, to measure the likelihood of a patient 
receiving a health check whilst holding other independent variables to account.  
 
Figure 6. 4     Multivariate regression model    
Model 2: Yi = β0 + β1Ei + β2Xi + εi  
A standard multivariate regression model was used to estimate the effect of exposure to the 
intervention (E), removal of incentives, on the outcome (Y), proportion of patients who received a 
health check, with adjustment for independent variables, which may have influenced the outcome (X). 
Source: (Craig et al., 2017) 
 
Selecting independent variables 
Construction of a multivariate regression model for this study involved selecting a range of 
independent variables, which may have influenced the outcome of whether or not a patient received a 




likelihood of a participant receiving a health check for each financial year from 2011/12 to 2015/16 
whilst holding the other independent variables constant.  
Potential independent variables were selected based on background knowledge of the literature (Shipe 
et al., 2019) and discussion with thesis supervisors about what would be meaningful and what was 
feasible given the delay in acquiring access to CPRD data. It was agreed that due to time constraints 
data analysis should concentrate on core demographics of each patient rather than include 
comorbidities. The logistic regression model, built on an empirical basis,  involved individually 
testing independent variables such as age, gender, SMI diagnosis (Bursac et al., 2008), before adding 
them to the model in a step-by-step iterative construction, known as stepwise forward selection 
procedure (Heinze et al., 2018). The multivariate model thus provided a more accurate estimate of 
effect between each independent variable and the dependent variable by adjusting for the other 
independent variables in the model (Bland, 2015). The final selection included in the regression 
model consisted of six core demographic variables: age; gender; SMI type; ethnic origin; and 
deprivation level. 
Categorising variables 
Reference categories were chosen on the basis of size and association with the outcome of  interest 
(Ranganathan et al., 2017).  Generally, a larger group within a variable, such as schizophrenia for SMI 
type, would form the reference point for the other categories (Tabachnick  and Fidell, 2013). For 
continuous variables such as age, decisions had to be made about how best to group the variable into 
categories in a way that would minimise information loss and the associated reduction in statistical 
power (Altman and Royston, 2006). For variables that were already categorical, but which had 
numerous categories, pragmatic decisions were made in an attempt to keep the model simple. 
Consequently, some of the very small categories within variables were merged, for example, ‘mixed’ 
and ‘other’ were combined in the ethnicity category. The sole dichotomous independent variable 
included in the model was gender, which remained unaltered from its binary state within the CPRD 
dataset. 
Independent variables included in the model 
For the variables with multiple categories or continuous numbers, decisions about how to categorise 
them were based on testing out different ways of doing it and then discussing the results with thesis 
supervisors. The final list of covariates included in the model comprised of six: financial year, age, 




 Age was converted from a continuous variable to a categorical variable, grouped into 4 
categories, with the reference category selected as 40-59 years. The other three categories 
were: under 40 years; 60-74 years; and 75 years and over. The age of 40 years was chosen as 
the first cut-off point because two of the health checks (cholesterol and glucose/HbA1c) were 
only incentivised for patients aged 40 years and above, meaning that sensitivity analyses 
could be conducted comparing outcomes relative to that age. 
 Gender was a dichotomous category in the CPRD dataset consisting only of male/female. For 
this study, male was selected as the reference category, to be compared with female.  
 SMI type was categorised into 4 types of diagnosis. Schizophrenia was chosen as the 
reference category to be compared with: bipolar disorder; depression with psychosis; and 
other affective disorders, which included other smaller categories of diagnosis including 
schizoaffective disorder.  
 Ethnicity used categories from the core 2011 Census Ethnic Categories (GOV.UK.). It 
consisted of White (disproportionately the largest group); Asian; Black; and Other, which 
included Mixed, another very small category.  
 Patient level area deprivation as measured by the Index of Multiple Deprivation in 2010 
(Department for Communities and Local Government). Deprivation was categorised by 
quintile: 1 the least deprived, selected as the reference category, and 5 the most deprived.  
6.11.4 Fixed effects 
Given that the core demographic variables were time invariant, a fixed effects model was selected to 
control for omitted variable bias, based on the assumption that whatever the effect omitted variables 
have on the outcome, they will have the same effect at a later time, therefore, the effects would be 
constant or ‘fixed’ (Allison, 2009). Financial year was thus included as a dummy variable for four out 
of the five years to control for the specific effect of time.   
6.11.5 Adjusting for standard error 
Both models adjusted the standard errors for clustering (Ryan et al., 2015) at the practice level. 
6.11.6 Missing data in CPRD 
Missing data within the CPRD dataset was minimal. Ethnicity and deprivation level were the only two 
covariates included in the model that contained missing data, consisting of less than 4.5% for ethnicity 
and 0.1% for deprivation across all five years. Despite there being no standardised cut-off point in the 
literature for what percentage level of missing data is acceptable for statistical analyses, it is 
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considered that less than 5% is unlikely to introduce bias (Bennett. D. A, 2001). Consequently, given 
the categories with missing data had less this, missing data was removed from the analyses. 
6.12 Strengths and limitations of observational data  
6.12.1 Data source 
One of the key strengths of using observational data from a primary care database such as CPRD is 
that it provides a much larger sample with wider geographical reach than would be possible with 
experimental data (Herrett et al., 2015). In addition, its sample of patients is largely representative of 
the general population. Moreover, because it is routinely recorded in clinical practice, it enables 
researchers to use real-world data, which has stronger external validity compared with RCTs 
(Kontopantelis et al., 2015a). Another core strength of CPRD is the quality of data recording which is 
consistently high, particularly after the introduction of QOF in 2004 (Khan et al., 2010). Finally, as 
data in the CPRD database are recorded at the patient level, it provides a rich dataset of granular data, 
which is particularly valuable to researchers (Gallagher et al., 2019).  
There are, however, potential limitations associated with using observational data. Primarily, there is 
an inherent risk of biases being introduced through inconsistent or inaccurate recording of data 
(McDonald et al., 2018). In addition, variation in coding may occur between practices and/or over 
time affecting the quality of data recorded, which may introduce bias in how care is recorded 
compared with how care is delivered (Springate et al., 2014). Sample size, though rarely a problem 
for primary care databases, can present an issue when using multiple data linkages, which typically 
reduce the number of eligible patients by up to half (Herrett et al., 2015). In addition, there is a 
possibility that separate data sources provide strands of unmatched data, although previous studies 
which used multiple data sources reported all data linkages to be of high quality (Ride et al., 2018, 
Jacobs et al., 2015a). Finally, relating specifically to CPRD, the database is overrepresented by larger 
GP practices in urban areas in the South and the North West of the country. Consequently, questions 
remain over the representativeness of UK practices regarding deprivation and practice list size 
(Kontopantelis et al., 2015b). 
6.12.2 Methods 
A core strength of quasi-experimental study designs is that researchers can estimate causal effects, 
which is not feasible using most observational approaches (Kontopantelis et al., 2015a).  Indeed, 
evidence suggests a difference-in-differences design is the quasi-experimental design that gets closest 
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to being able to measure causal inference (Wing et al., 2018). In addition, simple pre-post study 
designs cannot detect underlying trends: however, methods such as a difference-in-differences design 
addresses the problem by using a comparison group (in this case blood pressure) experiencing the 
same time trends, but not exposed to the policy change (Dimick and Ryan, 2014). As such, using a 
difference-in-differences approach is reliant on having access to and using pre-intervention data and it 
is this feature that allows for control of unobserved variables that typically bias estimates of causal 
effect. Furthermore, another strength of the statistical methods used for this study was the multivariate 
logistic regression model, which enabled the effect sizes of individual variables to be adjusted for 
while keeping other covariates constant. This controlled for confounding and provided estimates for 
the relative influence of independent variables (Peng et al., 2010).  
There are potential limitations, however, associated with using quasi-experimental methods. For 
difference-in-differences designs these relate largely to the assumptions that need to be met to ensure 
internal validity. As discussed earlier, a difference-in-differences design is not able to use 
randomisation to avoid bias from unmeasured confounders. Therefore, to compensate for not being 
able to randomly assign participants, assumptions are imposed to minimise the effect of possible 
confounders (Ryan et al., 2015). Principally, the key assumption that needs meeting is the ‘parallel 
trends’ assumption based on the premise that, in the absence of policy intervention, the difference 
between the treatment group (indicators where incentives were removed) and control group (indicator 
where incentives remained) would have remained constant over time (Zhou et al., 2016).  Additional 
risk to internal validity is caused when the ‘common shocks’ assumption cannot be met, when it is 
likely  an unexpected event (unrelated to the policy change) would have affected the intervention and 
the control group differently (Dimick and Ryan, 2014).  Finally, the main limitation associated with 
using regression models relates to the quality of data. Missing data or inconsistently recorded data can 
limit the strength of data analysis (Bland, 2015), however, this is unlikely to have affected this study 
as the basic demographics are very well recorded in CPRD (Ride et al., 2018). 
6.13 Chapter summary 
This chapter has provided rationale for why CPRD was selected as a suitable data source for this 
thesis. It has outlined the decisions made about the study design and statistical analysis plan, 
principally in relation to controlling for confounding, to maximise internal validity and ensure 
robustness of findings.  The chapter explained why an interrupted time series design was not deemed 
appropriate given the small number of post-intervention time points in the dataset and why a 
difference-in-differences design was a preferable alternative. It then discussed construction of a 
multivariate logistic regression model used to measure the influence of other confounding factors on 
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the outcome of interest. Finally, it described the strengths and limitations associated with using 





Chapter Seven: Quantitative Study Results 
7.1 Chapter content 
This chapter presents findings from the quantitative study carried out for this thesis, using the 
methods described in the previous chapter. Analyses were conducted primarily at the patient level, 
accompanied by some descriptive analysis at the practice level. The chapter begins by summarising 
data preparation and outlining participant characteristics. It then presents results from analysis using a 
difference-in-differences approach, which estimated the effect of removal of financial incentives on 
the proportion of participants receiving a health check, using blood pressure as a control. It goes on to 
present findings from analysis of secondary outcomes using a multivariate logistic regression model, 
which examined the likelihood of a participant receiving a health check whilst controlling for 
independent variables. Practice level data were then analysed to examine variation in indicator 
performance by number of SMI patients registered at a practice and area level deprivation.  
7.2 Data preparation 
Identifying eligible patients 
The study sample for this thesis comprised of 32,159 patients with a diagnosis of SMI recorded in 
primary care who met eligibility criteria (see Table 6.1, Chapter Six) for the five financial years 
included in the study period (2011/12 to 2015/16). As described in Chapter Six, the dataset for this 
thesis was drawn from the EMERALD study (Bellass et al., 2019), a larger longitudinal CPRD dataset 
spanning from April 1st 2000 to March 31st 2016 that included patients with and without SMI. Data 
preparation consisted of a number of procedures outlined in Appendix 7.1. 
7.3 Patient level descriptive analyses 
7.3.1 Summary statistics 
As shown in Table 7.1, once eligibility criteria had been applied, the total number of eligible patients 
decreased year on year across the study period. The study sample consisted of: 11,768 patients in 
2011/12; 11,682 patients in 2012/13; 10,630 patients in 2013/14; 9,057 patients in 2014/15; and 6,185 
patients in 2015/16, indicating the largest decrease in number of eligible patients was from 2014/15 to 




7.3.2 Participant characteristics by financial year 
Table 7.1 shows participant characteristics for each of the five financial years included in the study: 
 In 2011/12, the sample consisted of 11,768 patients of whom 50.2% were female with a mean 
age of 51.7 years old. Ethnic origin was recorded as White in 85.3% of patients, Asian in 
4.0% of patients and Black in 3.8% of patients.  SMI diagnosis was recorded in 51.4% of 
patients as schizophrenia, 35.6% of patients as bipolar disorder, 6.5% of patients as 
depression with psychosis and 6.5% of patients as other affective disorder, which included 
schizoaffective disorder. By deprivation quintile, 14.6% of patients were in the least deprived 
category and 25.3% of patients were in the most deprived category.  
 In 2012/13, the sample consisted of 11,682 patients of whom 50.0% were female with a mean 
age of 51.7 years old. Ethnic origin was recorded as White in 84.7% of patients, Asian in 
4.2% of patients and Black in 4.2% of patients.  SMI diagnosis was recorded in 51.1% of 
patients as schizophrenia, 36.0% of patients as bipolar disorder, 6.4% of patients as 
depression with psychosis and 6.5% of patients as other affective disorder, which included 
schizoaffective disorder. By deprivation quintile, 14.4% of patients were in the least deprived 
category and 25.8% of patients were in the most deprived category. 
 In 2013/14, the sample consisted of 10,630 patients of whom 50.2% were female with a mean 
age of 51.9 years old. Ethnic origin was recorded as White in 84.7% of patients, Asian in 
4.2% of patients and Black in 4.1% of patients.  SMI diagnosis was recorded in 50.3% of 
patients as schizophrenia, 37.0% of patients as bipolar disorder, 6.4% of patients as 
depression with psychosis and 6.2% of patients as other affective disorder, which included 
schizoaffective disorder. By deprivation quintile, 15.2% of patients were in the least deprived 
category and 24.9% of patients were in the most deprived category. 
 In 2014/15, the sample consisted of 9,057 patients of whom 50.6% were female with a mean 
age of 52.1 years old. Ethnic origin was recorded as White in 85.0% of patients, Asian in 
4.2% of patients and Black in 4.1% of patients.  SMI diagnosis was recorded in 49.9% of 
patients as schizophrenia, 37.2% of patients as bipolar disorder, 6.4% of patients as 
depression with psychosis and 6.4% of patients as other affective disorder, which included 
schizoaffective disorder. By deprivation quintile, 15.8% of patients were in the least deprived 
category and 25.4% of patients were in the most deprived category. 
 In 2015/16, the sample consisted of 6,185 patients of whom 50.7% were female with a mean 




4.1% of patients and Black in 4.0% of patients.  SMI diagnosis was recorded in 48.8% of 
patients as schizophrenia, 37.5% of patients as bipolar disorder, 6.5% of patients as 
depression with psychosis and 7.3% of patients as other affective disorder, which included 
schizoaffective disorder. By deprivation quintile, 16.9% of patients were in the least deprived 
category and 25.5% of patients were in the most deprived category. 
7.3.3 SMI patient sample 
Looking at the participant characteristics by financial year revealed similarities between this CPRD 
SMI patient sample and other studies that have used primary care databases in relation to SMI 
diagnosis type (Hayes et al., 2017) and deprivation level (Osborn et al., 2018). Gender and ethnicity 
were nationally representative of the UK population in general. 
 Gender: the proportion of males and females was relatively evenly distributed for each year 
of the study period with slightly more females compared with males (Clark, 2020).  
 Age: the overall mean and median ages were also consistent by financial year, although the 
median age demonstrated a small difference by gender with males slightly younger than 
females, at 48 years and 53 years, respectively.  
 SMI diagnosis type: the sample had a higher proportion with schizophrenia compared with 
bipolar disorder, similar to other studies that have used primary care databases (Hayes et al., 
2017). 
 Ethnicity: the sample was broadly representative of the population of England and Wales 
based on the 2011 census (GOV.UK.).  
 Deprivation: patient level area deprivation indicated little variation between years across the 
study period in the proportion of patients in each quintile. However, the proportions were not 
evenly distributed across the five quintiles of deprivation. Similar to other corresponding 
studies (Osborn et al., 2018, Kontopantelis et al., 2015b), there was a smaller proportion of 
SMI patients in less deprived quintiles with the largest proportion in the most deprived 
quintile.   
In summary, the participant characteristics of the sample for this thesis were largely comparable 






People with SMI have high rates of comorbidities (Smith et al., 2013).While comorbidities were not 
included in the dataset analysis for this thesis, reference to studies using similar data can provide a 
useful context for why the physical health checks were being conducted. Notably, a study using 
comparable CPRD data, found the most common comorbidities for people with SMI were: 
hypertension (>10%); diabetes (~10%); cardiovascular disease (>5%) (Lister et al., 2021). Evidence 
of elevated levels of comorbidity in the SMI patient sample underlines why the type of health checks 
(blood pressure, blood glucose/HbA1c, cholesterol) were originally selected – to identify patients with 
heightened risk of developing conditions most likely to cause premature mortality and morbidity 
(Martin et al., 2014).  
Inequalities  
People with SMI are more likely to have comorbidities than the general population though the level of 
inequality varies between conditions (Reilly et al., 2015). Analysis using data from THIN (The Health 
Improvement Network), a primary care database similar to CPRD, demonstrated higher rates of 
comorbidities among the SMI population compared with the general population. Rate ratios were 
particularly high for conditions targeted by the SMI QOF indicators such as diabetes (1.9), obesity 
(1.8) and cardiovascular disease (~1.5) though there was no apparent difference for hypertension 
between patients with SMI and the general population (Public Health England, 2018). In addition, 
patients with SMI are nearly twice as likely as the general population to experience multimorbidity 
(the diagnosis of more than one physical health condition along with their psychiatric condition). 
Furthermore, a recent study (under peer review) demonstrated SMI patients had a higher prevalence 
of multimorbidity at a younger age compared to comparators without SMI (Launders et al., 2021) 
which may account for why the relative risk of mortality is higher for SMI patients at a younger age 




Table 7. 1    Participant characteristics by financial year
 Financial 
year 
No. eligible* patients 
(total = 49,322) 
Gender 
  Male      Female 
Age (years) 
   Mean         Median 
No. of patients by SMI diagnosis type Ethnicity Deprivation level** 
(1 least, 5 most deprived) 
 











Bipolar disorder  
Schizophrenia   
Depression psychosis  
Other affective disorder  
4,184    (35.6%) 
6,051    (51.4%) 
763       (6.5%) 





































Bipolar disorder  
Schizophrenia    
Depression psychosis 
Other affective disorder  
 
4,202    (36.0%) 
5,974    (51.1%) 
742       (6.4%) 





































Bipolar disorder  
Schizophrenia   
Depression psychosis 
Other affective disorder  
3,936   (37.0%) 
5,351   (50.3%) 
682      (6.4%) 





































Bipolar disorder   
Schizophrenia   
Depression psychosis  
Other affective disorder   
3,371   (37.2%) 
4,521   (49.9%) 
584      (6.4%) 





































Bipolar disorder   
Schizophrenia   
Depression psychosis  
Other affective disorder   
2,317    (37.5%) 
3,016    (48.8%) 
401       (6.5%) 


























 * Eligible patients: aged 18 years or over at first SMI diagnosis; diagnosed with SMI at least 3 months (90 days) before start of each financial year; registered at practice 3 months before until end of each financial 
year 
** The English Indices of Deprivation 2010 (https://www.gov.uk/government/collections/english-indices-of-deprivation) 




7.3.4 Descriptive statistics: health checks by financial year 
Preliminary analysis consisted of generating the outcome variable for each different indicator: blood 
pressure, BMI, cholesterol and glucose/HbA1c, which involved calculating the proportion of eligible 
patients who had received a health check by financial year (from 2011/12 to 2015/16). The dependent 
variable was dichotomous, either ‘yes’ a patient had a recording of one or more checks for an 
individual indicator during a financial year, or ‘no’ there was no recording of a check. Table 7.2 
shows the crude numbers and proportion of eligible patients who received a check for each of the four 
different indicators by financial year, alongside the proportion who received a check for all four 
indicators during the same financial year. The same data are shown in Figure 7.1 using a two-way line 
graph to visually display the variation between indicators and across time, with a vertical line 
indicating the point at which incentives were removed.  
Pre-intervention 
As shown in Table 7.2, in the three years before financial incentives were removed (pre-intervention 
period), blood pressure was the indicator with the highest proportion of patients to receive a check 
with 84.2% in 2011/12; 81.2% in 2012/13; and 85.1% in 2013/14. Next was cholesterol, 78.6% in 
2011/12; 73.0% in 2012/13; and 79.4% in 2013/14. This was followed by BMI, 70.5% in 2011/12; 
64.2% in 2012/13; and 73.4% in 2013/14. The indicator with the lowest proportion of patients to 
receive a check was glucose/HbA1c with 64.9% in 2011/12; 58.1% in 2012/13; and 66.1% in 
2013/14. During the pre-intervention period, the proportion of patients to receive a check for all four 




Post-intervention, the two years after financial incentives were removed, blood pressure was the 
indicator with the highest proportion of patients to receive a check with 83.1% in 2014/15; and 82.1% 
in 2015/16. This was followed by cholesterol, 67.3% in 2014/15; and 65.1% in 2015/16. There was 
little difference between BMI and glucose/HbA1c, 55.4% and 53.4% in 2014/15; and 51.6% and 
53.4% in 2015/16, respectively. During the post-intervention period, the proportion of patients to 
receive a check for all four indicators in the same financial year was 35.2% in 2014/15; and 32.5% in 
2015/16. 
 
Overall, as illustrated in Figure7.1, in the period before incentives were removed the proportion of 




for glucose/HbA1c (~63%). Around half of the eligible patients received a check for all four 
indicators in the same financial year. In the period after incentives were removed, the proportion of 
checks recorded declined for all indicators, though it declined more for some than others. Blood 
pressure, which remained incentivised, continued to be the indicator with the highest proportion of 
checks recorded (> 80%). It also had the smallest percentage decline (< 5%) compared with the other 
three indicators (> 10%), where incentives had been removed. Similarly, the proportion who received 
a check for all four indicators in the same financial year also declined markedly post-intervention: 







Table 7. 2   Proportion of eligible patients who received a health check by financial year    
 
  
Financial year No. eligible* patients 
  No. of patients who received a health check (% of eligible patients)   
Blood pressure Body mass index Cholesterol Glucose/HbA1c All 4 health checks 



















































































* Eligible patients: aged 18 years or over at first SMI diagnosis; diagnosed with SMI at least 3 months (90 days) before start of each financial year; registered at practice 3 
months before until end of each financial year 

















2012/13 2013/14 2014/15 2015/162011/12
Financial year
Blood pressure Body mass index
Cholesterol Glucose/HbA1c












7.4  Patient level statistical analyses  
As described in Chapter Six, a difference-in-differences design was used to statistically analyse the 
effect of policy change (removal of incentives) on the proportion of patients who had health checks 
recorded. The difference-in-differences design consisted of two groups and two time periods: Group 1 
(BMI, cholesterol and glucose/HbA1c) exposed to policy change; and Group 2, the control group 
(blood pressure), unexposed to the intervention; before and after incentives were removed. Thus the 
removal of incentives for only three of the four physical health indicators created a natural experiment 
(Craig et al., 2017) as blood pressure, which remained incentivised, acted as a control.  
7.4.1 Meeting difference-in-differences assumptions  
As discussed in more detail in Chapter Six, the two main assumptions affecting the robustness of 
difference-in-differences designs are the ‘parallel trends’ assumption and ‘common shocks’ 
assumption (Zhou et al., 2016). Principally, the parallel trends assumption stipulates that if there had 
been no policy intervention, any differences between the control and the intervention group would 
have remained constant over time (Dimick and Ryan, 2014).  
Parallel trends assumption 
For this thesis, visual evidence was used to assess validity of the parallel trends assumption.  A two-
way line graph in Figure 7.2 shows that the difference between the mean average outcome score of 
the treatment group combined (BMI, cholesterol and Glucose/HbA1c) compared with the control 
group (blood pressure) was more or less constant across the three time points during the period before 
the policy intervention.  
 
The parallel trend assumption was further demonstrated at the individual indicator level, as shown by 
Figure 7.3 for BMI, Figure 7.4 for cholesterol and Figure 7.5for glucose/HbA1c, which compared the 
outcomes of each intervention indicator with the control in separate line graphs. Visually, the lines 
displayed for BMI, cholesterol and glucose/HbA1c were constant and in parallel with blood pressure 
for the period between 2011/12 and 2013/14, before incentives were removed.  Given that the 
intervention and control group had parallel trends  in the pre-intervention period, the trend for the 
control group (blood pressure) during the post-intervention period would have likely represented the 
counterfactual trend for the intervention group, had incentives not been removed (Angrist and 
Pischke, 2008). However, uncertainty remains and it has been argued that parallel trends pre-




should not be assumed that the control post-intervention represents the counterfactual (Kahn-Lang 
and Lang, 2019).  
Common shocks assumption 
The second assumption is the commons shocks assumption whereby any unexpected events (unrelated 
to the policy change) that take place during the study period are likely to have affected both treatment 
and control groups equally (Angrist and Pischke, 2008). In the case of this thesis, as discussed in 
Chapter Six, this assumption was strengthened as both Group 1 and Group 2 were part of the same 
population in the same primary care system over the same time period. The only difference between 
the treatment and control group was exposure to the policy change for the indicators where incentives 
were removed (Dimick and Ryan, 2014). Consequently, confounding between treatment and control 
groups was minimised.  
7.4.2 Difference-in-differences estimate  
Having visually displayed evidence that the parallel trends assumption was valid for this study by 
there being little difference between data points for the treatment and control groups in the two-way 
line graphs shown in Figure 7.3, Figure 7.4 and Figure 7.5 for the pre-intervention period, the next 
step was to formally test the size of the difference-in-differences effect using the Stata diff-in-diff 
command (Villa, 2016). This technique measured the difference between the post-intervention 
difference and pre-intervention difference, meaning that any significant differences between 
intervention and control groups post and pre-intervention would indicate ‘treatment effect’, or in the 
case of this study, removal of incentives effect.  
Before statistically measuring the difference-in-differences effect for each treatment indicator, an 
estimation of the differences could be seen by looking at the two-way line graphs displayed in Figure 
7.3, Figure 7.4 and Figure 7.5, which visually displayed the trends, showing that there was an 
immediate decrease in 2014/15 for all three indicators in the treatment group following removal of 
incentives, both in the level and gradient of the slope. In 2015/16, the final year of the study, there 
was a levelling off of the slopes for all the indicators where incentives had been removed.  
As shown in Figure 6.3 in Chapter Six, the difference-in-differences estimate was calculated as the 
difference between the differences (intervention – control group) after the intervention, minus the 
difference between the differences (intervention – control group) pre-intervention (Dimick and Ryan, 
2014). Although the changes were absolute increases or decreases, they represented changes relative 




7.4.3 Difference-in-differences estimate by indicator 
Table 7.3 and Figure 7.2 show the difference-in-differences estimate for all treatment indicators 
combined (BMI, cholesterol and glucose/HbA1c) compared with blood pressure, which was -11.1% 
(p<0.01), which suggests that overall activity for health checks where incentives had been removed 
had decreased by more than 10%. Analysis at the individual indicator level displayed more detailed 
findings. Table 7.4 and Figure 7.3 show  the difference-in-differences estimate for BMI compared 
with blood pressure was -14.6% (p<0.01). Table 7.5 and Figure 7.4 show the difference-in-differences 
estimate for cholesterol compared with blood pressure was -9.8% (p<0.01). Table 7.6 and Figure 7.5 
show the difference-in-differences estimate for glucose/HbA1c compared with blood pressure was -
8.8% (p<0.01).  
Overall, variation in the estimates between the three treatment indicators and the control indicate that 
the largest difference-in-differences pre and post-intervention was 14.6% for BMI. As discussed 
earlier, this corresponded with BMI having the largest decline in the proportion of health checks after 
incentives were removed. In contrast, the smallest difference-in-differences was 8.8% for 
glucose/HbA1c. This could be because glucose/HbA1c had the smallest proportion of checks pre-
intervention, which meant the overall difference with blood pressure was wide during both time 










    Table 7. 3     Proportion of eligible patients who received a health check by financial year 
Figure 7. 2   Removal of financial incentives for recording of all three treatment indicators combined 
 
Removal of financial incentives for recording of all treatment indicators (body mass index 
(BMI), cholesterol and glucose/HbA1c) compared with blood pressure   
Time Health check (%)* Standard error p-value 







 Intervention – control -13.7 0.003 P<0.01 





 Intervention – control -28.8 0.004 P<0.01 
 Difference-in-difference -11.1 0.005 P<0.01 
 
*Percent of eligible patients who received a health check  
**Means and Standard Errors are estimated by linear regression 
***Clustered Std. Errors 





Table 7. 4     Difference-in-differences estimate (BMI-blood pressure)  
Removal of financial incentives for recording of body mass index (BMI)  
Time Health check (%)* Standard error p-value 







 Intervention – control -14.2 0.005 P<0.01 





 Intervention – control -28.8 0.009 P<0.01 
 Difference-in-difference -14.6 0.009 P<0.01 
 
*Percent of eligible patients who received a health check  
**Means and Standard Errors are estimated by linear regression 
***Clustered Std. Errors 
R-square:    0.06 
 













2011/12 2012/13 2013/14 2014/15 2015/16
Financial Year
Blood pressure Body mass index















Table 7. 5     Difference-in-differences estimate  (cholesterol-blood pressure) 
Removal of financial incentives for recording of cholesterol 
Time Health check (%)* Standard error p-value 







 Intervention – control - 6.5 0.004 P<0.01 
After Control (blood pressure) 
Intervention (cholesterol 
82.7 
66.4   
  
 Intervention – control - 16.3 0.007 P<0.01 
 Difference-in-difference - 9.8 0.007 P<0.01 
*Percent of eligible patients who received a health check  
**Means and Standard Errors are estimated by linear regression 
***Clustered Std. Errors 
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Financial Year
Blood pressure cholesterol






Table 7. 6     Difference-in-differences estimate (glucose/HbA1c-blood pressure) 
Removal of financial incentives for recording of glucose/HbA1c 
Time Health check (%)* Standard error p-value 







 Intervention – control - 20.5 0.005 P<0.01 





 Intervention – control - 29.3 0.009 P<0.01 
 Difference-in-difference - 8.8 0.008 P<0.01 
 
*Percent of eligible patients who received a health check  
**Means and Standard Errors are estimated by linear regression 
***Clustered Std. Errors 
R-square:    0.07 
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Financial year
Blood pressure Glucose/HbA1c





7.4.4 Multivariate logistic regression  
Multivariate logistic regression was selected as the most appropriate technique to conduct analysis to 
estimate the likelihood of a receiving a health check whilst adjusting for other factors that may have 
influenced the outcome, such as time or demographic characteristics (Peng et al., 2010). As discussed 
in Chapter Six, this method required construction of a statistical model, to include individual variables 
which may have affected the outcome.  
Selecting variables 
As described in Chapter Six, variables were selected to be part of the regression model based on an 
understanding about what factors were likely to influence the outcome of interest, informed by 
background knowledge from the literature (Shipe et al., 2019) and discussion with thesis supervisors. 
Financial year was selected to measure the effect of time, accompanied by five core demographic 
variables: age; gender; SMI type; ethnic origin; and deprivation level.  
Categorising variables 
Reference categories were chosen on the basis of size and association with the outcome of  interest 
(Ranganathan et al., 2017), described in more detail in Chapter Six.   
7.4.5 Missing data 
Ethnicity and deprivation level were the only two covariates included in the model that contained 
missing data. For each financial year, the maximum level of missing data was ≤ 4.5% for ethnicity; 
and ≤ 0.1% for deprivation. However, as discussed in Chapter Six, missing data of less than 5% is 
unlikely to introduce bias into statistical analyses (Bennett. D. A, 2001).  
7.4.6 Secondary outcomes 
Table 7.7 shows the odds ratios for the likelihood of receiving a health check by financial year for 
each of the four indicators: blood pressure, body mass index, cholesterol and glucose/HbA1c. There 
was virtually no difference between the unadjusted and adjusted odds estimates for all four indicators, 
suggesting that the effect of financial year was not dependent on other covariates – age, gender, 
ethnicity, SMI type, deprivation – in the regression model (Bursac et al., 2008). The adjusted odds 
ratios in Table 7.7 therefore account for the overall likelihood of a patient receiving a health check for 





It is important to note that the financial year variable displayed in Table 7.7 has been presented 
separately from the demographic co-variables of age, gender, SMI type, ethnicity and deprivation, 
even though they were part of the same logistic regression model. This was to allow the effect of time 
on each different health check indicator outcome to be visually displayed within the same table. 
However, it does not present a univariate analysis, rather it is part of the multivariate analysis 
presented in a separate table to enhance the visual display of data. All other independent variable odds 
ratios are displayed together under each individual health check (see Table 7.8, Table 7.9, Table 7.10 
and Table 7.11). 
Year by year 
 In 2011/12 the likelihood of receiving a check for blood pressure, cholesterol and 
glucose/HbA1c was not significantly different from the likelihood in 2013/14 (reference 
category), the final year before incentives were removed. For BMI, however, the likelihood of 
receiving a check was 14% less in 2011/12 (OR: 0.86; 95% CI: 0.80 to 0.94) compared with 
2013/14. 
 In 2012/13, the odds of receiving a check were reduced for all indicators compared with 
2013/14: blood pressure was 25% less likely (OR: 0.75; 95% CI: 0.69 to 0.82); cholesterol 
31% less likely (OR: 0.69; 95% CI: 0.64 to 0.74); glucose/HbA1c 32% less likely (OR: 0.68; 
95% CI: 0.64 to 0.73); and BMI 36% less likely (OR: 0.64; 95% CI: 0.59 to 0.69).  
 In 2014/15, the first year following the removal of incentives, the odds of receiving a check 
were reduced for all indicators, compared with 2013/14: blood pressure was 14% less likely 
(OR: 0.86; 95% CI: 0.79 to 0.95); glucose/HbA1c was 45% less likely (OR: 0.55; 95% CI: 
0.52 to 0.59), cholesterol 49% less likely (OR: 0.51; 95% CI: 0.47 to 0.56) and BMI 56% less 
likely (OR: 0.44; 95% CI: 0.40 to 0.48). 
 In 2015/16, the final year of the study, the odds of receiving a check were reduced for all 
indicators, compared with 2013/14: blood pressure was 19% less likely (OR: 0.81; 95% CI: 
0.71 to 0.93); glucose/HbA1c was 44% less likely (OR: 0.56; 95% CI: 0.51 to 0.62); 
cholesterol 53% less likely (OR: 0.47; 95% CI: 0.42 to 0.52); and BMI 63% less likely (OR: 




 Table 7. 7    Odds ratios for the likelihood of receiving a health check by financial year
 Health check Financial year Unadjusted odds ratio Adjusted odds ratio1 95% confidence interval P value 
 Blood pressure 2011/12 0.94 0.96 0.87 to 1.05 0.326 
  2012/13 0.76 0.75 0.69 to 0.82 <0.001 
  2013/142 1.0 1.0   
  2014/15 0.86  0.86 0.79 to 0.95 0.003 
  2015/16 0.80 0.81 0.71 to 0.93 0.003 
       
 Body mass index 2011/12 0.87 0.86 0.80 to 0.94 <0.001 
  2012/13 0.65 0.64 0.59 to 0.69 <0.001 
  2013/142 1.0 1.0   
  2014/15 0.45 0.44 0.40 to 0.48 <0.001 
  2015/16 0.39 0.37 0.33 to 0.42 <0.001 
       
 Cholesterol 2011/12 0.95 0.96 0.88 to 1.04 0.281 
  2012/13 0.70 0.69 0.64 to 0.74 <0.001 
  2013/142 1.0 1.0   
  2014/15 0.53 0.51 0.47 to 0.56 <0.001 
  2015/16 0.48 0.47 0.42 to 0.52 <0.001 
       
 Glucose/HbA1c 2011/12 0.95 0.95 0.90 to 1.01 0.107 
  2012/13 0.71 0.68 0.64 to 0.73 <0.001 
  2013/142 1.0 1.0   
  2014/15 0.59 0.55 0.52 to 0.59 <0.001 
  2015/16 0.59 0.56 0.51 to 0.62 <0.001 
 1Adjusted for: financial year; age; gender; ethnicity; SMI type; patient level area deprivation (see Table 7.8, Table 7.9, Table 7.10 and Table 7.11) 
2Reference category 




7.4.7 Findings by individual indicators 
Results of the multivariate logistic regression analysis for blood pressure, BMI, cholesterol and 
glucose/HbA1c are displayed in Table 7.8, Table 7.9, Table 7.10 and Table 7.11, respectively, 
showing the effect of each independent variable in relation to other predictor variables, held at a 
constant.  Unadjusted odds estimates are presented alongside adjusted odds ratios to indicate how 
much the effect size changed when other independent variables were accounted for (Tabachnick  and 
Fidell, 2013). 
Individual checks rather than a combined model 
It is important to remember, as discussed in Chapter Two and Chapter Six, that the health checks for 
blood pressure, BMI, cholesterol and glucose/HbA1c were incentivised separately during the time 
period of this study: they were not part of a collective group of health checks, incentivised as a 
combined model, as had been the case prior to 2011/12. Consequently, for this thesis each indicator 
was analysed on its own, rather than as part of a collective group, which was indicative of the QOF 
annual physical health review  prior to 2011/12 (see Figure 6.1). To enhance comparability, each 
indicator was analysed using the exact same regression model. 
Although there may have been a preconceived expectation that patients who presented to a GP would 
have received all four of the physical health checks, the results in Table 7.2  indicate otherwise, 
showing that patients did not typically receive all four checks. For instance, in 2011/12, the first year 
the indicators had been separately rewarded, only 53% of patients received a check for all four 
indicators, compared with 84% for blood pressure, 71% for BMI, 79% for cholesterol and 65% for 
glucose/HbA1c. The multivariate analysis conducted for this study, therefore, focused on the effect of 






Figure 7. 6   Model 1: Blood pressure    
 
 Age was a predictor variable. Patients aged 60-74 years were nearly twice as likely to receive 
a blood pressure check (OR: 1.83; 95% CI: 1.64 to 2.04), and those aged 75 years and over 
were more than twice as likely (OR: 2.06; 95% CI 1.75 to 2.42), compared with those aged 
40-59 years. By contrast, those aged under 40 years were 49% less likely (OR: 0.51; 95% CI: 
0.47 to 0.56). No difference between the unadjusted and adjusted odds ratios suggested that 
aside from the other confounders, age was having an independent effect (Szumilas, 2010). 
 Gender was a predictor variable. Females were 73% more likely to have had a blood pressure 
check recorded compared with males (OR: 1.73: 95% CI: 1.60 to 1.88). The difference 
between the unadjusted and adjusted odds ratio was a 40% decrease, suggesting that the effect 
of gender was associated with other independent variables in the model (Bland and Altman, 
2000).  
 Ethnic origin was not a strong predictor variable. One category, Asian, was 19% more likely 
than White to have had a check for blood pressure (OR: 1.19; 95% CI: 1.01 to 1.42). Black 
and Other categories were not significantly different from White. The difference between 
unadjusted and adjusted odds ratios for Asian was more than a 20% increase, suggesting it 
was associated with other factors in the regression model. 
 SMI type was a predictor variable for two of the three categories. Patients with bipolar 
disorder were 43% more likely (OR: 1.43; 95% CI: 1.31 to 1.56) and patients with depression 
with psychosis 29% more likely (OR: 1.29; 95% CI: 1.09 to 1.51) to have had a blood 
pressure check compared to those with schizophrenia. The category of other affective 
disorders, which included schizoaffective disorder, was not significantly different from 
schizophrenia. The difference between unadjusted and adjusted odds ratios for bipolar 
disorder and depression with psychosis decreased by 30% and 40%, respectively, suggesting 
that other factors in the regression model were influencing the effect (Peng et al., 2010).  
 Patient level area deprivation was not a strong predictor variable. There were no significant 
differences in the likelihood of receiving a blood pressure check for any of the other 




Table 7. 8     Likelihood of receiving a health check for blood pressure*
 
 Variable Unadjusted OR Adjusted OR
1 95% CI P value 
 Age (years)  
40-592 
Under 40  
60-74   







0.47 to 0.56 
1.64 to 2.04 




       
 Gender  
Male2 
Female  2.13 1.73 1.60 to 1.88 <0.001 












1.01 to 1.42 
0.79 to 1.07 




       
 SMI diagnosis 
Schizophrenia2 
Bipolar disorder  
Depression psychosis  







1.31 to 1.56 
1.09 to 1.51 




       
 Patient level area deprivation  
(1=least, 5= most deprived) 













0.79 to 1.07 
0.77 to 1.04 
0.82 to 1.13 





       
 Constant   4.53 3.86 to 5.30 <0.001 
 1Adjusted for: financial year; age; gender; ethnicity; SMI type; patient level area deprivation  
2Reference category 
*Mean odds ratios for study period (from 2011/12 to 2015/16) 




Figure 7. 7   Model 2: Body Mass Index (BMI) 
 Age was a predictor variable. Patients aged 60-74 years were 23% more likely (OR: 
1.23; 95% CI: 1.14 to 1.32) to have had a BMI measurement recorded, compared 
with those aged 40-59 years. By contrast, patients aged under 40 years were 37% less 
likely (OR: 0.63; 95% CI: 0.59 to 0.68) and those aged 75 years and over 20% less 
likely (OR: 0.80; 95% CI: 0.72 to 0.89) to have had a BMI measurement recorded, 
compared with those aged 40-59 years.  There were no differences between the 
unadjusted and adjusted odds ratios for each category, suggesting that aside from the 
other confounders, age was having an independent effect.  
 Gender was a predictor variable. Females were 24% more likely to have had a BMI 
measurement recorded compared with males (OR: 1.24; 95% CI: 1.18 to 1.31).  The 
difference between the unadjusted and adjusted odds ratio was a decrease of less than 
10%, suggesting that aside from the other confounders, gender was having an 
independent effect. 
 Ethnic origin was not a strong predictor variable. One category, Asian, was 28% 
more likely than White to have had a BMI measurement recorded (OR: 1.28; 95% CI: 
1.14 to 1.44). Neither Black nor Other categories were significantly different from 
White. The difference between the unadjusted and adjusted odds ratios increased by 
less than 10% for all categories, suggesting that aside from the other independent 
variables, ethnic origin was having an independent effect.  
 SMI type was a predictor variable for only one category. Patients with bipolar 
disorder were 19% more likely (OR: 1.19; 95% CI: 1.11 to 1.40) to have had a BMI 
measurement recorded, compared to those with schizophrenia. Patients with 
depression with psychosis were 12% more likely (OR: 1.12: 95% CI: 1.00 to 1.27). 
There was no difference between other affective disorders and schizophrenia. 
Differences between unadjusted and adjusted odds ratios for all categories less than 
10%, suggesting that SMI type was having an independent effect.   
 Patient level area deprivation was a predictor variable for categories 4 and 5, the 
two most deprived categories. Category 4 was 21% more likely (OR: 1.21; 95% CI: 
1.08 to 1.36) and category 5 was 25% more likely (OR: 1.25; 95% CI: 1.11 to 1.40) 
to have had a BMI measurement recorded compared with 1, the least deprived 
category. All unadjusted and adjusted odds ratios were the same, suggesting that 




Table 7. 9     Likelihood of receiving a health check for body mass index* (BMI) 
 Variable Unadjusted OR Adjusted OR1 95% CI P value 
 Age (years)  
40-592 
Under 40  
60-74   







0.59 to 0.68 
1.14 to 1.32 




       
 Gender  
Male2 
Female  1.31 1.24 
 
1.18 to 1.31 <0.001 












1.14 to 1.44 
0.96 to 1.29 




    
 
   
 SMI diagnosis 
Schizophrenia2 
Bipolar disorder  
Depression psychosis  







 1.11 to 1.27 
1.00 to 1.27 




       
 Patient level area deprivation  
(1=least, 5= most deprived) 













0.93 to 1.15 
0.94 to 1.20 
1.08 to 1.36 





       
 Constant   2.31 2.05 to 2.60 <0.001 
 1Adjusted for: financial year; age; gender; ethnicity; SMI type; patient level area deprivation  
2Reference category 
*Mean odds ratios for study period (from 2011/12 to 2015/16) 




Figure 7. 8   Model 3: Cholesterol 
 Age was a predictor variable. Patients aged 60-74 years were 42% more likely to have had a 
recording of cholesterol (OR: 1.42; 95% CI: 1.30 to 1.55) compared with those aged 40-59 
years. In contrast, those aged under 40 years were 50% less likely (OR: 0.50: 95% CI: 0.47 to 
0.54). For the 75 years and over category there was no difference compared with those aged 
40-59 years. Unadjusted and adjusted odds ratios were virtually the same for each category, 
suggesting that aside from the other independent variables, age was having an independent 
effect.  
 Gender was a predictor variable. Females were 30% more likely to have had a recording of 
cholesterol compared with males (OR: 1.30; 95% CI: 1.22 to 1.38). The difference between 
the unadjusted and adjusted odds ratio was a 15% decrease, suggesting that gender was 
associated with other independent variables in the model. 
 Ethnic origin was not a strong predictor variable. One category, Asian, was 32% more likely 
than White to have a recording of cholesterol (OR: 1.32; 95% CI: 1.15 to 1.53). Black or 
Other categories were not significantly different from White. The difference between 
unadjusted and adjusted odds ratios for Asian was an increase of more than 15%. There was 
also a 20% increase between the unadjusted and adjusted odds ratios for Black and Other 
categories, suggesting that ethnicity was associated with other factors in the model. 
 SMI type was a predictor variable for two of the three categories. Patients with bipolar 
disorder were 27% more likely (OR: 1.27; 95% CI: 1.18 to 1.36) and patients with depression 
with psychosis 17% more likely (OR: 1.17; 95% CI: 1.03 to 1.33) to have had a recording of 
cholesterol, compared with those with schizophrenia. The other affective disorders category 
was no different from schizophrenia.  The difference between the unadjusted and adjusted 
odds ratios for all categories was less than 10%, suggesting that aside from the other 
independent variables, SMI type was having an independent effect. 
 Patient level area deprivation was a predictor variable for the two most deprived categories. 
Categories 4 and 5 were both 16% more likely to have had a cholesterol check, (OR: 1.16; 
95% CI: 1.03 to 1.31) and (OR: 1.16; 95% CI: 1.02 to 1.31) respectively, compared with 1, 
the least deprived category. All unadjusted and adjusted odds ratios were the same, suggesting 
that aside from the other independent variables, patient level deprivation was having an 





Table 7. 10    Likelihood of receiving a health check for cholesterol*       
 Variable Unadjusted OR Adjusted OR1 95% CI P value 
 Age (years)  
40-592 
Under 40  
60-74   







0.47 to 0.54 
1.30 to 1.55 




       
 Gender  
Male2 
Female  1.46 1.30 1.22 to 1.38 <0.001 












1.15 to 1.53 
0.97 to 1.25 




       
 SMI diagnosis 
Schizophrenia2 
Bipolar disorder  
Depression psychosis  







 1.18 to 1.36 
1.03 to 1.33 




       
 Patient level area deprivation  
(1=least, 5= most deprived) 













0.91 to 1.13 
0.91 to 1.15 
1.03 to 1.31 





       
 Constant   3.33 2.93 to 3.79 <0.001 
 1Adjusted for: financial year; age; gender; ethnicity; SMI type; patient level area deprivation  
2Reference category  
*Mean odds ratios for study period (from 2011/12 to 2015/16) 




Figure 7. 9    Model 4: Glucose/HbA1c 
 Age was a predictor variable. Patients aged 60-74 years were 49% more likely to have had a 
recording of glucose/HbA1c (OR: 1.49; 95% CI: 1.39 to 1.59), and those aged 75 years and 
over 25% more likely (OR: 1.25; 95% CI: 1.14 to 1.38), compared with those aged 40-59 
years. In contrast, those aged under 40 years were 70% less likely (OR: 0.30: 95% CI: 0.28 to 
0.32). Unadjusted and adjusted odds ratios were the same for each category, suggesting that 
aside from the other independent variables, age was having an independent effect.  
 Gender was a predictor variable. Females were 21% more likely to have had a recording of 
glucose/HbA1c compared with males (OR: 1.21; 95% CI: 1.14 to 1.28). The difference 
between the unadjusted and adjusted odds ratio was a 20% decrease, suggesting that gender 
was associated with other independent variables in the model. 
 Ethnic origin was not a strong predictor variable. One category, Asian, was 47% more likely 
than White to have had a recording of glucose/HbA1c (OR: 1.47; 95% CI: 1.28 to 1.68). 
Black or Other categories were not significantly different from White. The difference between 
unadjusted and adjusted odds ratios for Asian was an increase of 35%. There was also a 20% 
increase between the unadjusted and adjusted odds ratios for Black and Other categories, 
suggesting that ethnicity was associated with other independent variables in the model. 
 SMI type was a predictor variable for two of the three categories. Patients with bipolar 
disorder were 22% more likely to have had a recording of glucose/HbA1c (OR: 1.22; 95% CI: 
1.15 to 1.30) and patients with depression with psychosis 18% more likely (OR: 1.18; 95% 
CI: 1.05 to 1.33), compared with schizophrenia. The other affective disorders category was no 
different from schizophrenia. The differences between the unadjusted and adjusted odds ratios 
for bipolar disorder and depression with psychosis were 10% and 40%, respectively, 
suggesting that SMI type was associated with other independent variables in the model. 
 Patient level area deprivation was not a strong predictor variable. There were no significant 
differences in the likelihood of receiving a glucose/HbA1c check for any of the other 




Table 7. 11   Likelihood of receiving a health check for glucose/HbA1c*          
 Variable Unadjusted OR Adjusted OR1 95% CI P value 
 Age (years)  
40-592 
Under 40  
60-74   







0.28 to 0.32 
1.39 to 1.59 




       
 Gender  
Male2 
Female  1.42 1.21 1.14 to 1.28 <0.001 












1.28 to 1.68 
0.91 to 1.17 




       
 SMI diagnosis 
Schizophrenia2 
Bipolar disorder  
Depression psychosis  







 1.15 to 1.30 
1.05 to 1.33 




       
 Patient level area deprivation  
(1=least, 5= most deprived) 













0.91 to 1.13 
0.92 to 1.17 
0.97 to 1.24 





       
 Constant   1.92 1.72 to 2.19 <0.001 
 1Adjusted for: financial year; age; gender; ethnicity; SMI type; patient level area deprivation  
2Reference category 
*Mean odds ratios for study period (from 2011/12 to 2015/16) 




7.4.8 Summary: multivariate logistic regression  
By financial year  
The adjusted odds ratios displayed in Table 7.7 represent the likelihood during each financial year of a 
participant receiving a health check for all four different indicators, compared with 2013/14 (year 
before incentives were removed). Results summary by financial year: 
 In 2011/12, no significant differences in the odds of receiving a check for blood pressure, 
cholesterol and glucose/HbA1c, compared with 2013/14, year before incentives were 
removed and the reference category, thought odds of having a BMI recording were 14% less.  
 In 2012/13, all indicators had a significant reduction in odds, compared with 2013/14: the 
smallest decline was 25% for blood pressure; the largest, 36% for BMI.  
 In 2014/15, year immediately after incentives were removed, there were substantial decreases 
in the odds for each health check, compared with 2013/14: the smallest was a 14% decline for 
blood pressure; the largest, a 56% decline for BMI. 
 In 2015/16, the final year of the study, odds ratios for each indicator were at their lowest 
compared with 2013/14, ranging from 19% less for blood pressure to 63% less for BMI.  
 
Overall, findings showed that the odds of receiving a health check both before and after incentives 
were removed varied, though in the period post-intervention the decreases in odds were larger. Before 
incentives were removed, year on year changes in odds ratios for blood pressure, cholesterol and 
glucose/HbA1c followed a similar pattern. The exception was BMI where odds were significantly 
reduced in 2012/13, compared with 2013/14. After incentives were removed, in 2014/15 and 2015/16, 
odds declined significantly for cholesterol, BMI and glucose/HbA1c compared with 2013/14. The 
largest decrease for both years was for BMI. Despite remaining incentivised, odds also declined for 
blood pressure, though to a lesser extent.  
 
By predictor variable  
Identifying similarities and differences between indicators, in relation to the effect of independent 
variables, was made possible by having used the exact same regression model to adjust for 
independent variables, enhancing comparability. Having compared the data for each indicator, it was 
evident that there were both differences and similarities in the effect that independent variables had on 
the outcome, whilst controlling for other potentially confounding factors. These similarities and 





 Age: For all four indicators the under 40 years category was up to 70% less likely to have a 
check recorded compared with those aged 40-59 years. Conversely, the 60-74 years category 
was up to 83% more likely to have a check recorded. The 75 years and above category 
differed widely: a blood pressure recording was more than twice as likely compared with 
those aged 40-59 years, whereas a BMI measurement was 20% less likely. There were no 
differences between the unadjusted and adjusted odds ratios, suggesting that age had an 
independent effect, aside from other independent variables. 
 Gender: For all four indicators females were more likely than males to have a check 
recorded. Blood pressure had the largest increase in odds of 73%, whereas the other health 
checks had a smaller increase of ~25%. With the exception of BMI, there was a decrease in 
odds between the unadjusted and adjusted odds for all indicators. The largest was a 40% 
decline for blood pressure, suggesting that the effect of gender was not independent, but 
rather, it was associated with other independent variables in the model. 
 Ethnic origin: For all four indicators, Asian was up to 47% more likely than White to have 
had a measurement recorded. With the exception of BMI, there was an increase in odds 
between the unadjusted and adjusted odds for all indicators. The largest was a 32% increase 
for glucose/HbA1c, suggesting that other factors were accounting for the variation. 
 SMI type: For all four indicators, patients with bipolar disorder were up to 43% more likely, 
and those who had depression with psychosis up to 29% more likely, to have had a 
measurement recorded, compared with schizophrenia. For BMI and cholesterol were no 
differences between the unadjusted and adjusted odds ratios. In contrast, for blood pressure 
and glucose/HbA1c there was a decrease of up to 30% for bipolar disorder and up to 40% for 
depression with psychosis between the unadjusted and adjusted odds ratios, suggesting the 
effect of SMI type was not independent from other independent variables. 
 Patient level area deprivation: For blood pressure and glucose/HbA1c there were no 
significant differences between any of the four other categories compared with the least 
deprived, category 1. In contrast, for BMI and cholesterol, the two most deprived categories 
(4 and 5) were up to 25% more likely to have had a measurement recorded, compared with 
the least deprived, category 1. Differences between the unadjusted and adjusted odds ratios 
were minimal, suggesting deprivation had an independent effect on the likelihood of receiving 





Overall, mean effect size of independent variables varied in relation to whether or not a patient 
received a health check. Moreover, some effects were independent, whereas for others there was 
marked difference between the unadjusted estimates and adjusted odds ratios, indicating that the 
variable was associated with other factors. 
For the four health check indicators, the key similarities and differences in odds ratios between 
independent variables are shown in Figure 7.10. 
 
Figure 7. 10  Similarities and differences between independent variables     
 Age: all indicators more likely to receive a check if patient older than 40-59 years; blood 
pressure most likely; glucose/HbA1c least likely.  
 Gender: all indicators more likely to receive a check if patient female; blood pressure most 
likely; glucose/HbA1c least likely.  
 Ethnicity: all indicators more likely to receive a check if patient Asian; glucose/HbA1c most 
likely; blood pressure least likely.  
 SMI type: all indicators more likely to receive a check for patients with bipolar disorder; 
blood pressure most likely; BMI least likely.  
 Deprivation: only BMI and cholesterol more likely to receive a check if patient more 





7.5 Practice level analyses 
Following on from patient level analyses, data were analysed at the practice level to examine variation 
in practice performance with regards to the number of SMI patients registered at a practice and area 
level deprivation.  
7.5.1 Research questions and objectives 
1) How does the number of SMI patients registered at a practice (proxy for practice size) affect 
the proportion of patients who received a health check? 
2) How does practice level deprivation affect performance?  
The main objective was to increase understanding about the association between practice 
characteristics (size and deprivation level) and the proportion of patients who received a health check. 
In contrast with patient level analyses where the outcome was a dichotomous binary (whether or not a 
patient received a health check), at the practice level the outcome was continuous (the proportion of a 
practice’s SMI patients who had received a health check).   
7.5.2 Practice characteristics 
Before examining the spread of data and variation in practice performance in relation to number of 
registered SMI patients and deprivation, practice characteristics were summarised and presented in 
Table 7.12.  
Table 7.12 displays characteristics of all the practices included in the study by financial year. It shows 
the number and percentage of small/medium/large practices, categorised in relation to the number of 
registered SMI patients; the number and percentage of the patient sample within each practice 
category; and the proportion of patients within each deprivation quintile at the practice level.  
Small, medium, large practices – in relation to number of SMI patients registered 
This thesis used the number of SMI patients registered at a practice as a proxy for practice size as in 
the CPRD dataset the list size variable did not measure practice size as defined by the number of 
registered ‘active’ patients for a given year, but rather it represented the sum total of all patients ever 




the CPRD practice size variable was not an accurate reflection of the number of patients registered for 
each individual year. Indeed, some practices had list sizes of over 120,000 which was in excess of the 
largest practice list size recorded in England (NHS Digital, 2020). Consequently, to avoid practices 
being categorised as larger than they were, based on the CPRD definition, a new categorical variable 
was created using number of registered SMI patients. While also not an accurate measure of practice 
size, the proxy measure did reflect a practice’s level of responsibility for SMI patients and hence 
provided a useful alternative for this study. Practices were thus categorised into three groups relating 
to the number of patients with an SMI diagnosis registered at a practice (small: less than 28 SMI 
patients; medium: 28-48 SMI patients; and large: more than 48 SMI patients).  
In 2011/12, the first year of the study, the number of practices per category was relatively evenly 
distributed. However, as the years progressed the number of practices declined substantially, and 
unevenly, more so for small practices than large, which led to an increasing imbalance in the number 
of practices between categories. It is likely, however, that there would be correlation between practice 
list size and the number of SMI patients registered at a practice. Therefore, the rise in the proportion 
of practices with a high number of SMI patients would, on the whole, reflect a rise in the proportion 
of large practices as measured by practice list size, which was one of the structural changes occurring 
in primary care at the time (Kelly and Stoye, 2014). 
7.5.3 Proportion of practices by number of SMI patients registered 
Column A in Table 7.12 shows the number of practices in each category (small, medium, large) 
relating to the number of SMI patients registered at each practice, which is a reflection of their 
representation by that group. In 2011/12, there was a total of 315 practices in the study: 39% small; 
31% medium; 30% large. In 2012/13, the number of practices was 301: with 36% small; 33% 
medium; 31% large. In 2013/14, the number of practices was 264: with 30% small; 36% medium; 
34% large. In 2014/15, the number of practices was 214: with 24% small; 36% medium; 40% large. 
In 2015/16, the number of practices was 150: with 25% small; 34% medium; 41% large.   
Overall, the number of practices declined year on year throughout the study, in line with the decline in 
the number of patients, as described earlier in this chapter. Between the first and the final year, 
2011/12 and 2015/16, the total number of practices more than halved from 315 to 150.  There was 
also a trend for large practices, as measured by the number of registered SMI patients, to become 
overrepresented, from 30% in 2011/12 to 41% in 2015/16. By contrast, small practices followed a 
reverse trend and went from being overrepresented to becoming underrepresented, from 39% in 




7.5.4 Number of patients by practice representation of SMI patients 
Column B in Table 7.12 shows the number of patients in the study by financial year in relation to the 
number of SMI patients registered at practices. This demonstrates the proportion of the patient sample 
within each category.  Comparing column A (number of practices) with column B (number of 
patients) in relation to the number of registered SMI patients within each category 
(small/medium/large) demonstrates that, year by year across the study period, the proportion of large 
practices (those with highest numbers of SMI patients) increased, whilst the proportion of small 
practices decreased.  
Specifically, in 2011/12, the first year of the study, the total number of patients from large practices 
was 5,593 (48%) and from small practices was 2,824 (24%). Comparing the amount of patients with 
the amount of practices by the category for the number of SMI patients, it is evident that large 
practices had a disproportionate share of the patient sample. In 2011/12, large practices consisted of 
30% of the practice sample but contained 48% of the patient sample, whereas small practices were 
39% of the practice sample but only 24% of the patient sample. In 2015/16, the final year of the study, 
the disparity had increased further: large practices had 66% of the patient sample whereas small 
practices only had 8%. Contrastingly, practices with a medium number of SMI patients registered did 
not exhibit such profound changes in their share of the patient sample, remaining relatively consistent 
throughout the study period, from 26% to 31%. 
7.5.5 Practice level deprivation by practice representation of SMI patients 
Column C in Table 7.12 shows practice level area deprivation for all five financial years of the study 
in relation to the number of SMI patients registered at a practice. It displays the mean proportion of 
patients per quintile of deprivation for small, medium and large practices. For each financial year, 
large practices with the highest number of SMI patients had the highest proportion of patients in the 
most deprived quintile, category 5, which was ~3 times higher than the proportion in the least 
deprived quintile, category 1. By contrast, medium sized practices had the highest proportion of 
patients in the middle category throughout the study.  For small practices, with the lowest number of 
SMI patients, there were no evident patterns as data displayed variability both between deprivation 







Table 7. 12   Practice characteristics          
Financial 
year 
(A) Number of practices by practice 
representation of SMI patients* (%) 
(B) Number of patients by practice 
representation of SMI patients (%) 
 (C) Proportion of eligible patients by practice 
deprivation** (1 least, 5 most deprived)  
















































































































































































* Category defined by number of SMI patients registered at a practice: Large >48 patients; Medium 48-28  patients; Small<28  patients 





7.5.6 Variation in practice performance 
To increase understanding about the association between practice characteristics and performance, 
box plots were used to graphically display dispersion in the distribution of data indicating the 
proportion of a practice’s SMI patients who received a health check.  
By number of registered SMI patients (proxy for practice size) 
Figure 7.11, Figure 7.12, Figure 7.13 and Figure 7.14 display variation in performance between 
practices with similar numbers of SMI patients, categorised into small, medium, large. For each health 
indicator (blood pressure, BMI, cholesterol, glucose/HBA1c) there are two box plots for the before 
and after time periods, labelled pre-intervention and post-intervention. Results are summarised below: 
 Blood pressure: Figure 7.11 shows minimal changes to the spread of data post-intervention. 
Median values were similar for each category before and after, suggesting performance was 
not notably affected by the removal of incentives for other indicators. Large practices had the 
narrowest data range before and after, signalling less variation in performance compared with 
small and medium practices. Negative outliers, indicative of poorly performing practices, 
were present for each category at both time points. 
 Body Mass Index: Figure 7.12 shows a number of changes to the dispersion of data post-
intervention. Median values decreased for all, suggesting practice performance declined for 
each category in relation to the number of SMI patients registered at a practice. In contrast, 
the spread of data (length of the box plot) widened, more for medium practices, which 
indicated increased variation in performance. Large practices, which reflected the category of 
practices with the highest number of SMI patients, had the narrowest data range before and 
after. 
 Cholesterol: Figure 7.13 shows limited changes to the spread of data post-intervention. A 
decrease in median values suggested a decline in performance. Increase in the spread of data 
signalled wider variability in practice performance, particularly for medium practices. Large 
practices, reflecting the category of practices with the highest number of SMI patients had the 
narrowest range of data before and after.  
 Glucose/HbA1c: Figure 7.14 shows moderate changes to the spread of data post-intervention. 
A decrease in the median values for all categories indicated a decline in performance. There 
was minimal change, however, to the spread of data post-intervention. Large practices had the 




Figure 7. 11   Blood pressure by practice size 




















Pre-intervention (2013/14) Post-intervention (2014/15)
Variation in blood pressure checks by size of practice* pre-and-post intervention 
Large Medium Small
 
Figure 7. 12   BMI by practice size 




















Pre-intervention (2013/14) Post-intervention (2014/15)







Figure 7. 13  Cholesterol by practice size    




















Pre-intervention (2013/14) Post-intervention (2014/15)
Variation in cholesterol checks by size of practice* pre-and-post intervention
Large Medium Small
 
Figure 7. 14  Glucose/HbA1c by practice size 




















Pre-intervention (2013/14) Post-intervention (2014/15)






By practice level area deprivation 
Area deprivation at the practice level was measured by the Index of Multiple Deprivation in 2015 
(Department for Communities and Local Government), which categorised practices into quintiles: 1 
the least; 5 the most deprived. Figure 7.15, Figure 7.16, Figure 7.17 and Figure 7.18 display variation 
in performance for each health indicator relating to deprivation level. There are five box plots for the 
year before and five for the year after incentives were removed, which shows the variation in the 
spread of data for each quintile of deprivation. Results are summarised below: 
 Blood pressure: Figure 7.15 shows minimal changes to the spread of data post-intervention. 
Negative outliers were present for all quintiles in both the before and after time periods. 
 Body Mass Index: Figure 7.16 shows notable changes to the spread of data post-intervention. 
Median values decreased for each category, suggesting practice performance declined for all 
categories after incentives were removed. 
 Cholesterol: Figure 7.17 shows moderate changes to the spread of data post-intervention. 
Median values decreased for each category, suggesting practice performance declined. 
However, there were differences between quintiles: in the least deprived category 1, practice 
variation contracted indicating reduced variability; whereas for more deprived categories 3 
and 4, practice variation expanded, indicating wider variability in performance.  
 Glucose/HbA1c: Figure 7.18 shows modest changes to the spread of data post-intervention. 
Median values decreased marginally for all categories, suggesting practice performance 
declined slightly across all quintiles. Similar to cholesterol, there was notable contraction of 
variability for practices in category 1, coupled with expansion of variability in performance 




Figure 7. 15  Blood pressure by practice deprivation 
 
Figure 7. 16  BMI by practice deprivation     




















Pre-intervention (2013/14) Post-intervention (2014/15)
Variation in body mass index checks by practice level area of deprivation*
1 least deprived 2 3 4 5 most deprived
 




















Pre-intervention (2013/14) Post-intervention (2014/15)
Variation in blood pressure checks by practice level area of deprivation*




Figure 7. 17  Cholesterol by practice deprivation 




















Pre-intervention (2013/14) Post-intervention (2014/15)
Variation in cholesterol checks by practice level area of deprivation*
1 least deprived 2 3 4 5 most deprived
 
 
Figure 7. 18  Glucose/HbA1c by practice deprivation 




















Pre-intervention (2013/14) Post-intervention (2014/15)
Variation in glucose/HbA1c checks by practice level area of deprivation*





7.5.7 Summary of practice level analyses 
Box plots provided graphical evidence of the dispersion of data and variation in practice performance, 
regarding the proportion of a practice’s patients who had a health check recorded: pre-and-post-
intervention.  
Association between number of SMI patients registered (proxy for practice size) and practice 
performance: 
 Blood pressure had the narrowest box plots for all categories (small, medium, large), 
indicating the least variation in performance between practices; and the smallest changes 
post-intervention.   
 BMI, cholesterol and glucose/HbA1c all had a decrease in median values post-intervention, 
indicating a decline in the proportion of patients who received a health check; and a widening 
of the data range, particularly for small and medium practices. This demonstrated increased 
variability, which equated to patients being less likely to have had a test recorded at practices 
with fewer SMI patients.  
 The only similar finding for all indicators was that large practices had the narrowest data 
range, both before and after incentives were removed, suggesting practices with the highest 
number of registered SMI patients had a more consistent level of performance irrespective of 
incentives.  
Association between practice level deprivation and practice performance: 
 Blood pressure did not show any notable changes in the spread of data across both time 
periods.  
 BMI, cholesterol and glucose/HbA1c all displayed a decline in median values after incentives 
were removed, most substantially for BMI.  
 There was also a distinct widening of variability for the more deprived categories, suggesting 
that the performance of practices from more deprived areas became more inconsistent after 





7.6 Chapter summary  
This chapter has presented findings from the quantitative analyses conducted for this thesis at both the 
patient and the practice level. The key findings showed: 
 The removal of incentives resulted in a significant decrease in the proportion of patients who 
received a health check for all three indicators, compared with blood pressure the control. 
 Age was the most influential factor determining the likelihood of whether or not a patient 
received a heath check (younger patients less likely; older patients were more likely to), 
accompanied by several other demographic factors. 
 Patient level deprivation had virtually no effect on the likelihood that a patient received a 
heath check. 
 Practices with a higher number of SMI patients registered and from less deprived areas were 




Chapter Eight – Discussion, Implications and Conclusions 
8.1 Chapter content 
This final chapter brings together the principal findings from the qualitative and quantitative studies 
undertaken for the thesis. The chapter summarises what the research found and considers what the 
findings mean. It begins by restating the purpose of the thesis. It then presents key findings from each 
core component of research, followed by a discussion about how these relate to the wider literature. It 
goes on to discuss strengths and limitations specific to this thesis. It then synthesises findings from the 
contrasting paradigms, before considering the implications of the findings for policy and clinical 
practice.  The chapter concludes with recommendations for future research.  
8.2 Purpose of the thesis 
The purpose of this thesis was to enhance understanding about the complex array of factors affecting 
the quality of primary care for people with SMI. To achieve this, a mixed methods approach was 
selected to conduct two research studies from contrasting methodological paradigms. The main 
objectives for the thesis are restated below: 
 To provide contextual background for the research studies with an overview of the use of 
financial incentives to promote quality improvement in healthcare activity (Chapter Two). 
 To explore how patients and practitioners perceived and experienced the delivery of primary 
care for people with SMI (Chapter Five). 
 To estimate the effect that removal of financial incentives had on the likelihood that patients 
had physical health checks recorded, to ascertain how policy intervention impacted on the 
quality of primary care in relation to physical health monitoring of SMI patients (Chapter 
Seven). 
8.3 Summary of the key findings 
This thesis has attempted to strengthen understanding about factors that enhance and erode quality of 




8.3.1 Part One - Qualitative research 
Key findings from the thematic analysis of the qualitative research data, presented in Chapter Five, 
are summarised below: 
 Patients and practitioners shared an aspiration for patient-centred, holistic care but in reality 
expectations of being treated as a whole person were rarely met. Whilst practitioners claimed 
that system level factors such as implementing the QOF compromised their capacity to 
provide patient-centred care, patients believed their expectations were not met because 
practitioners prioritised other aspects of care over what was important to them, such as their 
daily functioning and quality of life. 
 There was a strong consensus among patients and practitioners that a breakdown in 
communication with secondary care had undermined quality of care, distancing services and 
delaying the sharing of information. Patients were left feeling ‘abandoned’ and ‘in limbo’ 
given the uncertainty about who would take responsibility for addressing their physical health 
needs relating to psychotropic medication. 
 Practitioners felt the current structure and organisation of primary care limited their agency, 
compromising their ability to enhance patient care. Despite displaying empathy for SMI 
patients, recognising their complex needs and vulnerabilities, most practitioners displayed 
frustration that serious mental illness was marginalised as a condition in primary care. They 
claimed SMI was not accorded the same level of priority or resources as other chronic 
conditions, which undermined their capacity to provide adequate quality of care to this patient 
group.  
 QOF physical health checks were viewed by both patients and practitioners as having had a 
detrimental effect on quality of care by prioritising a biomedical box ticking agenda in favour 
of holistic care. Moreover, patients claimed an ideal opportunity to discuss their physical 
health needs and to receive healthy living advice had been missed due to time constraints and 
a reluctance by practitioners to engage in dialogue during health checks.  
Meta-theme: concept of visibility 
The concept of visibility emerged inductively throughout the process of thematic analysis, acting 
as a thread that interwove many of the core themes and subthemes. Both patient and practitioner 
interview transcripts were densely populated with language and references to what was seen and 
what was missed, what was displayed and what was covered up, what was disclosed and what was 




findings. For instance, high levels of patient visibility – as reported in continuity of care – 
appeared to reflect good quality of care whereas partial or inadequate visibility – as shown by the 
lack of a whole person approach – represented poor quality of care.  
As discussed in Chapter Five, Theme 2 practitioner data displayed unanimity that serious mental 
illness existed on the margins and was not a core priority in primary care. Consequently, SMI was 
less visible and less well-resourced than other QOF chronic conditions such as COPD or diabetes, 
which had specialist clinics run by trained nurses. Patient discourse demonstrated a more complex 
understanding of the concept of visibility, however, as detailed within each core theme.  
Ultimately, even when patients attended practice and were physically visible, many felt their 
needs were not seen or heard by practitioners who tended to prioritise other aspects of care.  
The narrative case study of the QOF physical health checks discussed in Chapter Five further 
demonstrated the concept of visibility being transitory and inadequate, failing to see the patient as 
a whole person. Although patients who were engaged and who presented for a health check were 
more visible and had measurements recorded, patients who did not respond to invitation for a 
health check would likely have been exception reported and removed from the QOF outcomes 
data before payment calculation, a process which is reported to have boosted practice income 
(Jacobs et al., 2015b). As such, there was no incentive for GPs to chase those patients hardest to 
engage, typically the most vulnerable, who found it difficult to attend. This may have reflected a 
duty of care issue (CQC, 2021) where insufficient adjustments had been made to provide 
adequate access to all SMI patients. Given the high levels of exception reporting of SMI patients 
(Gutacker et al., 2015) it seems that implementation of the QOF reinforced the inverse care law 
(Tudor Hart, 1971) by rendering patients who did not engage as largely invisible. However, future 
research studies could now look in more detail about why patients are not included on a QOF 
denominator as exception reporting has been replaced by Personalised Care Adjustment (PCA) 
which requires practices to differentiate from a selection of reasons as to why a patient is removed 
from an indicator denominator (NHS England and BMA, 2021).  
8.3.2 Part Two – Quantitative research 
Key findings from the quantitative research study, presented in Chapter Seven, are summarised 
below: 
 The analysis of the primary outcome showed that the removal of QOF financial incentives for 
BMI, cholesterol and glucose/HbA1c resulted in a significant decrease in the proportion of 




pressure, which remained incentivised so acted as a control. The decrease was most marked 
for BMI. 
 Analyses of the secondary outcomes examined the effect of demographic factors on the 
likelihood of a patient receiving a heath check, and showed that age was the most influential 
factor, followed by gender. Patient level deprivation had no significant effect on the 
likelihood of a patient receiving a heath check, except for BMI and cholesterol where patients 
from more deprived areas were significantly more likely than patients from less deprived 
areas to have received a health check. 
8.4 Discussion – what the findings mean in the context of wider literature 
8.4.1 Part One - Qualitative research 
The findings from the qualitative research component of this thesis build a complex picture about 
factors believed to enhance and erode quality of primary care. Despite previous literature on serious 
mental illness and primary care being relatively sparse, one piece of research resonated with a number 
of core findings from this thesis. The Lester et al  (2005) focus group study, which explored patient 
and health professional views on primary care for people with serious mental illness, was the only 
other study – to my knowledge – to examine the topic from a dual perspective. Its patient narrative 
demonstrated a precedence for relational continuity, a finding that was mirrored by this thesis where 
patients accentuated the importance of seeing a GP who listened to them and who took them 
seriously.  
Regarding the practitioner narrative,  Lester et al (2005) provided evidence that although health 
professionals believed continuity was a critical element for enhancing quality of care for SMI patients, 
they felt it was being  increasingly threatened by the policy drive to increase access and practice size, 
a finding that was consistently echoed by this thesis. Furthermore, both the Lester study and this 
thesis identified a discord between patient and professional perspectives. On the one hand, both 
studies showed that practitioners had relatively low expectations for SMI patients, considering them 
to be a challenging group to engage, typically unreceptive to health living advice. Contrastingly, each 
piece of research demonstrated patients’ quest for knowledge about how to optimise their physical 
health, coupled with disappointment that they were consistently denied the opportunity to engage in 




However, other comparable studies looking at serious mental illness and primary care examined the 
topic from either the patient or the practitioner perspective.  One study exploring patient needs and 
preferences, conducted in the Netherlands (van Hasselt et al., 2013), chimed with evidence from this 
thesis, particularly in relation to a decline in communication between primary care and mental health 
services, which was shown to have eroded quality of care. Regarding perceptions of how the QOF 
impacted on care for people with SMI, several pieces of research provided corroborative evidence. 
One study exploring  practitioners’ views of the QOF (Lester et al., 2011) found that GPs believed it 
undermined other aspects of care, a finding strongly supported by this thesis, which has highlighted 
that practitioners believed that person centred care has diminished under the QOF. Lester et al (2011) 
defined this unplanned outcome as being one of the ‘unintended consequences’ of the QOF whereby 
incentivised aspects of care took priority over non-incentivised care. Additional corresponding 
evidence, which found that practitioners felt the QOF undermined GPs’ clinical judgement and 
compromised medical professionalism (Lester et al., 2013), was also mirrored by findings from this 
thesis. From the patient perspective, evidence on the effect of the QOF  also chimed with findings 
from this thesis, which revealed patients’ principal concern was that the QOF focused on recording 
measurements on a computer at the expense of other – in their eyes – more important aspects of care 
(Chevance et al., 2020).   
Aligning findings from this thesis with evidence from the wider literature that has explored views 
from other vulnerable patient groups, there are some notable comparisons.  From the patient 
perspective, one of the key findings from this thesis was that SMI patients valued  personalised and 
what they described as holistic care, over and above other aspects of care that are typically used to 
define care quality (Goodwin et al., 2011)such as rapid access (Gerard et al., 2008). This resonated 
with evidence from several studies of vulnerable patient groups that have emphasised the importance 
that patients place on a whole person approach (Mercer et al., 2007). From the practitioner perspective 
one of the key findings from this thesis was that, despite their aspiration to meet the complex needs of 
SMI patients, practitioners felt their capacity to provide personalised care had been compromised by 
structural changes which had affected the primary care delivery model (Freeman and Hughes, 2010), 
principally – as discussed earlier in relation to Lester et al (2005), – by expanding practice size which 
made achieving continuity of care increasingly challenging.  
In addition, findings from this thesis showed that the QOF can be reductionist and undermine clinical 
judgment in the context of care of patients with SMI. Similar findings about the QOF have been 
reported in the context of care of people with common mental health problems (Alderson et al., 2012) 
and long term conditions (Coventry et al., 2011), suggesting that, irrespective of the type of mental 




Moreover, by showcasing that patients’ critique of the QOF centred on lack of time and opportunity to 
engage in dialogue with their GP about how to optimise their physical health, this thesis builds on the 
evidence from other studies exploring the impact of QOF on self-management of chronic conditions 
(Blakeman et al., 2011).  
The findings from this aspect of the thesis are indicative of a wider and long-standing debate about the 
tension in primary care between a biomedical model and a more humanist biopsychosocial model of 
healthcare (Engle, 1979). Although patients displayed a strong preference for a humanist approach to 
enhance their quality of life, rather than focusing on efforts to extend its longevity, recent policy 
initiatives (NHS England, 2019b, NHS England, 2018a, NHS England, 2017) have demonstrated a 
more biomedical approach to addressing the SMI mortality gap, which has prioritised risk monitoring 
and the recording of measurements over patient-centred care. This resonated with other studies 
exploring self-management for people with chronic physical conditions, which have demonstrated 
that GPs tended to prioritise biomedical aspects of care over a more person-centred approach 
(Blakeman et al., 2006, Owens et al., 2017). Furthermore, there have been calls for a paradigm shift 
away from the biomedical model of clinically managing a condition, towards a more biopsychosocial 
model of enabling patients to live well with their condition (Entwistle et al., 2018a, Entwistle et al., 
2018b). 
In summary, findings from the qualitative study in this thesis support evidence from comparable 
studies which have shown that the quality of care for SMI patients was suboptimal. Both patients and 
practitioners have reported that policy interventions, such as the QOF, have reinforced the pre-
eminence of a biomedical model of monitoring risk of physical ill health at the expense of patient-
centred care, resulting in patients’ preferences being neglected. While efforts to address the mortality 
gap in people with SMI are much needed to correct the profound health inequalities experienced by 
this group, the unintended consequence might be that efforts to improve quality of life become less of 
a priority.  
8.4.2 Part Two – Quantitative research 
Findings from the quantitative research component of this thesis strengthen the relatively sparse 
literature on the effect of removing financial incentives from quality improvement schemes. As 
discussed in Chapter Two, research on the impact of financial incentive schemes has tended to focus 
on the effect of their introduction rather than their removal (Lester et al., 2010) hence, comparison 
with comparable studies was limited. To date, only a few studies have examined withdrawal of QOF 
indicators (Kontopantelis et al., 2014) and fewer still have included any of the four indicators 




focused specifically on the impact of removing QOF physical health indicators for people with SMI. 
Consequently, the findings from this study provide new evidence about the effect of policy change on 
the rate of physical health monitoring for people with SMI.  
Findings from this study supported those from a corresponding study (Minchin et al., 2018) that 
examined the effect of removing QOF incentives on the proportion of patients who had a health check 
recorded. Its selection of eighteen indicators included three of the same ones investigated for this 
thesis (blood pressure, BMI and glucose/HbA1c) although Minchin et al (2018) examined data at the 
practice level, whereas this thesis examined data at the individual patient level. The findings from 
Minchin et al for SMI indicators correspond with this those from this thesis, showing an immediate 
decrease in the recording of health checks for BMI and glucose/HbA1c in the first year after 
incentives were removed. Moreover, both studies estimated a larger decline for BMI compared with 
glucose/HbA1c. This could mean that fewer BMI checks were carried out, or it could mean, as 
proposed by Minchin et al (2018), that BMI checks were less rigorously recorded compared with 
glucose/HbA1c.  
Findings from this thesis resonated with Wilding et al (2018) which investigated the effect of removal 
of QOF indicators across a range of disease domains, commissioned by NHS England. Corresponding 
with this thesis and Minchin et al (2018), Wilding et al (2018) demonstrated a significant decline in 
the proportion of patients who had a health check recorded, with the most pronounced decrease being 
in the year directly after incentives were removed, indicating the response to the removal of financial 
incentives was immediate. This was evident across all indicators including the one indicator shared 
with this thesis, which was cholesterol for patients with SMI.  
Furthermore, Wilding et al (2018) used the same data source as this thesis (CPRD data at the 
individual patient level), which meant secondary outcomes were comparable. Findings from the 
secondary outcome analysis of this thesis supported those from the Wilding et al study, which 
demonstrated that independent variables such as age and gender affected the likelihood that a patient 
received a check. For instance, both studies showed that age was a strong independent variable, with 
the youngest and oldest groups least likely to have had a check recorded, both before and after 
incentives were removed. In addition, neither piece of research found evidence that the proportion of 
patients who had a check recorded was differentially affected by deprivation level. 
In contrast to findings from this thesis and the ones reported by Minchin et al (2018) and Wilding et al 
(2018), an earlier study (Kontopantelis et al., 2014) that examined the withdrawal of QOF financial 




cardiovascular disease) found that indicator performance levels remained relatively stable after 
incentives were removed. However, the authors stressed that there were caveats as all the indicators 
they had investigated remained indirectly or partially incentivised by other indicators, which may 
explain why the withdrawal of incentives appeared to have had no effect. Consequently, findings from 
the more recent Minchin et al and Wilding et al studies are more comparable to those in this thesis.  
In summary, findings from this thesis have reinforced the evidence that removal of incentives resulted 
in an immediate and significant decline in indicator performance.  
8.5 Strengths and limitations of this thesis  
This section considers strengths and limitations specific to this thesis in relation to the mixed methods 
research design and the conduct of the two research studies, which consisted of a statement of 
reflexivity for the qualitative component. A more generic and detailed consideration of the strengths 
and limitations associated with the contrasting methodological approaches used is presented in 
Chapter Four (qualitative) and Chapter Six (quantitative).  
8.5.1 Mixed methods design 
Using a mixed methods design to conduct the research, guided by a pragmatic philosophical 
approach, was one of the main strengths of this thesis as it enabled the most appropriate methodology 
and methods to be selected to address the research questions (Creswell and Plano Clarke, 2011). As 
discussed in Chapter Three, using two methods from contrasting research paradigms enabled the 
thesis to explore what and why questions, as well as to examine how many and how much questions 
(Green and Thorogood, 2004) allowing the research topic to be investigated from different angles. 
Moreover, integration and synthesis of findings from the qualitative and quantitative studies generated 
deeper understanding (Bryman, 2007) about the factors which enhanced and eroded quality of care, 
uncovering findings which may not have been visible through the lens of a single method of research 
(O'Cathain et al., 2010). Furthermore, given that this thesis appears to have been the first study to 
have used a mixed methods approach to examine the effect of the QOF on quality of care, one of its 
key strengths is originality.  
However, there are a number of limitations associated with using a mixed methods approach. 
Principally, as discussed in Chapter Three, it is challenging to combine methodologies from different 
paradigms using an approach that is still relatively new (Creswell, 2015). Another challenge of using 




qualitative data during analysis and interpretation, so that the findings of the combined analysis were 
greater than the sum of their parts (Tariq and Woodman, 2013). An additional challenge is that there 
may be resistance from scientific purists with conflicting worldviews who typically display disregard 
for mixed methods studies (Bryman, 2007), which can hinder dissemination. Nevertheless, when 
mixed methods studies are well conducted they can offer new insights and enrich understanding. This 
strength has been particularly useful for this thesis during the examination of  such a complex health 
research problem (Yardley and Bishop, 2015). 
8.5.2 Qualitative study – A Statement of Reflexivity 
Reflexivity is a critical part of enhancing the validity of qualitative research, as discussed in Chapter 
Four. Consequently, as detailed below, I endeavoured to be critically reflexive of my actions and their 
outcomes throughout the entire qualitative research process:  
Design 
One of the key strengths of this thesis was determined at the design stage where the decision was 
made to research the topic from the dual perspective of patients and practitioners. Although it entailed 
more complexity, it enriched the data and provided a more balanced account of primary care from 
different viewpoints. Given the literature on experiences of SMI in primary care has been dominated 
by studies that explored the perspectives of either patients or practitioners alone, this study makes an 
important contribution to the evidence base, building on the knowledge created by the few studies that 
have explored both SMI patient and provider views of primary care (Lester et al., 2005).  
REC approval  
Contrary to expectation from the literature (Patel et al., 2017) and my previous experience of primary 
care based studies (Gilbody et al., 2017), the Social Care Research Ethics Committee (REC) advised 
against reimbursing GPs or practice nurses for their time. This could have negatively impacted on GP 
recruitment by making it difficult for practices to commit to taking part in the study. In reality, 
however, it had virtually no effect on recruitment. There was only one instance where a GP decided 
her practice would not take part on account that the practitioners would not be reimbursed, even 
though it had been clearly stated on the study outline that GPs and practice nurses would not be 
remunerated. On the other hand, the REC positively endorsed offering patients a voucher to thank 
them for their time (Head, 2009). Interestingly the initial proposal to use a Love-to-shop voucher, 
which could have been used at multiple outlets, was rejected by the REC who specified that they did 
not consider it advisable to give patients with serious mental illness a voucher that could have been 




another example of stigma, demonstrated by the research ethics committee being overprotective of a 
vulnerable patient group (Millum et al., 2019) who they did not deem trustworthy to spend a Love-to-
shop voucher appropriately.  
Recruitment and engagement 
Whilst it proved more challenging to recruit patients with schizophrenia than patients with bipolar 
disorder, this was not entirely unexpected as a number of the GPs who I had liaised with prior to 
recruitment had suggested that it may be more difficult to engage patients with a diagnosis of 
schizophrenia. Fortunately, having envisaged it being challenging to recruit people with SMI (Bower 
et al., 2009), ethical approval and permissions were already in place to adopt alternative methods of 
recruitment that did depend on primary care, which minimised delay to the research process. 
Following recommendation by one of the study’s Expert by Experience advisers (CD), the final five 
patients were recruited via local mental health trust clozapine clinics. Being able to successfully 
recruit five additional patients with schizophrenia helped to rebalance the sample so it was more 
evenly represented by patients with diagnoses of bipolar disorder and schizophrenia. Overall, 
engagement with the study was excellent as nearly all the patients who agreed to take part completed 
their interview, with the exception of one patient who had been recruited via a clozapine clinic but 
who did not present for interview.  
Being reflexive about the process of recruitment also highlighted patient preferences for responding to 
an invitation to take part in the study. Initially, offering participants the opportunity to respond by 
completing a hand written expression of interest (EOI) form and posting it to the researcher in a pre-
stamped addressed envelope seemed a little outmoded, but in reality this proved the most popular way 
of responding as nearly two thirds of the sample opted to post back the EOI. The remainder of the 
sample used email or telephoned the landline number to confirm their interest in the study. Not one 
single patient contacted the researcher using the mobile phone number provided, which was 
somewhat surprising considering evidence from the literature (Young et al., 2019 ). This finding may 
be useful though in informing future studies about the benefit of including a written postal response 
option for this patient group. 
Expert by Experience advisers 
Another important contribution made the Expert by Experience advisers for this thesis related to 
designing patient materials and topic guides. Advisers played a central role in refining documents for 




invitation (see Chapter Four). They were particularly helpful in recommending changes to language 
and vocabulary to make it less academic and easier to read and comprehend (Gilbert and Stickley, 
2012). Furthermore, they advised on key aspects of the topic guide, stressing the importance of an 
opening narrative question to encourage participants to tell their story and feel comfortable speaking 
to the researcher, which echoed findings in the literature (Newman et al., 2017). Again, they 
recommended changing certain terms to make the language more meaningful for the target audience, 
for example, replacing the term ‘medication’ with ‘meds’ which was deemed more akin to how SMI 
patients would speak. 
Qualitative data collection  
During the process of data collection I made a conscious effort to be reflexive by following a number 
of procedures. First, I made notes at the end of each interview to record initial thoughts and 
observations about the participants and their living environment (Pope and Mays, 2006). Second, I 
tried my best to remain impartial and not to ask leading questions or to interrupt prolonged silences 
where participants took lengthy time to consider their responses. Finally, I focused on actively 
listening and responding to what participants had said rather than being governed by an agenda and 
moving swiftly on to the next topic (Abrahams, 2017).  
Generalisability 
As described in Chapter Four, due to the small sample size of the qualitative study it is difficult to 
make generalisations about the wider population of general practice practitioners or SMI patients. 
While the study sample contained a diverse range of views and experiences there are a number of 
factors that limit its representativeness.  
First, the practitioner sample was under-represented by female GPs and it had no representation from 
male practice nurses. Second, although the patient sample had a relatively even distribution of patients 
with different diagnoses (eleven with bipolar disorder and eight with schizophrenia),  similar to 
gender (eleven men and eight women), schizophrenia was disproportionately represented by men  (six 
males and two females). Furthermore, even though the age range for both diagnostic groups in the 
sample was relatively broad (spanning across four to five decades, with similar mean ages in the mid-
fifties), the patient sample was under-represented by young people.  
In addition, the study sample was recruited from research active practices which may not have been 
representative of practices in general. Moreover, the practitioner sample was represented by GPs and 
practice nurses who were interested in mental health and health research. Similarly, the patient sample 




interviewed tend to be healthier and have fewer unmet needs than those patients who are harder to 
reach (Ellard-Gray et al., 2015).  
Finally, the study sample contained no ethnic diversity as all participants identified as White British. 
This may reflect the demographics of where participants were recruited from as apart from two 
practices in Leeds the rest of the sample were recruited from practices in Harrogate, York, Hull, and 
the rural areas in between, which have fewer ethnic minorities compared with the larger urban areas 
within the Yorkshire and Humber region. Alternatively, it may reflect a lower uptake by ethnic 
minorities to participate in research as reported in the literature (Woodall et al., 2010). However, 
despite these limitations it should be remembered that qualitative research does not seek to be 
representative (Creswell, 2007).  
Safeguarding participants 
On reflection, the safeguarding of participants should have extended to practitioners as well as to 
patients. It would have been beneficial to have considered how to safeguard against distress and 
potentially difficult issues which may have arisen during practitioners’ discussion about the care 
provided for vulnerable SMI patients with complex needs (Guillemin and Gillam, 2016). Furthermore, 
consideration should have been given to the potential for practitioners to disclose sensitive 
information in relation to whistle blowing or revealing possible malpractice (Baez, 2002).  
In summary, consistently engaging in a process of reflexivity allowed me to consider aspects of the 
qualitative research that worked well, as well as to critically examine elements that were more 
challenging. Practicing reflexivity has enabled me to further develop my skills as an independent 
researcher. 
8.5.3 Quantitative study 
Data source – electronic health records 
One of the principal strengths of this thesis was that is used observational data (electronic health 
records) from the CPRD database, which enabled access to a large sample of SMI patients containing 
high quality data (Kontopantelis et al., 2018). Given that since the introduction of QOF in 2004 (Khan 
et al., 2010) data have been consistently well recorded, the data analysed during the timeframe of this 
thesis (2011-2016) were all up-to-standard and comprehensively recorded. Furthermore, as the data 
were recorded at the patient level they provided a rich granular dataset. The benefit of this, compared 
with using other primary care data such as NHS Digital – recorded at the practice level – is that it 




However, there were a number of limitations to using CPRD as a data source. First, given that the 
dataset contained multiple data linkages, including HES and ONS, the number of eligible patients was 
substantially reduced (Herrett et al., 2015). Even so, the sample size remained large enough to ensure 
there was sufficient power to conduct statistical analysis, despite a fall in the number of patients 
during the study. While it is not clear exactly why patient numbers declined throughout the study 
period, a number of factors may have contributed to this decline. For instance, if a patient was 
removed from a practice, either by moving to another practice or were deceased, they were not 
replaced by new patients so the overall number of patients declined. Furthermore, there was a decline 
in the number of practices year on year which can be explained by a combination of practice mergers, 
in addition to a decline in the proportion of practices contributing data to CPRD as Vision (the clinical 
computer system providing data to CPRD) occupied an increasingly smaller share of the market 
compared with competitors such as EMIS and SystmOne  (Kontopantelis et al., 2018). 
The second limitation related to data access, which involved a change to the data specification and a 
lengthy delay. As discussed in Chapter Six, the original plan had been to access a CPRD dataset 
remotely via the CALIBER platform at UCL, but this proposition had to be shelved due to licensing 
complications arising from the introduction of GDPR. While the EMERALD dataset (Bellass et al., 
2019) proved a valid replacement, changing to a different database did have limitations. Principally, 
despite having a large sample of SMI patients, it also included patients without SMI. Consequently, 
this thesis used a sample with fewer SMI patients than originally planned for, though as mentioned 
above there was still sufficient power to conduct analysis., Furthermore, the delay caused by 
discovering the CALIBER platform could not deliver data access to external institutions, and then 
having to obtain a replacement dataset, substantially limited the time available for analysis.  
Quasi-experimental methods 
Following a different-in-differences approach was one of the principal strengths of this thesis given 
that it is regarded as the quasi-experimental design that gets closest to being able to measure causal 
inference (Wing et al., 2018).  Moreover, following a quasi-experimental design to analyse real world 
data resulted in findings that have stronger external validity than the gold standard method of 
randomisation (Kontopantelis et al., 2015a). Consequently, the findings are more representative of 
what happens in practice and arguably more useful than experimental studies for informing health 
policy (Shadish et al., 2002).  
However, there were limitations associated with using a difference-in-differences design. First, 
several assumptions had to be met to ensure internal validity including the ‘parallel trends’ and 




lower attainment of all indicators in 2012/13 was inconsistent with data for the other financial years. It 
is unclear why this happened and what caused the drop in performance for all indicators in that year. 
While it is possible that the introduction of the Health and Social Care bill in 2012 could have 
negatively impacted on practices’ QOF performance, there is no direct evidence from this thesis to 
support this. There were also limitations associated with using regression models for secondary 
outcome analysis. Primarily this related to data quality as missing data or inconsistently recorded data 
would have limited the strength of data analysis (Bland, 2015). However, as discussed in Chapter Six, 
CRPD data were consistently recorded throughout the dataset used for this thesis and missing data 
was minimal. This compares similarly to other studies, which have reported CPRD data to be of high 
quality (Ride et al., 2018). 
Health checks – data issues   
One limitation of this study was that it only documented patients who had received a health check in 
primary care, and patients who had health checks elsewhere could have been missed. Some patients 
with SMI may have had a health check conducted in a different setting (secondary care mental health 
trust) which would not have been recorded in primary care. Because these data were not included in 
the CPRD dataset, this thesis may have underestimated how many patients had a health check each 
year. Moreover, at the same time QOF incentives were removed in primary care for (BMI, glucose 
and cholesterol), a CQUIN incentive was introduced for mental health trusts to carry out physical 
health checks on patients under their care (England, 2014). However, the absence of a shared IT 
system between primary and secondary care data sharing is an ongoing issue, which makes it 
challenging for researchers to obtain a complete picture (NHS England, 2016).  
An additional limitation regarding health checks is that, due to time pressures discussed earlier, it was 
not possible to compare the rate of health checks for SMI patients with the rate for the general 
population. NHS health checks for the general ‘healthy’ population, sometimes referred to as an 
‘MOT’, were introduced in 2009 with the aim of preventing people developing long term conditions 
(Robson et al., 2016). People aged 40-74 years were invited to have a check once every 5 years to 
assess their risk of heart disease, stroke, kidney disease and diabetes (Public Health England, 2021). 
So far there is limited evidence whether these NHS health checks were effective (Bunten et al., 
2020)and observed uptake and attendance is lower than anticipated (Martin et al., 2018). Moreover, 
there is uncertainty about whether participants in this study aged 40 and above were invited for a 
general health check because of their age or invited for a health check because they had a diagnosis of 
SMI. However, NHS health check invitations are once every 5 years compared with the QOF SMI 
physical health checks, which are annual, meaning that most participants in this study recalled 




8.6 Synthesis of findings  
8.6.1 Integration of findings 
Findings from the qualitative and quantitative studies were synthesised using a process of 
triangulation (Denzin, 1978). As defined in Chapter Three, the process of triangulation used for this 
thesis referred to using different methods to gain a more complete picture of the problem being 
investigated (O'Cathain et al., 2010). By integrating findings from two contrasting paradigms, it was 
possible to relate findings about complex human experiences of the QOF and its effect on quality of 
care for people with SMI with quantitative data driven findings about removal of QOF indicators. 
This resulted in deeper understanding of the research topic than would have been possible using a 
single methodological approach (Creswell and Plano Clarke, 2011). Evidence from the qualitative and 
quantitative studies on the removal of financial incentives was corroborative with both studies 
showing that removal of incentives resulted in a decline in the proportion of SMI patients who 
received a health check. Furthermore, the qualitative evidence uncovered a possible explanation for 
the quantitative findings, enriching understanding about the factors that influenced indicator 
performance.  
Prior to the integration of findings from the contrasting paradigms, analysis from the quantitative 
study suggested that the decline in performance following the removal of incentives was economically 
driven, due to the withdrawal of financial reward. However, the qualitative evidence suggested there 
were other factors underpinning the change in practice. These included the finding that GPs viewed 
the QOF as a barrier to providing patient-centred care and thus welcomed the removal of incentives, 
which could explain the immediate and significant decline in the first year. These practitioners 
revealed that without QOF incentives they would no longer record measurements for indicators unless 
there was a clinical need, reinforcing the argument that QOF undermined clinical judgment by 
incentivising GPs to conduct health checks on all patients rather than those most at risk. This could 
explain why there was an immediate decrease in the first year followed by a levelling off, which may 
indicate that after incentives were removed GPs stopped conducting health checks on patients where  
it was deemed unwarranted. 
Summary of the two studies  
Integrating findings from the qualitative and quantitative components of this thesis resulted in a 
deeper understanding of the research problem. Patient and practitioner narratives consisted of rich 
data which identified elements of practice that enhanced or eroded quality of care. The qualitative 




biomedical model. The quantitative study, on the other hand, demonstrated that the removal of QOF 
incentives resulted in a decrease in health checks. Considering both sets of findings together adds 
value as the qualitative study explains the outcome of the quantitative study (why health checks 
declined) which can provide useful information for future policy.  
What this means for future research  
A key message from this thesis is that qualitative studies should be an integral part of research design 
rather than just an ‘add-on’ as they are critical for identifying patient and practitioner concerns and 
aspirations. While quantitative data can measure outcomes, qualitative data can offer explanation and 
insight into how care can be improved and become more patient-centred – for example, by focusing 
on their needs for daily functioning. Evidence from this thesis suggests that incentivisation pushes 
practitioners to focus on the biomedical model which reduced practitioners’ capacity to provide 
holistic, patient-centred care and reinforced the prescriptive biomedical model.  
Looking ahead, the reintroduction of QOF indicators in April 2021, which had been removed in 
March 2014, represents a significant U-turn and re-affirms the importance and topical nature of this 
thesis. While some critics will welcome the reinstallation of cholesterol and glucose indicators (NHS, 
2021), evidence from this thesis sends a warning that reverting to the same biomedical model may not 
necessarily address physical health care priorities among people with SMI. Research is therefore 
needed to identify how to adapt QOF health checks or offer an alternative, which better addresses the 
unmet psychosocial and physical healthcare needs of people with SMI. Furthermore, the COVID 
pandemic has highlighted a widening of inequalities between people with SMI and those without 
(Spanakis et al., 2021). As such, it is a critical time to be conducting research in this area in attempt to 
prevent the gap from widening.  
 
8.6.2 Integrated findings: in context of current policy and research  
Before considering the implications of this thesis for policy and practice, it is useful to place the 
findings within the context of current policy and existing programmes of research. First, a recent 
policy change flagged in Chapter Six, which consisted of the reintroduction of the BMI indicator in 
2019 (NHS England, 2019a), appears at odds with evidence from this thesis. Given there was a 
significant decline in the rate of health checks for cholesterol and glucose/HbA1c, as well as for BMI, 
it is questionable as to why only the BMI indicator was reintroduced, particularly as an abnormal BMI 
measurement is arguably more visible to practitioners than abnormal cholesterol and glucose levels, 




However, there is closer alignment between findings from this thesis and comparable studies such as 
the DIAMONDS programme of research (DIAMONDS), which is focused on improving patient self-
management of diabetes in people with SMI. Such research is also looking beyond the confines of the 
QOF and could signal a new horizon of hope for people living with SMI. Additionally, the 
SCIMITAR study (Gilbody et al., 2019) produced pioneering evidence, which showed that contrary to 
expectation SMI patients had strong aspiration to give up smoking and improve their physical health,  
and, when given a bespoke smoking cessation intervention, they could be successful.  
Evidence that SMI patients benefit from tailored support was further reinforced by a recent meta- 
review of interventions (Meader et al., 2020) conducted by the Centre for Review and Dissemination 
(CRD), which explored the merits of addressing multiple SMI risk behaviours. The CRD study found 
that people with SMI need a personalised approach to healthy living and require existing interventions 
to be carefully tailored to their needs (HEALTH Study team, 2020). Furthermore, studies examining 
the physical health of young people at risk of developing psychosis have shown that providing 
customised support to improve an individual’s physical health can enhance their self-esteem and 
positively impact on their psychological wellbeing, which increases their motivation and confidence 
to improve their daily functioning (Carney et al., 2017). 
In summary, a rising number of research studies investigating SMI health inequalities has been 
accompanied by a growth in policy interest on the topic. Indeed, an NHS England lead interested in 
improving the physical healthcare for people with serious mental illness has enquired about the 
findings from this thesis in a quest to find alternatives to the biomedical model of the QOF.  
8.7 Implications for policy and clinical practice  
Implications for policy 
Findings from this thesis have uncovered considerable uncertainty on the policy front about how best 
to manage the physical health needs of SMI patients and reduce the mortality gap. The key findings 
point towards a need to: 
 Look beyond the QOF as a means of enhancing the quality of primary care for SMI patients 
as findings from this thesis indicate the QOF is too focused on the biomedical model of 
recording measurements at the expense of person-centred care.  
 Invest more resources in social prescribing to support SMI patients to make healthy lifestyle 




lack of robust research evidence on patient outcomes for social prescribing (Husk et al., 
2019), there are signs emerging that it can improve quality of life (Skivington et al., 2018) by 
empowering patients to take greater control over their health (Kimberlee, 2013).  
 Improve communication and contact between primary and secondary care, which underpins 
evidence from a recent King’s Fund report that highlighted the need for closer alignment 
between primary care and mental health trusts (Naylor et al., 2020). Findings from this thesis 
reinforce the report’s principal message that current arrangements for mental health in 
primary care are inadequate and do not serve the interests of patients or professionals. 
Furthermore, it recommended that primary care networks increase investment in mental 
health resources in general practice, ensuring they are carefully tailored to meet local need 
(Dixon Woods et al., 2005, Dixon-Woods, 2014) for effective implementation of NHS 
England’s Community Mental Health Framework.  
Implications for clinical practice 
Findings from this thesis have identified a need to: 
 Rebalance primary care priorities to ensure patients with SMI are no longer marginalised. 
Rather, they are accorded the same level of resources and quality of care as patients with 
other chronic conditions. 
 Provide training on mental health, including specifics on serious mental illness, for all 
employees within practices, including receptionists who are typically the first point of contact 
for assessing the urgency of care. 
 Enhance the role of practice nurses so they can deliver more aspects of care to SMI patients, 
capitalising on the extra time they may be able to give patients compared with GPs who are 
governed by increasing time constraints. 
8.8 Recommendations for future research 
Findings from this thesis have raised other important research questions, which could be investigated 
by future research studies:  
 Explore the role of incentives targeted at patients to find out what motivates people with SMI 




 Critically evaluate how digital technology could be used to enable patients to establish more 
regular and sustained contact with practitioners, and to promote the sharing of information 
and healthy living advice.  
 Conduct research specifically targeted at groups who were not part of this qualitative study, 
namely people from a non-White ethnic origin and those identifying as a gender alternative to 
male/female, to explore outcomes of marginalised groups.  
 Research geographical differences in perceptions of quality of primary care to identify if there 
are particular regions or localities where patients and practitioners report better or worse 
outcomes, to investigate the importance of place.  
 Explore perceptions of quality of care for the most vulnerable group of SMI patients with 
respect to the late Helen Lester’s James McKenzie Lecture 2012 Bothering about Billy 
(Lester, 2013). To investigate what matters to those people with the highest level of unmet 
need who often disengage and become invisible in primary care, defined as the inverse care 
law (Tudor Hart, 1971). 
 Conduct ethnographic research to explore the interactions between patients and practitioners 
during consultations. To gain an alternative, more nuanced interpretation of the exchange of 
information and communication between patient and GP.  
 Conduct experimental research using randomisation to test the effectiveness of social 
prescribing. 
8.9 Conclusion 
Findings from this thesis have unearthed high levels of unmet patient need. Despite growing interest 
in addressing the mortality gap, policy has thus far focused on a biomedical approach in attempts to 
extend life expectancy at the expense of addressing what matters to patients, namely how to enhance 
their daily functioning and improve their quality of life. This thesis has provided valuable evidence on 
factors affecting the quality of care for people with serious mental illness from both the patient and 
provider perspective. It has shown that currently the delivery of primary care to this patient group is 
inadequate: practitioners felt disempowered and too pressed for time to provide person-centred care; 
patients felt there was no time or scope for them to share their concerns, which prevented them being 
treated as a whole person. Future policy needs to draw on evidence from this thesis and comparable 
studies to raise expectations for people with SMI and begin listening to their call to be treated as a 




more time in primary care for this group would likely have added value longer-term and avoid a need 
to access more costly health services.  
Finally, it is a grave social injustice that people with SMI die 15-20 years earlier than the general 
population. Moreover, evidence showing the mortality gap is widening deepens this inequity. People 
with SMI deserve parity of esteem and they deserve to be granted the same quality of physical 
healthcare as those without SMI. The key message from this thesis is that we need to actively listen to 
people with SMI and to treat them as experts of their condition, so they can effectively inform 
research and policy development: to ensure future practice better meets their needs. In conclusion, this 
thesis has provided unique insight into the pressing need to enable people living with SMI to live well 
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Appendix 4. 1    REC approval 
 
 
   
 Social Care REC  
Ground Floor  
Skipton House  
80 London Road  
London  
SE1 6LH  
  
  
 Please note: This is the  favourable opinion of the  REC only and does not allow  you 
to start your study at NHS  sites in England until you  receive HRA Approval   
   
  
19 June 2017  
  
Ms Katharine Bosanquet  
ARRC Building Area 4, Dept. of Health Sciences,  
University of York, Heslington, York  
YO105DD  
  
Dear Ms Bosanquet   
  
Study title:  Meeting the physical healthcare needs of people with 
serious mental illness in primary care  
REC reference:  17/IEC08/0025  
IRAS project ID:  
  
225235  
Thank you for your letter responding to the Committee’s request for further information on 
the above research and submitting revised documentation.  
  
The further information has been considered on behalf of the Committee by the Chair.  
  
We plan to publish your research summary wording for the above study on the HRA website, 
together with your contact details. Publication will be no earlier than three months from the 





further information, or wish to make a request to postpone publication, please contact 
hra.studyregistration@nhs.net outlining the reasons for your request.  
Confirmation of ethical opinion  
  
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 
documentation as revised, subject to the conditions specified below.  
  
Conditions of the favourable opinion  
  
Management permission must be obtained from each host organisation prior to the start of the 
study at the site concerned.  
  
Management permission should be sought from all NHS organisations involved in the 
study in accordance with NHS research governance arrangements. Each NHS 
organisation must confirm through the signing of agreements and/or other documents 
that it has given permission for the research to proceed (except where explicitly 
specified otherwise).   
Guidance on applying for NHS permission for research is available in the Integrated 
Research Application System, www.hra.nhs.uk or at http://www.rdforum.nhs.uk.    
  
Where a NHS organisation’s role in the study is limited to identifying and referring 
potential participants to research sites ("participant identification centre"), guidance 
should be sought from the R&D office on the information it requires to give permission 
for this activity.  
  
For non-NHS sites, site management permission should be obtained in accordance 
with the procedures of the relevant host organisation.   
  
Sponsors are not required to notify the Committee of management permissions from 
host organisations  
  
Registration of Clinical Trials  
  
All clinical trials (defined as the first four categories on the IRAS filter page) must be registered 
on a publically accessible database within 6 weeks of recruitment of the first participant (for 
medical device studies, within the timeline determined by the current registration and 
publication trees).    
  
There is no requirement to separately notify the REC but you should do so at the earliest 
opportunity e.g. when submitting an amendment.  We will audit the registration details as 





To ensure transparency in research, we strongly recommend that all research is registered but 
for non-clinical trials this is not currently mandatory.  
  
If a sponsor wishes to request a deferral for study registration within the required timeframe, 
they should contact hra.studyregistration@nhs.net. The expectation is that all clinical trials 
will be registered, however, in exceptional circumstances non registration may be permissible 
with prior agreement from the HRA. Guidance on where to register is provided on the HRA 
website.    
  
It is the responsibility of the sponsor to ensure that all the conditions are complied 
with before the start of the study or its initiation at a particular site (as applicable).  
  
  
Ethical review of research sites  
  
Non-NHS sites  
 The Committee decided that the research did not require Site-Specific Assessment at non-NHS sites 
as it involves no clinical interventions and the Committee was satisfied that the risk to participants is 
likely to be negligible, and the study procedures will not significantly interfere with participant’s 
freedom of action or privacy or be unduly invasive or restrictive.  
  
Approved documents  
  
The final list of documents reviewed and approved by the Committee is as follows:  
Document    Version    Date    
Covering letter on headed paper         
Evidence of Sponsor insurance or indemnity (non NHS Sponsors only)      18 July 2016   
GP/consultant information sheets or letters   2.2   18 May 2017   
GP/consultant information sheets or letters   2.2   18 May 2017   
Letter from funder      25 August 2016   
Letters of invitation to participant   2.1   17 February 2017   
Letters of invitation to participant   2.1   23 February 2017   
Letters of invitation to participant   2.1   23 February 2017   
Other [CRN engagement]      10 April 2017   
Other [CV of Supervisor]         
Other [Background information]   2.1   23 February 2017   
Other [Safeguarding policy]   2.2   19 June 2017   
Participant consent form   2.2   22 May 2017   
Participant consent form      17 February 2017   




Research protocol or project proposal   2.3   19 June 2017   
Summary CV for Chief Investigator (CI)      01 February 2017   
  
Statement of compliance  
  
The Committee is constituted in accordance with the Governance Arrangements for Research 
Ethics Committees and complies fully with the Standard Operating Procedures for Research 
Ethics Committees in the UK.  
  
After ethical review  
  
Reporting requirements  
  
The attached document “After ethical review – guidance for researchers” gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including: 
• Notifying substantial amendments  
• Adding new sites and investigators  
• Notification of serious breaches of the protocol  
• Progress and safety reports  
• Notifying the end of the study  
  
The HRA website also provides guidance on these topics, which is updated in the light of 
changes in reporting requirements or procedures.  
User Feedback  
  
The Health Research Authority is continually striving to provide a high quality service to all 
applicants and sponsors. You are invited to give your view of the service you have received 
and the application procedure. If you wish to make your views known please use the feedback 
form available on the HRA website:  
http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance/     
  
HRA Training  
  
We are pleased to welcome researchers and R&D staff at our training days – see details at 
http://www.hra.nhs.uk/hra-training/   
  
17/IEC08/0025                          Please quote this number on all correspondence  
  
With the Committee’s best wishes for the success of this project.  
  





PP Dr Martin Stevens Chair  
  
Email: nrescommittee.social-care@nhs.net    
  
Enclosures:    “After ethical review – guidance for researchers” [SL-AR2]  
  
Copy to:  Ms Katharine Bosanquet  


















Appendix 4. 3     Safeguarding Vulnerable Research Participants                                                                                                                                                            
 
The following principles and procedures will govern the safeguarding of research participants 
during the interview study.  
People with serious mental illness are vulnerable research participants and require 
safeguarding. Although participants will not be asked any questions on suicide ideation, they 
may become distressed when talking about their physical health or the challenges they face 
navigating the health system. The researcher (chief investigator) will follow a humanist 
approach to this protocol when conducting participant interviews and will be alert to any 
potential vulnerability. 
Three main types of concern: 
A) Participant distress (quite likely) 
B) Non-suicide risk (less likely) 
C) Suicide risk (unlikely – exceptional circumstances) 
 
A) Participant distress and discomfort 
 If a participant becomes distressed while answering questions about their medical 
care, the researcher will stop the interview, listen carefully to their concerns and give 
them time and space to calm down and decide whether or not they want to continue 
with the interview. 
 Before recommencing the interview (if desired), the researcher would ask the 
participant about what other means of support they have from family and friends.  
 The researcher would also advise the participant to contact their GP or mental health 
team for support and signposting.  
 The researcher could suggest other sources for support, such as social services or 
Third Sector organisations, but as not qualified to offer professional advice, the 
participant’s GP or mental health team is the preferred option.   
_________________________________________________________________________ 
If a participant discloses risk, either to themselves or someone else, the researcher will stop 
the interview and listen calmly to what they say. The risk may be non-suicidal or suicidal.  
B) Non-suicide risk 
Instances of non-suicide risk may include, but are not restricted to: 
- Risk to others 
- Self-neglect  
- Risk from others (this includes events such as domestic violence) 




 If a participant discloses any information which raises concern, the researcher will 
stop the interview and discuss the concern with the participant and ask them what 
they would like the researcher to do. However, the researcher will also acknowledge 
that in some circumstances, he or she will have to break confidentiality without the 
consent of the participant. 
 If the participant would like the researcher to call the supervisor for advice, but the 
supervisor is unavailable to speak on the phone, the researcher will arrange to get 
back to the participant, once they have sought guidance from their supervisor.  
 The researcher would also advise the participant to contact their GP or mental health 
team for support and signposting. 
 To document the course of action, the researcher will complete the Non-Suicide Risk 
Form (Appendix 1) which, once countersigned and dated by the clinical lead, will be 
filed in the participant’s personal (non-data) file. 
 
C) Suicide risk 
 If a participant indicates that they are at risk of self-harm or have suicidal thoughts, 
the researcher will contact the clinical lead (supervisor) immediately by telephone in 
order to involve a supervisory clinician to discuss the level of risk and the necessary 
actions to take. 
 If the researcher is unable to contact the clinical lead they will contact the 
participant’s GP or mental health team. Even if a participant objects to this, the 
researcher will override their wishes and enact the breaching confidentiality 
statement from the patient information sheet and consent form: ‘Everything you 
say/report is confidential unless you tell us something that indicates you or someone 
else is at risk of harm’, and contact the GP/mental health team directly.  
 If necessary, if the participant displays active suicide ideation, the researcher will call 
a taxi to take the participant to A&E. The researcher would accompany the 
participant to A&E and not leave the participant until a clinician has taken 
responsibility for their care.  
 To document the course of action, the researcher will complete the Suicide Risk 
Form (Appendix 2) which, once countersigned and dated by the clinical lead, will be 




Appendix 1: Non-Suicide Risk Form 
The participant below has been identified as being a risk (other than self- harm/ suicide) 
during a qualitative interview.  
 
 
Participant ID Code:    
  
 








Yes  No  
Has the GP/MHT been contacted by the researcher? 
 
 
Yes  No  





Yes  No  
 
Summary of actions taken: 
 
(What advice was given by clinical lead, if spoken to? Was risk judged as passive or active? If GP 











Researcher Name: …………………………......................................................... 
 
Research Signature: ………………………………………  Date: ……………….. 
 
 
Name of Clinical Contact: ………………………….............................................. 
 
Clinical Contact Signature: …………………………….  Date: …………………. 
 
T P 




Appendix 2: Self- Harm / Suicide Risk Form 
 
The patient below has expressed thoughts of suicidal intent / self-harm during a qualitative 
interview.  
 
Participant ID Code:    
  
 








Yes  No  
Has the GP/MHT been contacted by the researcher? 
 
 
Yes  No  





Yes  No  
 
Summary of actions taken: 
 
(What advice was given by clinical lead, if spoken to? Was risk judged as passive or active? If GP 











Researcher Name: …………………………......................................................... 
 
Research Signature: ………………………………………  Date: ……………….. 
 
 
Name of Clinical Contact: ………………………….............................................. 
 
Clinical Contact Signature: …………………………….  Date: ………………….
T P 


























































































Appendix 6. 1   Original ISAC approval 
 
ISAC EVALUATION OF PROTOCOLS FOR 
RESEARCH INVOLVING CPRD DATA 
 
FEEDBACK TO APPLICANTS 
 
CONFIDENTIAL                                                                       by e-mail 
PROTOCOL NO: 18_054RA 
PROTOCOL TITLE:  




NIHR Doctoral Research Fellow 
Department of Health Sciences 




APPROVED WITH COMMENTS  










Protocols with an outcome of ‘Approved’ or ‘Approved with comments’ do not require resubmission to the 
ISAC. 
 






DATE OF ISAC FEEDBACK: 09/07/18 
DATE OF APPLICANT FEEDBACK:  
 
For protocols approved from 01 April 2014 onwards, applicants are required to include the ISAC 
protocol in their journal submission with a statement in the manuscript indicating that it had been 
approved by the ISAC (with the reference number) and made available to the journal reviewers. If 
the protocol was subject to any amendments, the last amended version should be the one submitted. 
 
** Please refer to the ISAC advice about protocol amendments provided below** 
 
Amendments to protocols approved by ISAC    Version June 2015 
During the course of some studies, it may become necessary to deviate from a protocol which has 
been approved by ISAC. Any deviation to an ISAC approved protocol should be clearly documented 
by the applicant but not all such amendments need be submitted for ISAC review and approval. The 
general principles to be applied in regard to the need for submission are as follows: 
 Major amendments should be submitted 
 Minor amendments need not be submitted (but must still be documented by the applicant and 
should normally be mentioned at the publication stage) 
 
In cases of uncertainty, the applicant should contact the ISAC secretariat for advice quoting the 




We consider an amendment as major if it substantially changes the study design or analysis plan of 
the proposed research. An amendment should be considered major if it involves the following 
(although this is not necessarily an exhaustive list): 
 A change to the primary hypothesis being tested in the research 
 A change to the design of the study 
 Additional outcomes or exposures unrelated to the main focus of the approved study* 
 Non-trivial changes to the analysis strategy  
 Not performing a primary outcome analysis 
 Omissions from the analysis plan which may impact on important validity issues such as 
confounding 
 Change of Chief Investigator 




 Any new proposal involving contact with health professionals or patient or change in regard 
to such matters 
 
* N.B. extensive changes in this respect will require a new protocol rather than an amendment - if in 
doubt please consult the Secretariat 
 
Minor Amendments 
Examples of amendments which can generally be considered minor include the following: 
 Change of personnel other than the Chief Investigator (these should be notified to the 
Secretariat) 
 A change to the definition of the study population, providing the change is mentioned and 
justified in the paper/output [NB previously major] 
 Extension of the time period in relation to defining the study population 
 Changes to the definitions of outcomes or exposures of interest, providing the change is 
mentioned and justified in the paper/output [NB previously major] 
 Not using linked data which are part of the approved protocol, unless the linked data are 
considered critical in defining exposures or outcomes (in which case this would be a major 
amendment) 
 Limited additional analysis suggested by unexpected findings, provided these are clearly 
presented as post-hoc  
 Additional methods to further control for confounding or sensitivity analysis provided these 
are to be reported as secondary to the main findings 
 Validation and data quality work provided additional information from GPs is not required 
 
To submit an amendment of protocol to the ISAC, please submit the following documents to the 
ISAC mailbox (isac@cprd.com)  
1. A covering letter providing justification for the request  
2. A completed and, if necessary, updated application form with all changes highlighted; if new 
linkages are required the current version of the ISAC application form must be completed. Otherwise, 
the original form may be amended as necessary 
3. The updated protocol document containing the heading 'Amendment' at the end of it. Please 
include all amendments to the protocol under this heading. No other changes should be made to the 
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Appendix 6. 3     EMERALD data specification   
 
EMERALD: Exploring Mental Illness and Diabetes through a Longitudinal Data study 










Summary of Changes 
 
Date 
0.1 Initial Draft Jessie Oyinlola n/a 08/01/2018 
0.2 Modified Sonia Cotton Quality Assurance 10/01/2018 




0.4  Modified  Jessie Oyinlola 
Updates to Data 
specification following 
review and further 
comments 
22/01/2018 
0.5 Modified  Najma Siddiqi 
Comments regarding 
matching and cohort 
identification 
04/02/2018 




1.0 Final Jessie Oyinlola Final 07/02/2018 
1.1 Modified Jessie Oyinlola 
Update of patient numbers 
and matching file 
02/03/2018 
1.2  Modified Jessie Oyinlola 




Prepared by:  Jessie Oyinlola [CPRD] 
Distribution:  Najma Siddiqi [University of York] 
Date: 7th February 2018 
 
Objective 
The overall aim of our research is to improve diabetes outcomes for people with Serious Mental 




determinants of diabetes and variation in diabetes outcomes for people with SMI, in order to 
identify potential healthcare interventions that can be tested further. 
The study has the following objectives: 
1. In people with SMI, to identify which socio-demographic, illness, family history and lifestyle 
factors are associated with the development of diabetes. 
2. In people with SMI and diabetes, to identify which socio-demographic, illness, family history 
and lifestyle factors are associated with variation in diabetes and mental health outcomes.  
3. In people with SMI, to compare healthcare interventions, physical and mental health 
outcomes in those with diabetes with those without diabetes. 
4. In people with diabetes, to compare healthcare interventions, physical and mental health 
outcomes in those with SMI and those without SMI. 
5. To compare diabetes care provision for people with and without SMI, and estimate costs for 
these.  
6. To identify which healthcare interventions (e.g. medication, referrals and care pathways) 
may be associated with better diabetes outcomes for people with SMI and diabetes. 
 
Study design:  
A retrospective cohort study 
Source Population 
The extraction population will comprise of all acceptable patients in CPRD (from the most recent 
snapshot available; December 2017) 
Data to be supplied:  
Primary Care (GOLD) data with ONS Death Registration, Full HES, Practice Level Index of Multiple 
Deprivation and Patient Level Index of Multiple Deprivation data (from Set 15) 
Cohort definition in CPRD GOLD 
From the source population in CPRD GOLD: 
 15,160,693 patients are acceptable1 
 15,160,196 patients meet gender criterion (Male and Female Only) 
 7,985,853 patients are eligible for the linkages required (this also means that patients will only 





From the cohort population in CPRD GOLD: 
                                                          
1 Acceptable patients are identified within the CPRD using pre-defined criteria (see Glossary Terms - 
Acceptable & UTS.pdf) 





 Inclusions  
o 70,622 patients had a record of SMI recorded in their Clinical or Referral File based on 
specific medical codes (See Appendix 1). 
o 48,408 patients had a record of SMI so that at least one event occurs within the study 
period (01/04/2000– 31/03/2016). Patients could have a record for SMI prior to the start 
of the study period. 
o 47,742 patients were aged 18 and above on the date of their diagnosis of SMI. 
o 32, 759 patients had the above events within their up-to-standard (UTS2) follow-up 
period 
 
 Exclusions  
None 




From the Dataset A population in CPRD GOLD: 
 Inclusions  
o 3,296 patients had a record of Type 2 Diabetes recorded in their clinical or referral file 
based on specific medical codes (See Appendix 2). 
o 3,296 patients were registered during the study period (01/04/2000– 31/03/2016). 
o 3,295 patients were aged 18 and above on the date of their diagnosis of Type 2 
Diabetes. 
o 2,805 patients had the above events within their up-to-standard (UTS) follow-up period 
 
 Exclusions  
o 44 patients had a record (in their clinical or referral file) for Type 1 Diabetes after the 
date of their diagnosis of Type 2 Diabetes (Appendix 3). 
 
The total number of patients in Dataset B was 2,761.  
 
Follow-up definition 
The start of follow-up will be defined as the latest of the patient registration date, the practice UTS 
date and 01/04/2000. The end of follow-up will be defined as the earliest of the patient transfer out 
date, the practice last collection date, the CPRD GOLD derived death date and 31/03/2016.  
 
Index date 
The index date is defined as the first record of a clinical diagnosis of Type 2 Diabetes between 
01/04/2000– 31/03/2016.  
                                                          






Control definition and matching (Dataset C) 
Up to four matched controls will be provided for each case in Dataset B. The controls (Dataset C) will 
comprise of patients from the source population who: 
o Had a record of Type 2 diabetes recorded in their clinical or referral file based on specific 
medical codes (See Appendix 2) (287,399 patients) 
o Had a record of Type 2 diabetes so that at least one event occurs within the study period 
01/04/2000– 31/03/2016 (243,859 patients)  
o were aged 18 and above on the date of their diagnosis of Diabetes (243,619 patients) 
o had the above events within their up-to-standard (UTS) follow-up period (197,716 
patients) 
Exclusions 
o had a record of SMI (ever) in their clinical or referral file (4,191 patients) 
o had a record (in their clinical or referral file) for Type 1 Diabetes (Appendix 3) after the 
date of their diagnosis of Type 2 Diabetes (2,914 patients). 
 
The total number of potential controls in Dataset C was 190,611. Data will only be provided for 
controls who are matched to a case.  
 
Controls will be matched based on: 
o Year of birth (within -/+ 2 years)  
o Gender and 
o GP practice  
 
Matching method 
Age at study start Matching 
CPRD will be using Age at study start matching. In this algorithm, the age of the case patient at the 
study start an event occurred, must match the age of the control patient at the study start within a 
given range.  




 The clients are aware that their codelists for Type 1 and Type 2 diabetes does not contain 
any of the generic diabetic codes (codes without a specific diagnosis of Diabetes e.g. 
“diabetic retinopathy”) nor are they identifying/ excluding patients based on prescriptions 
for anti-diabetic drugs. Therefore they may not capture all Type 2 Diabetic patients or 
exclude all Type 1 Diabetic patients as there may be instances where a patient will not have 




may have other forms of evidence for the type of diabetes they have (e.g. the medications 




A single dataset will be supplied containing all of the data for the patients of interest. This will 
contain no more than 42,332 patients. The full suite of primary care (GOLD) data will be supplied for 
the patients of interest and the linked data. 
 
Please note, a request for re-extraction of data will incur data costs.  
 
Data to be supplied  
1. Case file (see below) 
2. Matching file (See below) 
3. Practice list (See below) 
4. Primary care data (see CPRD GOLD Full Data Specification.pdf) 
5. Full HES APC (see Data_Dictionary_HES Full_set15_v2.0) 
6. ONS Death Registration data (see Documentation_Death_set15_v1.7.pdf) 
7.  Patient level deprivation data in 2010 in twentiles (see 
Documentation_SmallAreaData_Patient_set15_v2.3.pdf) 
8. HES Outpatient (see Documentation_HES_OP_set15_v1.6.pdf) 






Field name Description 
Patient 
identifier 
patid  The encrypted unique identifier given to a patient in CPRD 
SMI date smidate The date of an SMI diagnosis  
Medical 
Code 




The latest of the practice up-to-standard date, 01/04/2000 and the 




The earliest of the practice last collection date, the patient transfer out 
date, the CPRD GOLD derived death date and 31/03/2016. 
Medical 
Code 






The Matching file (17_161R_Matching_file.txt) contains the details of which cases (in Cohort B) 









The encrypted unique identifier given to a patient in the CPRD GOLD: 




The encrypted unique identifier given to a specific practice in 
CPRD GOLD: 






Listed for cases 
Birth year case_birthyear 
Patient’s birthyear: 




The latest of the practice up-to-standard date, 01/04/2000 and the 
patient first registration date: 




The age of the patient in the year of their start of follow up: 
Listed for cases 
Number of 
matches 




The encrypted unique identifier given to a patient in the CPRD GOLD: 
Listed for controls. Where a control could not be matched to a case this 




The encrypted unique identifier given to a specific practice in 
CPRD GOLD: 
Listed for controls. Where a control could not be matched to a case this 






Listed for controls. Where a control could not be matched to a case this 
field is empty. 
Birth year control_birthyear 
Patient’s birthyear: 
Listed for controls. Where a control could not be matched to a case this 




The latest of the practice up-to-standard date, 01/04/2000 and the 
patient first registration date: 
Listed for the controls. Where a control could not be matched to a case 




The age of the patient in the year of their start of follow up: 
Listed for controls. Where a control could not be matched to a case this 





The Practice list file (17_161R_Practice_list_file.txt) contains the number of patients registered at 
each practice included in the study. 
 
Practice List file 

















Appendix 7.1 Data preparation 
 
Summary of the processes involved in the preparation of data for analysis: 
 Cleaning and coding the dataset 
 Check data for missing values and data entry errors 
 Ascertaining participant eligibility  
 Source relevant read codes for each health check 
 Import clinical test files to merge each with readcode/medcode files 
 Append all clinical and test files for each health check 
 Convert wide patient data file to long format – reshape command in Stata 










BMI: Body Mass Index 
BMA: British Medical Association  
COPD: Chronic Obstructive Pulmonary Disease 
CPRD: Clinical Practice Research Datalink 
CRN: Clinical Research Network 
CVD: Cardiovascular Disease 
DNA: Did Not Attend 
DSM: Diagnostic and Statistical Manual of Mental Disorders 
EHR: Electronic Health Record 
GP:  General Practitioner 
HES: Hospital Episode Statistics 
HSCIC: Health and Social Care Information Centre  
ICD: International Classification of Diseases 
IT: Information technology 
ITS: Interrupted Time-Series  
NHS: National Health Service  
NICE: National Institute for Health and Care Excellence 
OECD: Organisation for Economic Cooperation and Development  
ONS: Office of National Statistics 
PN: Practice Nurse 
QOF: Quality and Outcomes Framework 
RCT: Randomised Controlled Trial 
SMI: Serious Mental Illness 
THIS: The Health Improvement Network 
UCL: University College London 
UNSW: University of New South Wales 
UK: United Kingdom 
US: United States 
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